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 Abstract 
 
1 
Abstract 
 
Cochlear implants (CIs) constitute the interface between the sound-deprived brain of patients 
suffering from sensorineural hearing loss and the auditory scene surrounding them. By electrically 
stimulating the auditory nerve (AN), CIs mimic coding principles of the cochlea and provide the 
user with auditory information, enabling speech comprehension in half a million implantees. 
Unfortunately, current is hard to steer in the cochlear fluids, limiting the spatial selectivity and 
thus the spectral resolution of electrical hearing restoration. As light can be conveniently confined 
in space, optogenetic stimulation of the genetically modified AN might overcome this limitation. 
Indeed, cochlear optogenetics with high temporal fidelity was demonstrated upon viral gene 
transfer of ultrafast Channelrhodopsins in early postnatal mice, and field potentials in the 
auditory midbrain of transgenic mice indicated increased spectral selectivity of cochlear 
optogenetics. Furthermore, optical cochlear implants (oCIs) based on light emitting diodes have 
been developed for multi-site illumination of the AN. However, a long way remains to be gone 
before considering clinical translation. Working with adult Mongolian gerbils whose AN has been 
virally transduced with the Channelrhodopsin-variant CatCh, this thesis addresses three 
milestones towards the development of cochlear optogenetics: First, perception of optogenetic 
AN activation has been demonstrated on the behavioral level, which is essential when considering 
that oCIs must convey behaviorally relevant information to future users. Second, cochlear 
optogenetics has been demonstrated to activate the auditory pathway in a tonotopic manner and 
with increased spectral selectivity as compared to mono- and bipolar electrical stimulation. This 
finding is of uppermost importance, since clinical translation of cochlear optogenetics is only 
justified if a substantial advantage of optogenetic over electric sound encoding is to be expected. 
Third, virus-mediated gene transfer in adult gerbils has been combined with microsystems 
technology to facilitate multi-channel optogenetic AN activation. 16-channel oCIs based on 
microscale light emitting diodes enabled AN activation with higher spectral selectivity as 
compared to electrical stimulation, and hence demonstrate the feasibility of a translational oCI 
approach. Furthermore, functional activation of the AN by optogenetics has been demonstrated 
in a gerbil model of sensorineural hearing loss, both on the physiological and behavioral level. 
These results suggest that optogenetic hearing restoration is behaviorally relevant and might 
indeed overcome the major bottleneck of electrical CIs, raising hope that the quality of artificial 
sound encoding for future patients might be improved by optical cochlear implants.   
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Introduction 
 
“The brain is the most important organ, according to the brain“ 
– Unknown 
 
Starting my PhD thesis with this quote allows me to briefly share my enthusiasm for neuroscience 
with the reader: While I do not necessarily believe that the brain is the most important organ of 
the body, it is arguably the most complex and fascinating organ of the body. Not only does it allow 
us to navigate, forage and reproduce successfully in a complex environment, but also attributes 
such as emotions, high level cognition, and speech are rooted in the brain. Without our brains 
there would be nothing like relationships, visions or the thrilling joy of reward, to name only a 
few. These features not only make our lives enjoyable, but are also key features of neuroscientific 
research (and research in general), which in turn helps us to understand the organ that gives rise 
to these features. If brain function is disturbed, all of this is at risk – reason enough to motivate 
tens of thousands of researchers worldwide to understand the brain in health and disease, as well 
as finding ways to restore normal brain function. Advances in hard- and software technology as 
well as tremendous funding – due to growing public and economic interest in neuroscience – 
make the 21st century a golden age for neuroscientific research and I am really grateful to be part 
of this movement and contribute my tiny share in understanding the brain and treating neuronal 
dysfunction.  
 
 
Sensory systems and the importance of audition – a personal note 
 
Breaking the brain down to the very basics, one could argue that the brain is our survival-organ. 
By integrating various sensory inputs originating from the external world with inherited instincts 
and acquired experience of the brains internal world, it produces goal-oriented behavior 
necessary to survive and reproduce. To do so, different organisms rely on a variety of highly 
specialized senses, which allow them to accomplish this demanding task under their individual 
circumstances and in their individual environments. In case of primates – including humans - the 
basic senses which collect environmental inputs are olfaction, gustation, somatosensation, vision 
and audition (even though we actually have more senses, e.g. balance or proprioception). Even 
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though all of these senses are of great importance, I still want to make a case for audition: while 
olfaction, gustation and somatosensation are senses which scan the external world in close 
proximity to the observer, vision and audition collect also cues from far away and thus greatly 
extend the area that the organism interacts with. Both of these senses contribute tremendously 
to the basic functions that make the organism survive – like the detection of potential 
nourishment and predators as well as communication and reproduction with conspecifics. While 
vision – at least for primates – might be more important for a fast scan of the environment and 
thus improves the chances to survive for each individual, audition enables precise and efficient 
information exchange between individuals, and thus extends the environment that the organism 
interacts with also to the environment that conspecifics share their information about (both in 
space and in time). The communication humans developed during their evolution is a basic 
requirement for networking and developing sophisticated culture, ultimately leading to the highly 
complex man-environment that we live in. For this reason I believe that the sense of audition 
played a crucial role in shaping nowadays world, which makes it a fascinating object to study 
(beyond – of course - the obvious reasons that interest a sensory neuroscientist).  
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Anatomy and physiology of the auditory system 
 
The outer and middle ear:  
Each detector – which sensory systems essentially are – is specialized to detect a specific signal 
from the physical world. In case of audition, the adequate signals are pressure waves, i.e. density 
differences in the surrounding medium which fluctuate in time. These pressure waves are 
collected by the pinna of the outer ear and directed on the ossicular chain in the middle ear via 
the ear canal and the tympanic membrane (figure 1A). The ossicles – namely malleus, incus and 
stapes – convey pressure waves of the surrounding medium (typically air) arriving at the tympanic 
membrane into pressure waves in the fluid filled cochlea. Due to their anatomy, ossicles amplify 
pressure waves about 20-fold (via leverage and differences in the dimensions of the tympanic 
membrane and the oval window), enabling the transition of pressure waves from the surrounding 
medium into the cochlear fluid.   
 
The inner ear:  
The cochlea itself, a snail-shaped, bony structure, consists of three distinct fluid-filled cavities 
(scala tympani, delimited via the basilar membrane from the scala media, which in turn is 
delimited via Reissner’s membrane from the scala vestibuli) coiled around the central pillar of the 
cochlea, the modiolus. At the cochlear apex, the scala tympani and the scala vestibuli are 
connected via the helicotrema, and both are filled with a liquid called perilymph. At the cochlear 
base, two membrane-covered windows are found: the oval window in the scala vestibuli and the 
round window in the scala tympani.  When the stapes moves, it also moves the oval window 
membrane; perilymph in the scala vestibuli is pushed towards the cochlear apex and in turn 
pushes the perilymph in the scala tympani via the helicotrema towards the round window, which 
is bulged outward (figure 1B). These pressure waves cause motion while traveling through the 
cochlea, most importantly at the basilar membrane. Due to its physical properties – it gradually 
increases in width and decreases in stiffness from the cochlear base towards the apex – its 
displacement depends on the frequency of pressure waves: While high frequencies deflect the 
stiff and narrow part at the cochlear base, low frequency waves travel up to the cochlear apex 
and mainly deflect the wider and more flexible part of the basilar membrane. As a result, a place-
frequency code is established in the cochlea, where different frequencies of pressure waves 
(originating from different frequencies of sound) cause basilar membrane deflections at different 
cochlear locations – a phenomenon of great importance that will accompany the reader 
throughout this thesis. 
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Transduction – from sound to spikes  
The responsible organ for signal 
transduction – the organ of Corti – is 
located on the basilar membrane in 
the scala media. It is covered by a 
second membrane, the tectorial 
membrane, which is connected to the 
basilar membrane via the rods of 
Corti (pillar cells). At its top, the organ 
of Corti faces the potassium-rich 
endolymph, and at its base the 
perilymph, which resembles regular 
extracellular saline. The sensory cells 
responsible for neural transduction 
are called hair cells. Hair cells are 
embedded in a variety of supporting 
cells and can be separated into 
approximately 3500 inner (in 
between the modiolus and the rods 
of Corti) and 15-20,000 outer hair 
cells (distal to the rods of Corti; figure 
1C). Hair cells are named after the 
~100 stereocilia which are located at 
the top of each cell and extend into 
the tectorial membrane (in the case 
of outer hair cells) or just below the 
tectorial membrane (inner hair cells). 
Stereocilia are anatomically 
connected via tip-links and house 
mechanically gated cation channels. 
In resting state these channels are 
partially open, resulting in modest 
potassium influx from the endolymph 
 
Figure 1: Anatomy of the ear. (A) Illustration of the human ear. (B) 
Illustration of the inner ear in its natural shape (left) and in a 
hypothetical uncoiled state (right). White arrows in the uncoiled 
cochlea indicate the travelling pressure wave, starting at the oval 
window under the footplate of the stapes. (C) Illustration of the organ 
of Corti. Panel A and Panel C have been taken and partially modified 
from “smart – servier medical art”, which provides artwork without 
licensing (www.smart.servier.com; 12th of August, 2019).  
 Introduction 
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into the inner hair cell. If a pressure wave now propagates along the cochlea, the basilar 
membrane (and consequently the hair cells in the organ of Corti) moves with respect to the 
tectorial membrane, which leads to deflection of the hair cell bundles. Dependent on the 
direction of movement, these deflections cause an increase or decrease in the mechanical tension 
on the cation channels. If tension on these channels increases, it causes the channel into a open 
state, eliciting inward potassium current and thus depolarizing the cell. Vice versa, the probability 
of channel opening decreases with decreasing tension, reducing potassium influx and 
hyperpolarizing the cell. Since waves – by nature – are phasic events, the potassium influx and 
thus the intracellular potential of hair cells oscillates with the phase of the pressure wave moving 
the basilar membrane, at least for frequencies up to one kHz (Russell and Sellick, 1983). In 
depolarized phases, voltage gated calcium channels at the base of inner hair cells are opened, 
leading to calcium influx, which in turn triggers the release of glutamate from the hair cell. The 
released glutamate subsequently activates afferent fibers of the primary neurons in the auditory 
system, the spiral ganglion neurons (SGNs), which – if activation is strong enough – initiate action 
potentials. The somata of the bipolar SGNs are housed in Rosenthal’s canal in the modiolus, with 
their peripheral neurites reaching to the base of inner hair cells and their axons (which together 
form the auditory nerve) projecting to the cochlear nucleus of the brainstem, thus sending 
information about signals from the external world to the central nervous system.  
 
The (simplified) neuronal code for sound:   
Waves are characterized by their frequency (i.e. the number of cycles in a given time window) and 
their amplitude (i.e. the pressure difference of the medium through which waves propagate). In 
the case of sound waves, the frequency is perceived as pitch, while the amplitude is perceived as 
loudness. As discussed above, sounds of different frequencies deflect the basilar membrane at 
different locations, which results in inner hair cell and subsequent spiral ganglion activation at 
spatially distinct positions in the cochlea (‘place code’; figure 2, top vs bottom). The activation of 
distinct neuronal populations by sound waves of different frequencies is maintained throughout 
the auditory pathway up to primary auditory cortex – a phenomenon called tonotopy. 
Due to this labeled-line feedforward-processing, the brain is able to infer the frequency of an 
acoustic signal by the spatial pattern of neuronal activity in the auditory system – giving rise to 
pitch perception. A second mechanism for pitch perception – up to frequencies of 2-4 kHz – is 
phase locking, where stimulus frequency is not only represented by tonotopy, but also by the 
timing of neuronal responses: The occurrence of each action potential at a given phase of the 
sound wave triggering this action potential signals stimulus frequency, since it is identical to the  
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frequency of the stimulus (‘time code’). 
However, at higher frequencies (starting 
from approximately 2-4 kHz) neurons are 
not able to follow the stimulation 
frequency any longer in a phase-locked 
manner, since they are limited by their 
maximal firing rates (due to the time 
constant of the inner hair cell membrane 
and due to the duration of an action 
potential and the corresponding 
refractory time in spiral ganglion neurons). 
These frequencies are exclusively 
represented by tonotopy. Regarding the 
intensity of a sound, it was already 
mentioned that the deflection of inner 
hair cell bundles and thus the 
depolarization of inner hair cells depend 
on the degree of basilar membrane 
displacement: In consequence, waves of higher amplitude cause stronger activation of inner hair 
cells, more glutamate release and finally the initiation of more action potentials in subsequent 
spiral ganglion neurons (‘rate code’). In addition, waves of higher amplitude displace the basilar 
membrane over a larger area, resulting in activation of a larger population of inner hair cells and 
downstream neurons (figure 2, left vs right). Thus, sound intensity is coded by the amount of 
action potentials in response to a given stimulus on the level of single neurons and by the 
recruitment of bigger neuronal ensembles on the population level. In contrast to the inner hair 
cells that drive sound encoding in SGNs, outer hair cells amplify and sharpen sounds in a 
frequency-specific manner and thus contribute to hearing sensitivity and frequency resolution. 
 
This is of course a very simplified view and most sounds in our environment are complex sounds, 
composed of several frequencies and intensities. On top, it is also important to detect the location 
of a sound, and since different sounds in our environment have different meanings, the auditory 
system is required to discriminate between signal and noise. These features of sound analysis 
(and some more) are mainly taken care of by the central auditory system. However, for the 
 
Figure 2: Neural coding for basic features of sound. While 
sound frequency (top vs bottom) is coded by distinct 
populations of neurons, amplitude is coded by firing rate in 
individual neurons and by recruiting higher numbers of neurons 
on the population level. 
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further understanding of this thesis it will be very helpful to mainly remember the above 
mentioned (basic) mechanisms for coding of sound frequency and intensity. 
 
 
The central auditory pathway and auditory plasticity:  
 
Once leaving the cochlea, auditory information is processed in a variety of relay stations which are 
highly interconnected by both feedforward and feedback connections. Even though auditory 
processing is still not fully understood, some major pathways have been identified, and the most 
important one will be described in this section. Auditory information is send to the central 
nervous system via the auditory nerve (formed by axons of SGNs), which unilaterally project to 
the ipsilateral cochlear nucleus. While the ventral part of the cochlear nucleus extracts 
information regarding spike timing and the activation pattern of SGNs, the dorsal part of the 
cochlear nucleus also receives non-auditory inputs and is involved in relating auditory information 
to the listener’s posture, i.e. position of the head. The main output of the cochlear nucleus is 
projected from its ventral part to both the ipsi- and the contralateral superior olivary complex, 
which is the first station to receive binaural information. Differences in time and intensity of this 
binaural information are used by the superior olive in order to localize sound, before the 
information is passed to the inferior colliculus (auditory midbrain).  In the inferior colliculus, all 
ipsi- and contralateral ascending pathways converge (even though the contralateral input is 
dominant) and spatial data from vertical and horizontal planes is integrated. Besides its function 
in reading out the computation of sound source localization in the olivary complexes, the inferior 
colliculus is involved in multi-modal sensory reflexes (e.g. startle reflex or vestibulo-ocular reflex) 
and sensitive to amplitude modulations of acoustic stimuli, playing a major role in speech 
recognition. Axons of the inferior colliculus then project to the medial geniculate body of the 
thalamus, which depicts the last subcortical relay of the auditory pathway and is involved in the 
processing of relative sound intensity and duration. The medial geniculate body is also believed to 
direct attention towards different auditory stimuli, thus playing a role in discriminating signal 
from noise. Output from the thalamus is send to the auditory cortex, where the perception of 
auditory stimuli happens and the listener identifies auditory objects. The auditory cortex is highly 
interconnected with all kind of auditory as well as non-auditory cortical and subcortical areas and 
not only perceives auditory objects, but also passes this information to higher brain areas in order 
to guide attention, integrate multi-sensory information, relate this information to internal 
processes of the brain such as memory and finally make decisions and initiate (or not initiate) 
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adequate motor responses of the listener. Besides the connections to higher brain areas, the 
auditory cortex has projections to the auditory thalamus (medial geniculate body), midbrain 
(inferior colliculus), and brainstem (superior olivary complex, cochlear nucleus), which serve the 
modulation of cochlear sensitivity and the strength of reflexes (Terreros and Delano, 2015). An 
important feature of the auditory cortex (and to a certain degree also of subcortical auditory 
structures) is its high degree of plasticity. Due to different mechanisms, the cortex is able to 
change its properties in response to sound both during development and in mature organisms, 
and by doing so it is able to ideally use its resources in order to optimize auditory performance 
(Irvine, 2018). Even though most of plastic changes in the cortex are caused by modulating the 
excitation-inhibition balance of already existing neuronal connections, cortical plasticity can have 
many forms and ranges from the timescale of seconds (in the case of stimulus-specific adaptation 
(Khouri and Nelken, 2015, 2015)) to long-term changes in the case of perceptual learning such as 
musical training or language development (Irvine, 2018). Not only has plasticity in the auditory 
cortex been linked to perceptual learning, attention, memory, it also enables the auditory system 
to counteract and compensate for different forms of hearing impairment – at least to a certain 
degree (Irvine, 2018). For example, after damaging a given cochlear region, neurons in the 
tonotopically corresponding location in auditory cortex change their frequency selectivity away 
from the damaged range of frequencies and instead responded to frequencies coded by adjacent 
cochlear regions (Robertson and Irvine, 1989). However, plasticity is not always beneficial, as it 
has for example been linked to tinnitus (Irvine, 2018). In the case of profound hearing loss or 
deafness, cortical plasticity is utilized for hearing restoration in a different way: Plasticity enables 
the identification and interpretation not only of natural acoustic stimuli, but also of artificial 
stimuli, such as electric stimulation of spiral ganglion neurons – a fact that is of particular 
importance for the function of cochlear implants, which will be discussed later in this thesis (Kral 
and Sharma, 2012). Due to neuronal plasticity, activity patterns of cochlear implant stimulation – 
which reflect basic principles of sound encoding in the cochlea – can be interpreted sufficiently 
well to restore speech comprehension. Outcomes in speech understanding of cochlear implant 
users are typically higher in children implanted during critical periods as compared to adult 
implantees, and furthermore appropriate training improves speech understanding, both of which 
are factors contributing to brain plasticity also beyond the auditory system (Kral and Sharma, 
2012).  
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Auditory pathologies: prevalence and consequences 
 
As in probably every biological system, failure also happens in the auditory system, and 
unfortunately it happens with an alarmingly high prevalence: According to the World Health 
Organization, approximately  ~466 million people worldwide – which account for 6.1 % of the 
human population – suffer from disabling hearing loss, resulting in an economic impact of ~750 
billion dollar globally spent on the treatment of hearing loss (www.who.int/deafness/en; 12th of 
August, 2019). 1 out of 800 children is born with profound hearing impairment, and 15% of the 
adult population experience at least mild hearing loss and approximately one third of the 
population above 65 years of age suffers from hearing impairment (Moser, 2015a; Steel, 2000). 
While approximately half of the cases of hearing impairment in children can be assigned to 
genetic mutations, the remaining ones are caused by environmental factors (Moser, 2015a). In 
addition, acquired hearing loss – mainly noise induced or age related – contributes to make 
hearing loss the most prevalent sensory disorder. Consequences of hearing loss are diverse and 
severe: During early childhood, and especially during critical windows of development, the 
auditory system relies on sensory input in order to establish, mature and maintain the sense of 
audition (Kral, 2013). Furthermore, the acquisition of vocal speech strongly depends on the 
auditory system (José et al., 2014). During adulthood, hearing impairments can cause decreased 
professional capabilities, risk for diseases such as depression, and decreased quality of life in 
general (Husain et al., 2014; Zinchenko et al., 2018). In elderly, hearing impairment has been 
linked to cognitive decline and dementia (Shen et al., 2018; Uchida et al., 2019). Furthermore, 
over all ranges of age, hearing impairment causes social isolation which in turn is linked to 
manifold subsequent disadvantages.  
 
Hearing loss (or hearing impairment) can generally be classified into three subtypes: conductive, 
sensorineural and central hearing loss. Conductive hearing loss originates from alterations in the 
outer or middle ear that hinder the sound wave to reach the cochlea, for example occlusion of the 
ear canal, perforation of the tympanic membrane or effusion of fluids in the middle ear. It mostly 
has mild to moderate severity, and is typically successfully treated in otolaryngology by middle 
ear microsurgery or can be overcome by hearing aids (Dougherty and Kesser, 2015; Lee and 
Bance, 2018). Central hearing loss originates in the central nervous system and can be caused by 
lesions in the brainstem, inferior colliculus or auditory cortex (which depicts the minority of cases) 
or in a more complex manner in combination with various brain diseases. Central hearing loss 
often co-exists with cognitive decline and possible symptoms include auditory hallucinations, 
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neglect, and the inability to filter auditory signals and discriminate speech from noise. Up to date, 
central hearing loss is the least understood – but fortunately also the least prevalent – form of 
hearing loss (Gates, 2012; Gates et al., 1996).  
 
Sensorineural hearing loss (SNHL), resulting from dysfunction of the cochlea and/or auditory 
nerve, depicts the most prevalent form of hearing loss, accounting for approximately 90% of all 
cases (Zhang et al., 2018b). SNHL might either be caused by genetic mutations, age, or various 
external factors, such as physical trauma, noise or ototoxic substances. Since neither hair cells nor 
SGNs regenerate, SNHL is permanent, and even though various treatment options are currently 
investigated, they are still far away from application in human patients (Lee and Bance, 2018). 
Thus, state of the art treatment options for SNHL either aim at the amplification of sound using 
hearing aids (in mild and moderate cases) or bypass damaged or missing hair cells and directly 
stimulate spiral ganglion neurons electrically using cochlear implants (in cases of profound 
hearing loss and complete deafness).  
 
 
Re-building audition: restoration of sensorineural hearing loss 
 
As mentioned above, no causal treatment for sensorineural hearing loss is available up to date, 
and the development of such treatment options is at the preclinical stage. Strategies to treat 
SNHL depend on the exact pathological mechanism of SNHL and include regenerative approaches 
as well as gene-therapeutic options. The most promising strategy to treat genetically caused SNHL 
is gene therapy, where a healthy version of the mutated gene is introduced into the inner ear in 
order to replace the non-functional version and would allows for protein expression with normal 
function. However, even though gene therapy to treat SNHL has been demonstrated in mouse 
models of genetic deafness (Akil et al., 2012; Al-Moyed et al., 2019; Askew et al., 2015; Lentz et 
al., 2013), there are still major challenges that need to be addressed before considering clinical 
trials: First and foremost, safe and cell-type specific viruses need to be identified and stable long-
term expression of the introduced gene needs to be demonstrated (Moser, 2015a). Second, a safe 
way to deliver the virus into the anatomically complex inner ear needs to be developed without 
causing any additional damage to the middle ear, to remaining hair cells in the inner ear or to the 
vestibular system (Moser, 2015a; Zhang et al., 2018b). Complicating it further, as genetic deafness 
often goes along with rapid cochlear degeneration, many deafness genes would need to be 
 Introduction 
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delivered and expressed in early, including prenatal, stages (Chang et al., 2015; Choi et al., 2011; 
Zhang et al., 2018b). Also, some of the identified deafness genes (for example otoferlin or some 
usher genes) are very large, making it challenging to pack them in adeno-associated viruses (AAVs; 
which up to date are the most promising candidates for gene delivery). Strategies to overcome 
this limitation, including dual-AAV approaches, are investigated, but different viral vectors, such 
as adenoviruses, offer alternative options (Moser, 2015a). Even if these requirements are met, 
there are various genes that cause hearing loss. More than 100 of these genes have been 
identified, and each of them requires the development of a tailor-made therapy, but lots of cases 
for which genes have not even been identified yet are still remaining (Moser, 2015a). 
Furthermore, noise induced hearing loss as well as age related hearing loss, which are even more 
prevalent than genetic defects, would still leave the need for alternative hearing restoration 
besides gene therapy (Dombrowski et al., 2018).  
 
Similar to a gene-therapeutic approach, where hair cells should be regenerated from supporting 
cells, one possible alternative to gene therapy is based on drugs: In cases of acquired deafness 
where hair cells are lost completely, hair cell regeneration could be forced by trans-differentiation 
of neighboring supporting cells. It has been shown that pharmacological compounds can alter 
intracellular signaling pathways of cochlear supporting cells and, by doing so, induce 
transformation of these cells into new hair cells, at least in vitro (Géléoc and Holt, 2014; White et 
al., 2006). Even though induced transformation of supporting cells into hair cells has not been 
demonstrated in vivo yet, these findings suggest a possible way of hearing restoration via 
pharmacological intervention. A second way to treat acquired hearing loss is based on the re-
introduction of stem-cell derived hair cells into the cochlea. Towards hair cell replacement, 
cochlear progenitor cells have been created from embryonic stem cells in vitro and started to 
express hair cell genes and displayed hair bundles when introduced into the inner ear or develop 
into sensory epithelia in culture (Koehler et al., 2013; Li et al., 2003; Oshima et al., 2010). Further, 
it has even been suggested to replace lost spiral ganglion neurons by stem cells: It has been 
shown that neural progenitors derived from embryonic stem cells, once transplanted into 
Rosenthal’s canal, innervated inner hair cells in the organ of Corti and sent projections to the 
brainstem (Corrales et al., 2006). A second study confirmed the findings of progenitor 
differentiation and furthermore demonstrated improved auditory function starting four weeks 
after transplantation (Chen et al., 2012). Even though these technologies still need to be refined 
and have their own obstacles, such as integration of SGNs into mature neuronal circuits or proper 
hair bundle alignment in the case of hair cell replacement, pharmacological interventions and 
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stem cell therapies are promising candidates to restore auditory function upon acquired hearing 
loss resulting from hair cell damage or loss of hair cells or SGNs (Géléoc and Holt, 2014). 
 
 
Cochlear implants: a success story of neuroprothesis 
 
Until treatment options such as pharmacological, gene or stem cell therapies will become 
available for clinical application, which might take decades, cochlear implants (CIs) depict the only 
option for partial hearing restoration in patients suffering from profound SNHL or deafness (Steel, 
2000). In patients with SNHL, CIs bypass the defective transduction from sound to neuronal 
signals by directly stimulating SGNs with electric current. Basically, a CI consists of a linear array of 
stimulation electrodes embedded in silicone, which is placed via the round window in the scala 
tympani and winds up the cochlea along its tonotopic axis, an internal stimulator, and a 
corresponding external audio processor. The audio or speech processor picks up signals from the 
surrounding auditory scene and extracts their most prominent frequency components as well as 
their relative intensities. Different spectral components are then matched to different electrodes, 
placed at the tonotopically corresponding regions in the cochlea (Fig. 3A, B). The corresponding 
intensity in each spectral channel determines the amplitude of electric current that is injected 
into the cochlea in order to stimulate each region (Lenarz, 2018). Even though excitation of SGNs 
via electric current is an unnatural mode of stimulation, the brain is able to interpret the resulting 
SGN activity and decipher auditory information, which is on one hand attributed to the prominent 
tonotopic organization in the auditory system, and on the other hand to the high degree of brain 
plasticity and to extensive training of the patients (Kral and Sharma, 2012; Lenarz, 2018; 
Middlebrooks et al., 2005; Moore and Shannon, 2009). Artificial sound encoding via cochlear 
implants is effective enough to restore open speech comprehension in most of approximately half 
a million implanted people, making the cochlear implant the arguably most successful 
neuroprothesis (Middlebrooks et al., 2005; Moser, 2015b).  
 
However, despite the enormous success of cochlear implants, electrical sound encoding is far 
away from being perfect and there is an unmet need for improved hearing restoration: When 
electric current is injected into the cochlea to stimulate SGNs, its spread is relatively large, due to 
the high content of ions in the electro-conductive environment of the cochlea (Kral et al., 1998).  
This spread of electric current leads to recruitment of rather large subsets of spiral ganglion 
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neurons and – due to their tonotopic arrangement – to rather coarse coding of spectral 
information (Fig. 3B, Shannon, 1983). The result of this current spread is crosstalk between the 
individual stimulation channels, which limits the number of independent channels to typically less 
than ten (Friesen et al., 2001)., as compared to ~800-1300 different sound frequencies that 
regular hearing subjects are able to distinguish (Formby, 1986; Meurmann, 1954) (and even 
higher values reported from musicians (Liang et al., 2016)). A second limitation of electrical SGN 
stimulation is the low dynamic range: SGNs respond with an intrinsically low dynamic range (1-2 
dB (Miller et al., 2006)) to electrical stimulation (as compared to 30-40 dB in response to natural 
acoustic stimulation (Viemeister, 1988)). Furthermore, large SGN populations are concurrently 
activated at similar thresholds, limiting intensity coding on the population level. These 
mechanisms restrict the dynamic range of the electrically stimulated auditory pathway to 10-20 
dB , whereas the normal hearing system can code a dynamic range of up to 120 dB (Rubinstein, 
2004; Zeng, 2004). Ultimately, the restricted frequency and intensity coding of cochlear implants 
results in limited signal perception, leading to poor speech recognition in background noise and 
the inability of many users to appreciate music (Friesen et al., 2001; Kohlberg et al., 2014; Zeng 
and Galvin, 1999). Consequently, the improvement of artificial sound encoding is still under 
investigation and strategies to improve eCI outcomes to the users include various approaches: 
One way towards improvement might be advanced coding strategies, such as dual electrode 
configurations or multi-polar stimulation (Donaldson et al., 2005; George et al., 2015; Snyder et 
al., 2004). Another way could be the improvement of the interface between electrodes and neural 
tissue, which can either be achieved by the use of intra-neural electrodes (Middlebrooks and 
Snyder, 2007; Pinyon et al., 2014) or by stimulated outgrowth of SGN neurites towards the 
electrodes (Pinyon et al., 2014). Finally, optical stimulation of SGNs using focused light has been 
proposed for activation of more confined SGN populations and hence improved frequency 
resolution (Hernandez et al., 2014; Izzo et al., 2007; Richter et al., 2011). 
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Overcoming the bottlenecks: towards optical cochlear implants 
 
Since light can conveniently be confined in space, it has been suggested to use optical stimulation 
in order to specifically stimulate small subpopulations of the tonotopically organized spiral 
ganglion to improve frequency resolution of artificial sound encoding (Fig. 3B, C; 31, 50–52).  
 
 
First studies using infrared neural stimulation have demonstrated comparable spatial spread of 
SGN activation between infrared optical stimulation and acoustic stimulation by in vivo 
electrophysiology (Richter et al., 2011) and higher spatial confinement of infrared optical 
stimulation as compared to electrical stimulation by activity-driven gene expression in histological 
 
Figure 3: Natural vs artificial sound encoding in the cochlea. (A) Pressure waves in the air (left) are decomposed in a 
frequency dependent manner (center) and activate mechanosensitive hair cells at the respective cochlear location 
(right). (B/C) Acoustic signals are analyzed by an external processor which maps the predominant frequencies and 
corresponding amplitudes of a signal to the stimulator (electrode or optical emitter). Spiral ganglion neurons around 
the region at which the pressure wave of intracochlear fluids would naturally excite hair cells are then directly activated 
with electric current (B) or light (C). Since light can be better confined in space than electric current, oCIs promise to 
activate the spiral ganglion with higher spatial selectivity (right, B vs C). This figure was kindly provided by Dr. Daniel 
Keppeler, Institute of Auditory Neuroscience. 
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analysis of the spiral ganglion (Izzo et al., 2007). While these studies have been very encouraging 
for the development of optical cochlear implants, the technology of infrared neural stimulation 
has some major drawbacks: First, the energy requirements for infrared neural stimulation are 
quite high (typically in the range of tens of Microjoule with a peak illumination of ~ 100 mW; 
(Matic et al., 2013; Richter et al., 2011)). Second, the mechanism by which infrared stimulation 
activates neurons is not clear yet and still remains to be clarified (Young et al., 2015). Third – and 
most important – infrared stimulation of the spiral ganglion neuron could not be confirmed in 
different studies using animal models of sensorineural hearing loss, which depict the adequate 
model system for hearing restoration in cochlear implant users (Kallweit et al., 2016; Schultz et al., 
2012; Thompson et al., 2015; Verma et al., 2014). 
 
In contrast to infrared neural stimulation, optogenetic activation of Channelrhodopsin (ChR (Nagel 
et al., 2003))  expressing neurons enables cell-specific excitation via a well-defined molecular 
mechanism at low light intensities (Boyden et al., 2005).  ChRs, which are light-gated ion channels 
naturally found in algae where they support phototaxis, have been shown to mediate light-gated 
ion conductance in oocytes of Xenopus laevis one and a half decades ago (Nagel et al., 2002, 
2003). Soon thereafter, Channelrhodopsin-2 has been used to evoke action potentials in 
mammalian neurons in a fast, non-invasive and cell-type specific manner (Boyden et al., 2005). 
Since this milestone, the optogenetic toolbox has been expanded tremendously by using directed 
mutagenesis of already known ChRs as well as large-scale screening of naturally occurring opsins: 
The variety of available optogenetic tools now includes light gated ion-channels and -pumps 
(Shevchenko et al., 2017; Yizhar et al., 2011) both for neural excitation and inhibition (Wietek et 
al., 2014; Yizhar et al., 2011), with time constants ranging from milliseconds to minutes (Berndt et 
al., 2008; Klapoetke et al., 2014; Yizhar et al., 2011), characterized by faster kinetics (Gunaydin et 
al., 2010; Klapoetke et al., 2014; Mager et al., 2018), increased light sensitivity of neurons 
(Kleinlogel et al., 2011), and shifted peak action spectra (Klapoetke et al., 2014; Mager et al., 
2018; Yizhar et al., 2011). Thus, optogenetic techniques for precise neural control not only have 
rapidly gained great importance in neuroscientific research (Fenno et al., 2011; Knöpfel et al., 
2010), but furthermore raise hope to be applied for innovative therapies of disorders such as 
Parkinson’s disease (Delbeke et al., 2017), cardiac dysfunction (Schneider-Warme, 2018), epilepsy 
(Tønnesen and Kokaia, 2017), and sensory disorders such as blindness (Scholl et al., 2016)  and 
deafness (Dombrowski et al., 2018).  
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In the past years considerable progress has been made towards optogenetic hearing restoration: 
In a first proof of principle study, the feasibility of optogenetic activation of the auditory pathway 
has been demonstrated in transgenic mice broadly expressing Channelrhodopsin-2 under the 
Thy1 promotor (Arenkiel et al., 2007) by recordings of optically evoked auditory brainstem 
responses (oABRs), recordings of action potentials in single auditory nerve fibers, and recordings 
of local field potentials in the inferior colliculus (Hernandez et al., 2014). Indeed, current source 
density analysis revealed a smaller spread of excitation upon optogenetic stimulation as 
compared to monopolar electrical stimulation. Furthermore, cochlear optogenetics could restore 
auditory activity in deaf mice (Hernandez et al., 2014). Follow-up studies were performed in mice 
following virus injection into the cochlea during the first postnatal week in order to express ChR-
variants with faster gating kinetics in spiral ganglion neurons: In one study, injections of AAV2/6 
carrying the ChR-mutant f-Chrimson under the human synapsin promotor (hSyn) led to 
homogeneous opsin expression in SGNs across all cochlear turns, with a mean transfection rate of 
~80% (Mager et al., 2018). F-Chrimson, an opsin with a red-shifted action spectrum and faster 
closing kinetics (τoff = 3.2 ms), enabled optogenetic stimulation of SGNs with good temporal 
fidelity up to several hundred Hertz at low light intensity thresholds (~ 0.5 µJ), demonstrated by 
recordings of oABRs and activity of individual auditory nerve fibers (Mager et al., 2018). Opsin-
mediated activation of SGNs could furthermore restore activity in the auditory pathway (Mager et 
al., 2018) of a mouse model of age-related hearing loss (Shnerson et al., 1981). In a second study, 
a viral construct mediating neural expression of the blue-light activated ChR-variant Chronos has 
been optimized for the auditory system (Keppeler et al., 2018): Chronos (Klapoetke et al., 2014), 
the fastest naturally occurring opsin known today (τoff < 1 ms), was combined with an export signal 
for improved endoplasmic reticulum export (ES; taken from inward rectifying potassium channels 
(Kir2.1) (Gradinaru et al., 2010; Hofherr, 2005; Ma et al., 2001)), a trafficking signal for improved 
membrane localization (TS; also taken from channels of the Kir2.x family (Gradinaru et al., 2010; 
Stockklausner et al., 2001)), and packaged in the recently engineered AAV-PHP.B for enhanced 
viral transduction (Deverman et al., 2016). Early postnatal injection of the AAV-PHP.B-Chronos-
ES/TS construct in the mouse cochlea enabled highly efficient Chronos-expression in spiral 
ganglion neurons, oABRs at thresholds of 5 μJ and 100 μs per pulse, and spiking of individual SGNs 
up to several hundred Hertz repetition rate (Keppeler et al., 2018). Together, these studies 
demonstrate that a major requirement for optogenetic hearing restoration – efficient 
transduction of auditory neurons with opsins mediating light-induced generation of action 
potentials at firing rates that approach the physiological rates observed in SGNs – can be met by 
tailored optogenetics. 
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Besides the biological feasibility of light-based SGN-activation, a second prerequisite for 
optogenetic hearing restoration concerns the technological site: biocompatible multi-channel 
optical stimulators, small and flexible enough to allow for cochlear implantation and stable 
enough to work over decades, must be developed to facilitate excitation of the optogenetically 
manipulated auditory nerve. Also towards this end considerable work has been done in the past 
years: One study demonstrated the fabrication of gallium-nitride (GaN) based light emitting 
diodes in the micrometer range (µLEDs) which are linearly arranged on a flexible substrate based 
on polyimide and silicon (Goßler et al., 2014). In this study, an optical cochlear implant (oCI) 
housing 15 µLEDs with a size of 150x150 µm (from which up to three µLEDs could be addressed 
separately) was successfully inserted into the model of a rat cochlea. A second implant with four 
linearly arranged µLEDs (50x50 µm) was implanted into a mouse cochlea via the round window. 
Driven by a current of 1 mA, the output power of these four µLEDs at a wavelength of 405 nm was 
60µW, corresponding to an optical power density of 6 mW/mm² (Goßler et al., 2014). Following 
up on this work, an epoxy-based, biocompatible and translucent oCI, 350 μm wide and 1.5 cm 
long, housing a total of 144 µLEDs which can be addressed in a matrix, has recently been realized 
(Klein et al., 2018). Besides the enormous increase in the number of individual light emitters, the 
presented oCI showed a reduction in thermomechanical bending as compared to the previous 
implants and a maximum temperature increase of 1 °C at driving currents up to 10 mA, which are 
further requirements for safe in vivo application. Finally, the optical power (at a wavelength of 
462 nm) has been increased by almost two orders of magnitude to 0.82 mW (when driving the 
implant with 10 mA), corresponding to a power density of 407 mW/mm² (Klein et al., 2018). Even 
though functionality and stability of optical cochlear implants in vivo remains to be demonstrated, 
these studies proof the general feasibility of industrial oCI fabrication at the level of wafers which 
fulfill basic requirements of potential oCIs regarding size, number of emitters and light output 
while considering thermomechanical properties such as flexibility and heating of the implants. 
Together, the biomedical and technological developments towards oCIs during the past years 
raise great hope that the mayor limitations of nowadays CIs might be overcome and the quality of 
artificial hearing for deaf patients might be improved in the future.  
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Scope of this thesis: validating cochlear optogenetics in adult Mongolian gerbils 
  
Even though tremendous work towards the development of optical cochlear implants has been 
done in the past years, a long way remains to be gone before considering the translation of oCIs 
towards clinical application. While Chronos and f-Chrimson are promising candidates as molecular 
tools to mediate cochlear optogenetics, a reliable method for neural transduction, also in the 
adult organism, needs to be established. Not only must this transduction be efficient and long-
lasting, but it must also be specific, ideally involving the use of SGN specific promotors. Having the 
molecular requirements checked, the technological development of stable and functional oCIs 
must be realized – not only for the light-emitting intracochlear part of the implant, but also for 
the oCI processor, including a coding strategy to transform real world sounds into optical signals 
while minimizing the energy requirements for oCI coding. In a next step, these technologies must 
be verified in preclinical studies using appropriate animal models. First and foremost, functionality 
of oCIs must be demonstrated: Neural activation of SGNs as well as subsequent signal 
propagation along the auditory pathway must be characterized and behaviorally relevant 
perception of these stimuli must be demonstrated, ideally during the whole lifespan of the model 
organism and in animal models of sensorineural hearing loss. Second, the benefit of oCIs 
compared to eCIs must be demonstrated. Only if fundamental improvement of this technology 
over the limitations of electrical CIs is expected, the clinical translation of cochlear optogenetics 
can be justified. Third, the technology must be translated to a non-human primate model in order 
to confirm that the results obtained from rodent work are also valid in primates. Finally, biosafety 
studies must be conducted and all necessary tools to realize optical cochlear implants must be 
optimized for application in humans. Out of these challenges that need to be addressed towards 
the development of an optogenetic cochlear implant, this thesis deals with three major tasks:   
 
Perception of cochlear optogenetics and optogenetic hearing restoration:  
One basic requirement for optogenetic sound encoding is the perception of optogenetic SGN 
stimulation. Towards this end, a fiber-based single channel oCI has been implanted via the round 
window into the cochlea of adult Mongolian gerbils, in which SGNs have been optogenetically 
transduced by intramodiolar injections of AAV2/6 carrying a plasmid encoding the Calcium 
Translocating ChR2- CatCh. Light-evoked auditory brainstem responses have then been recorded 
over the following weeks, in some animals up to four months after implantation, to verify 
optogenetic SGN activation on a physiological level. In parallel, these animals have been trained in 
a behavioral task using the shuttlebox paradigm to indicate perception of optogenetic SGN 
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stimulation via avoidance behavior. Avoidance behavior was subsequently also triggered by using 
acoustic stimulation, suggesting at least some degree of similarity between the perception of 
acoustic and optogenetic stimuli. After training the animals in the task, thresholds for intensity 
and duration of light pulses have been determined to estimate the energy requirements of oCI 
coding. Finally, optogenetic SGN stimulation has been shown to restore activation of the auditory 
system both on a physiological and behavioral level in a gerbil model of sensorineural hearing 
loss, where inner hair cells have been lost upon intracochlear kanamycin application. 
 
Comparison of spectral selectivity upon optogenetic and electrical SGN stimulation:  
To justify the development of oCIs, an increase in spectral resolution as compared to eCIs – which 
are currently used in clinical settings – must be demonstrated. Towards this end, SGNs of 
optogenetically modified, isoflurane-anesthetized Mongolian gerbils have been stimulated via 
optical fibers at three distinct positions in the cochlea, while multi-channel electrophysiological 
recordings have been performed in the tonotopically layered inferior colliculus. As a comparison, 
SGNs of wildtype gerbils have been stimulated either acoustically or electrically via clinical-style 4-
channel eCIs. Using an activity-based analysis of neural activation in the inferior colliculus, the 
spread of cochlear excitation upon neural stimulation with the different modalities could be 
estimated: It was shown that the spectral selectivity of optogenetic SGN stimulation is 
comparable to acoustic stimulation using pure tones at low stimulus intensities. Furthermore, 
optogenetic stimulation was spectrally more selective than bipolar electrical stimulation at 
modest and high stimulus intensities, while it outperformed monopolar electrical stimulation at 
all stimulus intensities. Thus, an increase in spectral selectivity of oCI versus eCI coding has been 
demonstrated, suggesting that optical cochlear implants based on optogenetics might overcome 
the major bottleneck of eCIs.  
 
In vivo validation of μLED based optical cochlear implants:  
Towards the technical development of optical cochlear implants, functionality of µLED-based 16-
channel oCIs has been demonstrated in optogenetically modified Mongolian gerbils. Multi-
channel electrophysiological recordings have been performed in the inferior colliculus of 
isoflurane-anesthetized gerbils, while SGNs have been stimulated optically by either driving 
individual µLEDs, groups of four neighboring µLEDs, or all 16 µLED of the oCI at a time. It was 
shown that individual µLEDs of the oCI were able to evoke neural responses in the inferior 
colliculus, and that the strength of neural responses increased when recruiting additional µLEDs. 
The spread of excitation upon µLED-based oCI stimulation – even when stimulating with groups of 
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four subsequent µLEDs – was shown to be more specific than the spread of excitation upon 
electrical SGN stimulation. Taken together, this study demonstrates the feasibility of SGN 
activation by µLED-based oCIs with increased frequency resolution as compared to eCIs.  
 
In conclusion, the results of this thesis demonstrate the perception of optogenetic SGN 
stimulation with reasonable energy requirements in a gerbil model of sensorineural hearing loss. 
Furthermore, the increased frequency selectivity of optical over electrical CIs has been 
demonstrated using optogenetic stimulation via optical fibers. Finally, in vivo functionality of a 
µLED-based, 16-channel optical CI has been demonstrated. Taken together, these results raise big 
hopes that optogenetic hearing restoration might overcome the major bottleneck of electrical 
hearing restoration and thus improve the quality of artificial sound encoding for future patients.  
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One Sentence Summary 
Virus-mediated expression of the calcium translocating channelrhodopsin (CatCh) in cochlear 
neurons of adult gerbils enables optogenetic stimulation of the auditory pathway and restores 
auditory driven behavior. 
 
Abstract 
Cochlear implants (CIs) partially restore hearing via direct electrical stimulation of spiral ganglion 
neurons (SGNs). However, spread of excitation from each electrode limits spectral coding. Here 
we explored the use of optogenetics to deliver spatially-restricted and cell-specific excitation in 
the cochlea of adult Mongolian gerbils. We characterized the light-induced activity in the auditory 
pathway by electrophysiological and behavioral analysis. Modiolar injection of adeno-associated 
virus (AAV) coding for the light-sensitive calcium translocating channelrhodopsin (CatCh) in adult 
gerbils successfully infected SGNs of all cochlear turns. SGNs showed stable and long lasting CatCh 
expression and electrophysiological recording from single SGNs showed that light stimulation up 
to few hundred Hertz (Hz) induced neuronal firing. Moreover, light-induced optical auditory 
brainstem responses (oABRs) were comparable to normal acoustic ABR (aABR). In normal hearing 
animals, chronic optical CI (oCI) elicited stable oABRs over weeks. Light stimulation was able to 
induce cued avoidance behavior that was transferred to acoustic stimulation. Neurons of the 
primary auditory cortex responded with change in firing rates with increasing light power. In adult 
deafened gerbils, light stimulation generated oABR and induced cued avoidance behavior 
indicating partial restoration of auditory function. In conclusion, our data show that optogenetic 
sound encoding is feasible with low thresholds and high temporal fidelity in an adult rodent 
model, suggesting that optogenetics might be used to develop CI with improved restorative 
capabilities. 
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Introduction 
 
Approximately 360 million people suffer from disabling hearing impairment (HI) (1). HI hampers 
communication and often causes social isolation, depression and reduction in professional 
capabilities. Sensorineural HI is the most common form of hearing loss; it results from cochlear 
dysfunction or degeneration typically involving loss of sensory hair cells. Hearing aids and 
electrical cochlear implants (eCIs) provide partial restoration of hearing for sensorineural HI. The 
eCI bypasses dysfunctional or lost cochlear hair cells via direct electric stimulation of SGNs and 
provides most of the approximately 500.000 users with open speech comprehension (2–4). One 
of the goals of current CI research is to increase the coding of spectral information that is very 
limited in eCIs because of wide spread of current around each electrode contact (5). The resulting 
channel-crosstalk limits the number of useful frequency channels to less than ten and explains 
why eCI users suffer from poor speech comprehension in noisy environments. Increasing the 
frequency resolution of coding has been explored using multipolar stimulation, intra-neural 
electrodes, engineered outgrowth of neurites towards eCI contacts and stimulation by optical CI 
(oCI) (6–12).  
 
A first proof-of-principle study on optogenetic SGN-stimulation used transgenic mice and rats as 
well as prenatal adeno-associated virus (AAV) mediated gene transfer to mouse SGNs and 
demonstrated activation of the auditory pathway up to the inferior colliculus and a lower spread 
of cochlear excitation for fiber-based oCI than for monopolar eCI (12). However, much remains to 
be done in order to further develop, characterize and optimize oCIs on their way towards 
potential clinical translation. Critically, a postnatal approach for manipulating SGNs across all 
cochlear turns needs to be established. Moreover, although oCI have been shown to improve 
frequency selectivity compared to eCI, this seemed to be traded in for poorer temporal fidelity of 
oCI coding (12). Higher temporal fidelity of oCI coding might be achieved by using faster 
channelrhodopsins (ChRs) such as Chronos, which has already been tested for optogenetic 
stimulation of the auditory brainstem, or the recently developed ChR2 variant CatCh. CatCh 
seems to support rapid repolarization due to enhanced Ca2+ influx recruiting more large-
conductance Ca2+-activated K+-channels and might thus be of interest for oCI coding (13–16). 
Finally, although mice and rats are often the species of choice in preclinical studies, testing oCI in 
other species with a hearing system more closely resembling human condition is critical to 
understand the translational potential of oCIs. 
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Here, we established AAV-mediated expression of CatCh in SGNs of adult Mongolian gerbils and 
characterized optogenetic stimulation by electrophysiology and behavioral analysis. The gerbil is 
of particular interest for preclinical studies of oCI, because in contrast to other rodents, its hearing 
extends to the low frequency range used by the human ear and its cochlea is relatively large (only 
approximately 2.5-fold smaller than the human cochlea). We demonstrate that optogenetically-
driven activity achieves good temporal fidelity. Using chronic oCIs we show the reliability of 
optogenetic stimulation over weeks and find that it potently cues avoidance behavior. We 
characterize the response of single neurons of the auditory cortex to oCI stimulation. Finally, we 
show that oCI restores some auditory function in a gerbil model of ototoxic deafness. 
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Results 
 
Optogenetic manipulation of the adult spiral ganglion via direct modiolar AAV-CatCh-injection: We 
first tested the transfection properties of Chronos and CatCh using various administration routes 
in adult gerbils (fig. S1A). Compared to the strong abundance of CatCh in the plasma membrane of 
SGNs, Chronos showed a more intracellular expression pattern and did not evoke oABRs (fig. S1B, 
C); therefore we decided to use AAV2/6 carrying CatCh linked to the reporter protein enhanced-
Yellow-Fluorescent-Protein (eYFP) under control of the human synapsin (hSyn) promoter for 
injections into the modiolus of adult gerbils (8-19 weeks of age) (Fig. 1A). We adapted a 
retroauricular approach previously used to graft neural precursor cells (17). We approached the 
spiral ganglion from the bulla using a fine dental file bypassing the scala tympani to inject 2-3 µl of 
AAV-CatCh-suspension (Fig. 1B-D).  
 
The number of SGNs and their expression of CatCh-eYFP were analyzed by confocal microscopy of 
immunolabeled mid-modiolar cryo-sections 4–12 weeks after injection in animals that showed 
functional response to optical stimulation (46%, 44 out of 96 injected animals). CatCh-eYFP 
expression was limited to SGNs of the injected ear, which showed prominent labeling in the 
plasma membrane of somata and neurites all the way to the inner hair cells (IHCs, Fig. 1E). SGNs 
of all three cochlear turns (apex, mid and base) were transduced to a similar extent (on average 
approximately 30%, Fig. 1F). A mild loss of SGNs across all turns was observed in the injected 
cochlea (approximately 25%, significant in comparison with the right non-injected side, p < 0.001, 
Fig. 1G). A similar extent of SGN loss was also found in AAV-CatCh-injected ears that largely lacked 
CatCh-expression (approximately 35 %, significant in comparison to the right non-injected side, p 
= 0.006), suggesting that the SGN loss likely resulted from damage caused by the pressure 
injection into the fixed volume of Rosenthal’s canal housing the SGNs (fig. S2).  
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Figure 1. AAV-CatCh-mediated optogenetic manipulation of cochlear SGNs in adult gerbils. (A) Scheme of the AAV-
construct used to transduce SGNs with CatCh-eYFP. (B) Depiction of retroauricular injection of the AAV-CatCh. (C) 
Photo of the retroauricular approach to the middle ear of a gerbil (r = rostral, d = dorsal): the bullostomy provides a 
view into the middle ear. (D) Montage of images showing the round window (RW) niche and dye-filled glass capillary, 
which points to the manually drilled hole. (E) Confocal images of immunolabeled mid-modiolar cochlear cryosections 
(representative section of a middle turn) of an AAV-CatCh injected adult gerbil. eYFP (green) marks transduced SGNs, 
calretinin (magenta) generically marks SGNs, scale bar: 100 µm. It should be noted that the apparent abundance of 
CatCh in the cytoplasm results from the maximum projection as individual z-sections demonstrate a clear membrane 
expression. Inset (upper left): calretinin-positive but eYFP-negative inner hair cell (arrowhead) with associated eYFP-
positive, peripheral SGN neurites, scale bar: 10 µm. Inset (upper center): Close-up single z-section of SGNs, highlighting 
the apparent plasma membrane expression of the construct. Scale bar: 10 µm. (F) Box plot showing fraction of eYFP 
expressing SGNs for the apical, middle and basal cochlear turn of the injected left ear. No expression was found in the 
non-injected right ear (n=9). (G) Box plot showing SGN density for the apical, middle and basal cochlear turn of the 
injected left ear and the non-injected right ear (n=9, (*): p<0.05 [t-test]). Data in F and G are shown as mean ± SEM. 
 
 
Characterization of optical activation of the auditory pathway by auditory brainstem responses: To 
characterize the light-induced activation of the auditory pathway, we first recorded oABRs using 
fiber-coupled laser stimulation 4-12 weeks after AAV-CatCh-injection (Fig. 2A). Blue light 
stimulation through a cochleostomy in the middle cochlear turn or through the round window 
evoked oABRs in AAV-CatCh-injected animals (Fig. 2B, fig. S3). Optical stimulation induced one to 
four peaks in the ABR, which likely reflected the synchronous activation of CatCh-expressing SGNs 
(first peak) and the downstream auditory pathway (subsequent peaks). oABR amplitudes varied 
between animals and were positively correlated with the fraction of CatCh-expressing SGNs (fig. 
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S4A, B). Increasing light intensity resulted in increased oABR amplitude (quantified by the 
difference between the first positive [p1] and negative peak [n1]) and decreased the latency to 
response (Fig. 2C, D; quantification for the second positive and negative peak [p2-n2] is shown in 
fig. S4C, D). Even though the average threshold of acutely measured oABRs amounted to 4.6 mW 
(± 2.8 mW, n = 14), stimuli as weak as 1-2 mW (duration: 1 ms, rate: 10 Hz, 1-2 µJ per pulse) were 
sufficient to drive oABRs in some animals. In 8 out of 20 animals, increasing the light intensity 
increased oABR amplitudes over more than one order of magnitude the response did not plateau 
in the majority of animals (75% without a plateau) such that we could only approximate an 
apparent dynamic range from the stimulus-amplitude functions, which amounted to 16.02 ± 6.14 
dB. The latency of the first oABR peak was 0.95 ± 0.17 ms.  Analyzing oABR in response to 
different stimulus durations we found that oABRs could be elicited by stimuli as short as 200 µs 
(fig. S4E, F).   
 
Analysis of the dependence of oABRs on the stimulus rate (duration: 1 ms, intensity: 21 - 32 mW) 
showed that increasing stimulus rate reduced oABR amplitude and prolonged latency; however, 
oABRs remained sizable up to stimulus rates of at least 200 Hz (Fig. 2E-G, fig. S4G, H).  
 
Quantitative comparison of acoustically-evoked ABR (aABR) from unrelated, non-injected gerbils 
and oABR data with the highest laser intensity possible at our setup (~30 mW) showed similar 
amplitudes with clicks of 40 dB peak equivalent sound pressure level (SPL), while larger 
amplitudes of aABRs evoked by clicks of 50-70 dB exceeded those of oABRs (Fig. 2H-J, fig. S5A). 
Latencies of oABRs were significantly shorter than for aABRs evoked by clicks even at 80 dB SPL (p 
< 0.0001, fig. S5B).  
 
P1-n1-amplitude declined and p1-latency increased with increasing stimulation rate for both 
oABR and aABR (Fig. 2L, M). To evaluate the magnitude of the effect of stimulation rate on ABR 
amplitude, we measured the p1-n1-amplitude ratio measured at 150 Hz over 10 Hz stimulation 
rate.  For aABR the ratio amounted to 0.39 ± 0.15, indicating a 2.5-fold reduction (mean ± SD, 
n=13 gerbils). For oABR, the ratio was 0.67 ± 0.37, indicating a 1.5-fold reduction (mean ± SD, 
n=20 gerbils). Altogether these results suggest that the CatCh-mediated optogenetic coding 
achieves a temporal fidelity similar to that of acoustic coding. 
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Figure 2. Characterization of optical and acoustic ABR in gerbils. (A) Experimental workflow: 4 – 12 weeks after AAV-
CatCh injection oABRs were recorded and compared to aABRs of the same gerbils as well as to those of non-injected 
animals. Light of a 473 nm laser was coupled in by a 200 µm optical fiber via a cochleostomy on the middle cochlear 
turn or through the round window. (B) oABRs from a representative AAV-CatCh-injected adult gerbil with varying light 
intensities (radiant flux, 1 ms at 10 Hz). Colors code the stimulus parameters. (C) Amplitude of oABR p1 – n1 as a 
function of light intensity (1 ms light pulses at 10 Hz). (D) Latency of oABR p1 as a function of light intensity for the 
same 20 gerbils (grey) as in C. (E) oABRs from a representative AAV-CatCh-injected adult gerbil with varying stimulus 
rates (32.2 mW for 1 ms). (F) Amplitude of oABR p1 – n1 as a function of stimulus rate (1 ms light pulses with high light 
intensities of 21 - 32 mW). (G) Latency of oABR p1 as a function of stimulus rate for the same 20 gerbils (grey) as in F. 
Grey lines in C, D, F, G symbolize different animals (n=20), blue line represents mean with vertical error bars indicating 
SD. Horizontal error bars in C, D represent the SD of the mean light intensity in the respective bin. (H) aABRs (80 dB SPL, 
0.3 ms) recorded at increasing acoustic click stimulation rate. (I) Quantification of aABR (n=13) p1 – n1 amplitude as a 
function of stimulation rate for acoustic clicks. Grey lines symbolize different animals; black line represents mean with 
vertical error bars indicating SD. (J) aABR p1 latency plotted against stimulation rate of auditory clicks (n = 13). (K) 
oABRs (blue, 32.2 mW, 1 ms at 10Hz) and aABRs (black, click of 0.3 ms, 70 dB, at 10 Hz) recorded in three 
representative AAV-CatCh-injected adult gerbils. (L) p1-n1 amplitude as a function of stimulus rate normalized against 
p1-n1 amplitude of 10 Hz aABRs (black) and oABRs (blue); data are shown as mean ± SD. (M) Latency of p1 as function 
of stimulation rates normalized against p1 latency of 10 Hz aABRs (black) and oABRs (blue) (mean ± SD). Data in C, D, F, 
G, L and M are pooled for oABR measurements in acutely and chronically implanted animals. 
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Electrophysiological characterization of optical activation of single spiral ganglion neurons: To 
further validate the CatCh-mediated SGN stimulation and scrutinize the temporal fidelity of 
stimulation, we performed juxtacellular recordings in vivo from individual SGNs during blue light 
stimulation from an optical fiber inserted through the round window (18). In order to maximize 
the chances to record SGNs, we inserted the electrode under visual control directly into the 
auditory nerve. At 10 Hz, 20 out of 29 SGNs fired one spike to each laser pulse; the remaining 9 
SGNs responded with multiple spikes (2.6 ± 0.68 spikes/pulse), suggesting the presence of 2 
separable clusters of SGNs (Fig. 3A, B). The first spike elicited by each pulse in a 10 Hz train was 
significantly more synchronized to the stimulus for the SGNs responding with a single spike (jitter 
= 0.26 ± 0.49 ms) than for the multiple spike-responding SGNs (jitter = 1.66 ± 1.49 ms, p-value ≤ 
0.01, Fig. 3C). Raster plots and peri-stimulus-time-histogram in response to light pulse trains of 10, 
100 and 300 Hz are shown for both a representative single spike and a representative multiple 
spike unit (Fig. 3D-F and Fig. 3G-I, respectively). Light pulses triggered spikes with high temporal 
fidelity as evident from high vector strength (0.85 ± 0.07) up to a stimulus rate of 100 Hz (Fig. 3J). 
At higher repetition rates, vector strength dropped to 0 for most SGNs, and remained low but 
significant in some SGNs (average for all SGNs: vector strength = 0.1 ± 0.06, p < 0.001, Rayleigh 
test). The vector strength of non-transduced SGNs in response to acoustic click trains revealed 
phase-locked responses up to the highest tested rate (500 Hz, Fig. 3J (black dashed line), fig. S6). 
The highest frequency leading to synchronized responses was 100 Hz for most of the single spike-
responding SGNs (Fig. 3K). On average the maximal frequency eliciting synchronized responses to 
optical stimulation was significantly higher for multiple spike-responding SGNs (242.8 ± 127.2 vs. 
121.4 ± 57.7 Hz, p ≤ 0.001, Fig. 3L). In contrast, optogenetically-driven single spike-responding 
SGNs increased their discharge rate up to 100 Hz, followed by a drop to ~0 spikes/s at higher 
rates, whereas multiple spike-responding SGNs sustained the response also for higher rates (Fig. 
3M). Above 100 Hz, the discharge rate of multiple spike-responding SGNs to light pulse trains was 
comparable to acoustic click trains (Fig. 3M, black dashed line). At repetition rates ≥ 100 Hz single 
spike-responding SGNs preferentially displayed phasic responses (adaptation ratio ≥ 10, n = 12/15 
cells) whereas multiple spike-responding SGNs responded in a tonic fashion (adaptation ratio < 
10, n = 9/9 cells, Fig. 3N). These recordings directly demonstrate optogenetic SGN excitation and 
corroborate the ABR results indicating substantial temporal fidelity with optogenetic stimulation. 
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Figure 3: Characterization of SGN responses to optogenetic stimulation. (A-B) Representative juxtacellular SGN 
recordings during the first 200 ms of a 900 ms pulse train (1 ms, 20 mW) with a repetition rate of 10 Hz of an exemplary 
single spike- (A) and a multiple spike-responding SGN (B). (C) Quantification of the first spike jitter elicited per light 
pulse for single spike- (green) and multiple spike- (red) responding SGNs. (D-I) Raster plots and peri-stimulus time 
histogram of a single spike- (D-F) and a multiple spike-responding SGN (G-I) in response to 900 ms train pulses of 10, 
100 and 300 Hz. (J) Vector strength as a function of repetition rate (n = 29). Blue lines correspond to the population 
mean, green lines to single spike-responding SGNs, red lines to multiple spike-responding SGNs and dashed black line to 
acoustic stimulation of control SGN (see figure S4 for details). (K, L) Distribution (K) and quantification (L) of the cut-off 
frequency (highest frequency with a significant vector strength) for single spike- (green) and multiple spike- (red) 
responding SGNs. (M) Discharge rate as a function of repetition rate (n = 29). (N) Adaptation ratio as a function of the 
number of spikes per light pulse in response to 10 Hz light pulse train. A color scale is used to represent the repetition 
rate. Data are expressed as mean ± SEM, and the statistical difference between groups were tested by Mann–Whitney 
U test (*** p-value ≤ 0.001) 
 
Chronic oCI development and electrophysiological characterization: In order to study a possible 
percept elicited by optogenetic SGN-stimulation we developed and implanted a chronic fiber-
based single-channel oCI in gerbils 4-8 weeks after AAV-CatCh or phosphate buffered saline (PBS 
control) injection (Fig. 4A). Functionality of the oCI was monitored by regular oABR recordings 
(every other day during the first week after surgery and once a week afterwards), eliciting stable  
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responses in AAV-CatCh injected, but 
not PBS-injected animals (AAV-CatCh: 
n = 7, PBS: n = 5 [2 of these 5 animals 
have been implanted and measured 
chronically], Fig. 4B). Chronic oCI 
produced stable and reliable 
responses over more than 3 weeks in 
all gerbils. Two animals were 
continuously tested until after 
behavioral experiments and 
displayed stable responses for more 
than 100 days (Fig. 4C). oABR 
amplitudes were similar between the 
last day of behavioral testing and the 
day after surgery (1.33 ± 0.86 μV 
after surgery, 0.99 ± 0.42 μV after 
behavioral testing, p = 0.14, n = 7) 
indicating a largely stable 
physiological response over time (fig. 
S7A). The mean oABR threshold 24h 
after chronic oCI surgery amounted 
to 6.9 ± 2.46 mW and was 
significantly elevated compared to 
oABRs measured in acute 
experiments (4.6 ± 2.8 mW, n = 7 for 
chronic, n = 14 for acute 
measurements, p = 0.038, fig. S7B, C). However, thresholds decreased over time and 3 weeks 
after implantation the responses were comparable to acute experiments (4.7 ± 2 mW, p = 0.44, 
fig. S7C). The position of the implanted fiber relative to the spiral ganglion was investigated with 
X-ray tomography of the cochlea (19). In these studies on five postmortem specimens the 
aperture always pointed slightly off the central axis of the modiolus (Fig. 4D, fig. S8). Therefore 
the optical fiber was not optimally orientated toward the SGNs. 
 
 
 
Figure 4. Chronic fiber-based, single-channel oCI. (A) Left: Chronic 
fiber-based single-channel oCI (arrow) housed in a stainless-steel 
capillary (scale 1 cm), center left: oCI (I) placed through the round 
window into the scala tympani just above the stapedial artery (SA); 
dashed line: bullostomy; center right: oCI 3 weeks after surgery (r: 
rostral, d: dorsal). Right: Gerbil, 3 days after implantation. Arrowhead: 
ferrule for optical fiber connection (B) oABRs of a AAV-CatCh injected 
animal (top) at the day of implantation (day 0) as well as 1, 3, 5 and 7 
days after implantation, no oABR was found in PBS-injected animals 
(bottom), blue bars indicate optical stimuli. (C) oABR amplitudes (p1 – 
n1, top) and latencies (p1, bottom) during the course of behavioral 
experiments (n = 7 up to day 40 post implantation; two animals to 
day 115); each line correspond to a single animal. (D) X-ray 
tomography of the cochlea including implant to confirm the fiber’s 
position after behavioral experiments. Green: Basilar membrane. 
Purple: Rosenthal’s canal. Black: Steel capillary. Blue: Optical fiber. 
Star: Cochlear apex. Scale bar: 500 µm. 
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Behavioral assessment of chronic oCI: In order to test whether the electrophysiological responses 
triggered by optical stimulation had functional effects on behavior, we chose the shuttle-box 
paradigm of negative reinforcement learning (Fig. 5A-C). The test has been successfully used for 
auditory studies in gerbils and employs mild electrodermal stimulation of the paws to reinforce 
crossing a barrier to a safe compartment upon a sensory target stimulus (20). To adapt the 
animals to the arena without risk of damage to the oCI we performed one session with acoustic 
click trains (Fig. 3D). This session was followed by subsequent optogenetic training. Gerbils 
learned to react to optogenetic stimuli over roughly a week, typically reaching more than 80% hit-
rate on day 6 of the daily training program (Fig. 5E).  
 
 
Figure 5. Optogenetically cued avoidance behavior. (A) Outline of the task: After an initial training period, the gerbil 
changes the compartments of the shuttle-box upon stimulus presentation (acoustic or optogenetic). (B-C) Picture of 
the shuttle-box (front wall removed) in a sound-attenuating chamber (B) and of a gerbil in the setup (C). Arrowhead: 
interface between ferrule and optical fiber. (D-E) Behavioral performance during the course of shuttle-box training for 
a single habituation session using acoustic stimuli (D) and the subsequent training period using optogenetic stimulation 
(E). Solid and dashed lines show mean hit and sham rates ± SEM for AAV-CatCh- (blue, n=7) and PBS-injected (orange, 
n=2) animals. Filled and empty markers show hit and sham rates, respectively, for each individual animal.(F): Hit rates 
in response to target (blue) and non-target (purple) trials during a control experiment with a blocked (left) and re-
opened (right) beam path. (G): Transfer from optogenetic to acoustic cues for avoidance behavior. (H) Second control, 
performed after transfer to acoustic stimulation. Different marker shapes correspond to different animals and are 
consistent throughout the figure. (I-L) Average hit rates and behavioral thresholds of individual animals for light power 
(I, J) and pulse duration (K, L). Solid and dashed lines indicate mean hit and sham rates ± SEM across all animals (I: n=7, 
K: n=5). Filled and empty markers show hit-rates for target and non-target trials, respectively. Behavioral thresholds 
were defined as the weakest stimuli eliciting significant performance in each individual animal (Chi-Square-Test, p < 
0.01). 
 
 
 
36 
Spontaneous crossing during non-target trials (interspersed trials without cue stimuli and negative 
reinforcement) occurred in typically 20% of these trials. Our results showed that learning strictly 
required opsin-expression by SGNs: hit-rates for target and non-target trials did not differ in PBS-
injected animals, even though they were stimulated with relatively strong light pulses (10 ms x 30 
mW = 300 µJ). Hit-rates of AAV-CatCh-injected animals broke down upon blocking the light path 
in the ferrule (still producing light emission at the coupler but not in the cochlea itself) and were 
restored immediately after re-opening the path, suggesting that the behavioral responses were 
not induced by visual cuing (the blue-light emission at the coupler) or by other sensory cues (Fig. 
5F). Optogenetically-trained gerbils transferred the avoidance behavior to acoustic stimulation: 
hit-rates in acoustic stimulation sessions were comparable to hit rates using optogenetic 
stimulation from the first acoustic session on and two out of five tested gerbils crossed the barrier 
to the safe compartment already in response to the first acoustic stimulus, suggesting at least 
some degree of generalization between the percepts elicited by optogenetic and acoustic 
stimulation (Fig. 5G).  
 
Following basic shuttle-box training, we estimated behavioral thresholds for light intensity and 
duration of the laser pulses. Here, within one session, target trials of either different light 
intensities or different pulse durations, as well as non-target trials, were presented pseudo-
randomly. After six identical sessions (60 repetitions of each trial type), for each light intensity and 
pulse duration, we compared the hit-rate of individual animals for each stimulus condition to the 
hit rate of non-target trials in the same animal (p < 0.01). Testing different light intensities ranging 
from 0.1 – 25 mW, we found that the hit-rate dropped sharply below 1.8 mW on average (1.8 µJ 
per pulse, Fig. 5I, J). This is below the thresholds obtained for acute recordings of oABR (4.6 µJ, 
see above) and single neuron responses in auditory cortex (3.11 µJ, see below). The average 
threshold for stimulus duration was approximately 140 µs (individual thresholds for 4 out of 5 
animals were as short as 50 µs; Fig. 5K, L).  
 
Neuronal response properties in primary auditory cortex and cochlear spread of excitation: In an 
effort to further characterize the auditory signaling elicited by oCI, we performed in vivo 
extracellular recordings from layer IV of the contralateral primary auditory cortex (AI) while 
stimulating the AAV-CatCh-transduced SGNs at the base of the cochlea with blue light (Fig. 6A). 
When an AI neuron was isolated, we first mapped its best frequency (BF, sound frequency for 
which the maximal spike rate was obtained). BFs progressed to higher frequencies along 
electrode tracks and covered the tonotopic range (Fig. 6B). A total of 43 neurons in AI were 
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studied of which 38 responded to pure tones with frequencies in the hearing range of gerbils. Out 
of these 20 neurons responded to optogenetic SGN stimulation (1 ms pulse length, approximately 
1 Hz repetition rate) albeit at different thresholds. Among the total set of 43 neurons studied, 22 
responded to individual light pulses. 
 
A range of response types was found: the majority of the neurons showed monotonically 
increasing firing rates with growing light intensity, whereas the firing rate of other neurons first 
rose but then decreased upon further enhancing light intensity (non-monotonic response, 
Monotonicity index < 0.5; Fig. 6C, D). Neurons with high BF (8-32 kHz) had a mean threshold of 1.4 
± 1.0 mW (SD, n = 5) consistent with the oABR and behavioral thresholds. Thresholds of lower BF 
neurons (<8 kHz) were significantly higher (8.0 ± 9.5 mW, n = 12, p = 0.046), indicating that limited 
light spread in the cochlea occurs (Fig. 6E, fig. S9).  
 
We followed up the aspect of light spread within the cochlea by a Monte Carlo ray tracing model 
based on an x-ray imaged gerbil cochlea with the 200 µm optical fiber implanted into scala 
tympani via the round window (fig. S10A). We modeled three million rays (λ = 473nm) in order to 
investigate the spread of excitation at the center of Rosenthal’s canal, where the somata of SGNs 
are housed. With a fiber output of 1 mW (chosen from the thresholds for most sensitive neurons 
recorded in AI in the range around 10 kHz) we estimated the threshold for neuronal excitation in 
Rosenthal’s canal to be 0.06 mW/mm² and the bandwidth of excitation to range from 10 – 14.7 
kHz (0.56 octaves, fig. S10B, C). As expected, we observed an increased light spread with fiber 
outputs of 5 and 10 mW that reached super-threshold irradiances at cochlear regions with BFs of 
5.7 - 26.3 kHz (2.2 octaves) and 3.05 - 32.1 kHz (3.4 octaves), respectively (fig. S9B, C). For these 
stronger light intensities, additional peaks of excited SGNs were observed: 0.51 - 0.87 (5mW) and 
0.39 – 1.34 kHz (10 mW, fig. S10B, C). We note that the projection of light from the round window 
does not represent the appropriate optical stimulation strategy for a future oCI.  
 
Therefore, we also modelled the spread of excitation for light delivered by a small optical fiber (10 
µm of diameter with a 0.1 NA) as an ideal light emitter placed at four different locations in the 
center of scala tympani along the tonotopic axis each facing Rosenthal’s canal that houses the 
SGN somata (fig. S10D). Our simulations revealed narrow light spread and indicated that 
excitation of distinct populations of SGNs can be achieved using optogenetic stimulation at 
emitter intensities in the range of microwatts (fig. S10E, F).  
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Figure 6. Responses of single AI neurons to optogenetic SGN stimulation. (A) Schematic shows the experimental 
approach: after initial mapping of the tonotopic representation to identify field AI of the contralateral auditory cortex, 
a single tungsten electrode was tangentially inserted and advanced to study the activity of single AI neurons (single 
unit) within the thalamo-recipient layer IV. (B) Neuronal responses of 3 individual neurons to pure tones along a 
representative recording track. The best frequencies (BF) of neurons varied systematically along each electrode track 
where BFs were lower dorsally and increased ventrally.   (C) Neuronal responses to individual laser pulses (1 ms, at 1 
Hz) applied to the contralateral cochlea in a monotonic (left) and non-monotonic unit (right). (D) Distribution of 
monotonicity-indices of all recorded unit. Dashed bar indicates a monotonicity index of 0.5 to discriminate between 
monotonic and non-monotonic units. (E) Comparison of acoustic and optical response properties. BFs are plotted 
against the corresponding laser threshold for each single unit (n = 20).  
 
Hearing restoration in a gerbil model of ototoxic deafness: Finally, we explored the potential of 
chronic oCI for restoring hearing in a gerbil model of ototoxic deafness. After measuring aABRs, 
AAV-CatCh injected gerbils were trained to detect 70 dB click trains using the shuttle-box 
paradigm. Animals were then deafened by bilateral, intracochlear injections of kanamycin (2 µl of 
100 mg/ml, (21)). Deafness was confirmed by absence of aABR (up to the highest sound pressure 
level amenable to our sound system (110 dB SPL) and the inability to perform shuttle-box 
behavior with acoustic stimulation (Fig. 7A).  
 
We then implanted single-channel oCIs and demonstrated optogenetic activation of the auditory 
pathway by means of oABR (Fig. 7B, C). Post-hoc immunofluorescence analysis indicated the 
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absence of hair cells from kanamycin-deafened ears (Fig. 7D). oABR thresholds of kanamycin-
treated chronically implanted gerbils were comparable to kanamycin-untreated chronically 
implanted gerbils (mean ± SD: 7.9 ± 3.5 mW, n = 4 in treated animals; 6.9 ± 2.4 mW, n = 7 in 
untreated animals). Next, we tested whether these acoustically trained animals, which could not 
use acoustic cueing any longer upon deafening, could transfer the learned behavior or would (re)-
learn the behavior by the optogenetic stimulation (Fig. 7E-G). One of the four gerbils tested 
immediately crossed to the safe compartment upon the first optogenetic stimulation with a hit-
rate of more than 80%, suggesting transfer of the acoustically cued behavior to the optogenetic 
cue; the other animals learned to use the optogenetic cue within a few days. On average, 
acoustically pre-trained and kanamycin-treated oCI implanted gerbils took 2.0 days (± 0.8 SD, n = 
4) to re-learn the task using an optical cue compared to 3.5 ± 1.7 days (n = 4, not different) when 
learning the task using acoustic stimulation in naive animals. As expected, the deafened gerbils 
could no longer use the acoustic cue even at the highest sound pressure levels amenable to our 
shuttle-box system (100 dB SPL, Fig. 7H). In conclusion, oCI stimulation of SGNs restored 
activation of the auditory pathway in a gerbil model of human ototoxic deafness as revealed by 
analysis of physiological and behavioral responses.  
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Figure 7. Restoration of hearing in a gerbil model of ototoxic deafness (A) Experimental workflow: after AAV-CatCh-
injection auditory brainstem responses were recorded, gerbils were trained in the shuttle-box for six days using 
acoustic stimulation and finally deafened by bilateral intracochlear injections of Kanamycin solution. After deafness 
was confirmed using aABRs and a single shuttle-box session, animals were implanted with an optical fiber. 
Subsequently, oABRs were recorded and shuttle-box experiments were performed using optogenetic stimulation. (B) 
(B) aABR thresholds (individual data and mean ± SEM, n = 4) for logarithmically spaced pure tones ranging from 1 to 16 
kHz as well as click stimuli, before (black triangles and solid line) and after deafening (red triangles and dashed line). (C) 
Representative aABR in response to a 60 dB click stimulus before deafening (black, top.). Absence of aABRs in response 
to 100 dB click stimuli as well as 1, 4 and 16 kHz pure tones after deafening (grey, middle). oABRs in AAV-CatCh 
injected oCI-implanted deafened animal (blue, bottom). Vertical dashed lines indicate stimulus onsets. All traces were 
recorded from the same animal. (D) Histological verification of IHC loss upon deafening. Overview of the apical turn of 
the organ of Corti in a control animal (top left) and a kanamycin deafened animal (bottom left). Phalloidin was used to 
stain actin prominently expressed in hair cells and supporting cells (red), Calretinin was used to stain spiral ganglion 
neurons and IHCs (cyan): arrowheads point to the location of IHCs. Note the lack of IHCs in the deafened animals. Scale 
bar: 100 µm. Right: Magnification of the regions outlined on the left side, respectively. Note that spiral ganglion 
afferents are still present in the deafened animal (bottom right). Scale bar: 10 µm. (E) Learning curves of shuttle-box 
behavior using 70 dB acoustic stimulation before deafening (E), 70 dB after deafening (F), optogenetic cues (G) and 
acoustic cues up to 100 dB after deafening (H). Solid and dashed lines indicate the mean hit-rates ± SEM for target and 
non-target trials, respectively. Filled and empty markers indicate the individual rates for each animal (n=4). Different 
marker shapes correspond to different animals and are consistent throughout the figure. 
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Discussion 
 
Here, we established the Mongolian gerbil as a rodent model for developing the oCI. We achieved 
AAV-mediated expression of CatCh in cochlear SGNs of adult Mongolian gerbils and characterized 
optogenetic stimulation by electrophysiology of single neurons and neural populations, as well as 
by behavioral analysis. CatCh-mediated optogenetic SGN stimulation drove the auditory pathway 
up to the primary auditory cortex and elicited avoidance behavior. Intramodiolar AAV-CatCh 
injection achieved CatCh expression in approximately 50% of the injected cochleae, where about 
30% of the SGNs were transduced. We did not find evidence for viral spread beyond the injected 
ear. All three cochlear turns were transduced to a similar extent which contrasts the primarily 
basal expression obtained with transuterine AAV-injection (12). The injection caused loss of SGNs 
(25%) that is likely to be due to the pressure injection, as it was also found in AAV-CatCh injected 
ears where no opsin expression was observed. As calretinin is thought to stain a subset but not all 
SGNs, the use of calretinin staining for identification of SGNs might have caused an 
underestimation of the number of SGNs and an overestimation of the transduction rate (22). 
Hence, despite calretinin labelling the vast majority of SGNs in our experience, future studies 
should employ more global neuronal markers to indiscriminately label all SGNs, such as beta III 
tubulin (23). Nonetheless, despite the relatively low SGN transduction rate in the present study, 
we obtained electrophysiological and behavioral responses in adult CatCh-positive gerbils. The 
finding that oABR could already be elicited when 10% of the SGNs were transduced contrasts our 
previous study in which at least 40% of the transduced SGNs were needed in order to support 
optophysiological responses (12).  
 
In contrast to the very large (10s - 100s of µV) and delayed (3 ms) optically-evoked far-field 
potentials reported for transgenic mice and rats, we observed smaller and earlier potentials with 
targeted viral optogenetic manipulation of the ear of gerbils (12). These differences might be due 
to a more localized expression of CatCh in SGNs using injections into the adult spiral ganglion, 
compared to the Thy1.2-driven broad neuronal expression of ChR2 employed in our previous 
work that might have resulted in optogenetic stimulation extending to structures beyond the 
auditory pathway. In support of this hypothesis, in the present study oABRs and aABRs were more 
similar in amplitude and showed the expected short latency for direct optogenetic SGN 
stimulation. oABRs remained sizable for stimulus rates of up to 200 Hz, and the oABR-amplitude 
reduction of 1.5 fold observed when raising stimulus rate from 10 to 150 Hz, was favorable 
compared to the aABR amplitude reduction (2.5-fold), indicating that temporal fidelity of 
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optogenetic coding might approach near physiological performance. We consider this an 
important advance over our previous work, which indicated much lower temporal fidelity 
(responses were only found up to 70 Hz) (12). Our juxtacellular recordings from single SGNs 
confirmed specific, synchronized optogenetic excitation of SGNs up to repetition rate of 100 Hz 
for all recorded fibers. This result supports the temporal fidelity reported by oABR and is in 
accordance with the closing kinetic of CatCh (16 ms measured at room temperature) (14). The 
lower spike time fidelity and limited spike probability at stimulus rates beyond 100 Hz observed 
are likely compensated at the neuronal population level, as several SGNs jointly encode 
information from each place of the tonotopic map (24). 
 
We found considerable differences in oABR amplitudes among the gerbils. This variability might 
be due to differences in transduction rate, amount of CatCh expression among the transduced 
cells and positioning of the optical fiber. Nonetheless, the key features such as the dependence of 
p1-n1 amplitude and p1-latency on the radiant flux and rate of stimulation were comparable 
among different CatCh transduced animals. We could not determine the exact light propagation 
from the fiber aperture within the cochlea and hence, it was not possible to determine the precise 
irradiance at a given point of the SGNs. However, we employed a Monte Carlo ray tracing model 
to estimate the irradiance at the site of neural excitation. Considering the maximum light intensity 
used in our behavioral experiments (30 mW) we estimate the maximal irradiance at the site of 
SGN somata to be  approximately 2 mW/mm², which is within the safe range for optogenetic in 
vivo applications (up to ~75 mW/mm² for 0.5-50 ms pulses; even up to ~300 mW/mm² in some 
studies) (25, 26). Furthermore, the oABR long-term stability for > 100 days observed here suggests 
absence of tissue damage due to optogenetic stimulation. 
 
In 40% (8/20) of the tested animals oABR increased in amplitude when increasing light intensity 
over more than one order of magnitude, indicating an output dynamic range of optical coding > 
20 dB. As the response did not plateau in the majority of animals the average apparent dynamic 
range of 16 dB is likely an underestimation. This contrasts with coding with eCI where typically < 
10 dB dynamic range were reported (4). This might reflect the lower spread of excitation with 
optical stimulation as well as differences in the expression of CatCh among SGNs at the tonotopic 
place of stimulation. Recordings of oABR revealed a minimal stimulus duration of < 200 µs and an 
energy threshold of approximately 4.6 µJ per pulse. Recordings of single neuron firing in primary 
auditory cortex confirmed this energy threshold. A recent study in awake primates demonstrated 
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that approximately 40 % of neurons in the auditory cortex could be driven by contralateral eCI 
stimulation (27) while we observed 52 % of neurons driven by oCI in the gerbil.  
 
Our chronic experiments employed a fiber-based single-channel oCI that enabled stable 
stimulation over several weeks. This allowed longitudinal tracking of oABR and behavioral analysis 
of oCI function in individual gerbils. The absence of learning by PBS injected animals rules out the 
sensation of opto-thermal or opto-acoustic effects in the cochlea as a behavioral cue. In AAV-
CatCh injected gerbils, behavioral estimates of thresholds for light pulse intensity and duration 
were lower than those obtained in our oABR experiments, indicating that activation of few 
neurons might suffice to trigger SGN stimulation. Still, behavioral experiments might have 
overestimated the energy threshold of oCI, because post-mortem X-ray phase-contrast 
tomography of the implanted cochlea indicated non-optimal projection to the spiral ganglion 
from the fiber. Therefore, the behavioral estimate of the energy threshold (2 µJ) is lower than the 
threshold obtained with physiological methods but might still overestimate the light required for 
triggering auditory perception.  
 
Nonetheless, lowering the energy requirement, which currently exceeds the energy per pulse in 
eCI (0.2 µJ for biphasic pulses of 80 µs, remains an important objective in order to fully capitalize 
on the potential of oCI for miniaturizing the stimulation site (for example using 50 µm sized LEDs 
compared to hundreds of µm for eCI), avoid potential phototoxicity and thermal effects as well as 
to enable acceptable battery lifetimes in future clinical oCI (4, 28, 29). Such efforts include 
achieving greater transduction rates as well as stronger expression by optimizing virus-capsid, 
promoter and virus preparation and better positioning of emitter(s) in scala tympani by arrays of 
µLEDs or waveguides (29). Indeed, our optical modelling indicated that placing an “ideal emitter” 
into scala tympani might dramatically lower the energy required. Moreover, we expect that the 
higher energy requirements of the oCI due to the larger number of stimulation channels 
compared to eCI can be offset by lower rates of stimulation closer to the physiological SGN firing 
rates (24). 
 
Studies of acoustically- and optogenetically-guided avoidance behavior in the shuttle-box 
indicated that acoustic percepts were formed with both modes of stimulation of the auditory 
pathway (sound and light). Interestingly, immediate transfer of optogenetically-trained behavior 
to acoustical stimulation was observed in all five gerbils investigated whereas the opposite 
(transfer of acoustically-induced behavior to optogenetic stimulation) was found for one of four 
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acoustically-trained, subsequently deafened and oCI-implanted gerbils. By combining bilateral 
deafening by intracochlear kanamycin injection with chronic oCI, our results suggest that 
restoration of auditory function might be achieved with oCI.  
 
Taken together, the results of our present study demonstrate the feasibility of optogenetic 
activation of the auditory system following AAV-CatCh transduction in SGNs in adult gerbils. We 
find good temporal precision of optogenetically driven spiking in CatCh-expressing SGNs. Activity 
propagates up to primary auditory cortex. Furthermore, acoustic perception was confirmed in 
behavioral experiments with hearing and deaf animals. Our work increases the viability of 
cochlear optogenetics as an alternative hearing restoration technology and lays the foundation 
for in depth preclinical research.  
 
Next to the far from complete viral transduction of the spiral ganglion and the employment of 
CatCh, which has a relatively slow deactivation, our study was limited by the use of oCIs based on 
single optical fibers with non-ideal light projection onto SGNs. Our ray tracing model supports the 
expected potential for more spatially confined stimulation of SGNs when choosing appropriate 
positioning of emitters. Next steps of developing oCIs towards clinical application should include 
studies of spectral resolution combining appropriate multichannel stimulation like waveguide 
array-based or µLED-based multi-channel oCIs with electrophysiological and/or psychophysical 
studies of frequency and/or emitter discrimination (29). Such investigation of the cochlear spread 
of excitation with more realistic oCIs will help to determine the number of independently usable 
stimulation channels of future oCIs. 
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Materials and Methods 
 
Study design: We aimed to investigate optogenetic viral constructs to transduce spiral ganglion 
neurons in an adult rodent model for their potential for optogenetic hearing restoration. Animals 
transduced with a suitable construct were further investigated with physiological, 
immunohistochemical, imaging and behavioral methods. 
 
Statistical Analysis: All data displayed in the figures is expressed as mean ± standard deviation, 
unless stated otherwise. Unless noted otherwise an alpha level of 0.05 was considered significant.  
 
SGN recordings: The presence of two subpopulations of spiral ganglion neurons was confirmed 
using Akaike’s information criterion computed on the number of spike per pulse in response to 10 
Hz light pulse train. Significance of different cutoff-frequencies in these subpopulations was 
confirmed using the Mann–Whitney U test. Vector strength of SGNs was checked for significance 
using the Rayleigh-Criterion. If the Rayleigh statistic L was larger than 13.8, the null hypothesis 
was rejected at the 0.001 significance level and insignificant vector strengths were set to 0.  
 
oABRs: An independent two-sample t-test was used to analyze potential threshold differences of 
optically evoked ABRs in acute measurements vs chronically implanted animals. The relation 
between oABR amplitude and YFP-expressing SGNs was analyzed by using simple linear 
regression.  
 
Behavior: As the behavioral output of an animal in the shuttlebox (compartment change/no 
compartment change) is a categorical one, sham and hit rates for each animal were compared 
against each other using a Chi²-test (p < 0.01) to determine significant performance.  
 
Auditory cortex recordings: Threshold differences for optical stimulation of auditory cortex units 
tuned to low (1-8 kHz) and high (8-32 kHz) frequencies were analyzed using a one-sided 
independent two-sample t-test. Statistical analyses were performed using Matlab R2016a, R 3.4.4 
and Python 3.6. 
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Supplementary methods 
Animals 
Experiments were performed in 131 male and female Mongolian gerbils (Meriones unguiculatus; 
44 CatCh-positive; 52 CatCh-negative; 11 Chronos-negative; 5 PBS-injected and 19 wildtype). The 
exact number of animals contributing to each experiment is listed in table S1. Injections were 
performed on animals older than 8 weeks and for all other experiments animals were older than 
12 weeks of age. All experiments were approved by the local animal care and use committee and 
the authorities of the State Lower Saxony. 
 
Postnatal intracochlear injection of Adeno-Associated virus (AAVs) 
Gerbils were anesthetized with isoflurane (4 % at 1 l/min for induction, 1-2 % at 0.4 l/min for 
maintenance) during postnatal intramodiolar injections of AAVs and placed on a remote-
controlled heating blanket (Hugo Sachs Elektronik – Harvard Apparatus). Appropriate analgesia 
was achieved by subdermal injections of buprenorphine (0.1mg/kg bodyweight (BW)). Anesthetic 
depth was ensured by frequent testing of the absence of the hind-limb withdrawal reflex. 
Accordingly, the isoflurane concentration was adjusted. All following surgical steps were 
performed under microscopic control. The left middle ear was accessed by exposing and carefully 
opening the bulla using a retroauricular approach. A small hole was drilled into the basal modiolus 
using a KFlex dental file (no. 15) going through the upper circumfence of the round window niche, 
bypassing the scala tympani. The right ear was left untreated and served as a control in 
histological analyses. Approximately three microliters of Adeno-associated Virus solution (3.2x1012 
-2.7x1013 genome copies/µl) were injected into the modiolar center via quartz micropipettes 
(Science products, pulled on a P-2000 laser puller, Sutter Instruments; tip diameter ~ 20 μm) 
connected to a pressure microinjector (100 – 125 PSI, PLI-100 pico-injector, Havard Apparatus). 
Control group received equal volume of AAV-free phosphate buffered saline (PBS). Retroauricular 
autologous connective tissue was used to cover the opened bulla and the surgical situs was closed 
by suturing the skin. All animals were allowed to recover for at least 4 weeks after injection.  
 
Recording of Auditory Brainstem Responses (ABRs) 
ABRs were recorded by needle electrodes inserted underneath the pinna, on the vertex and on 
the back near the tail of the animal. The potential difference between vertex and mastoid 
subdermal needles was amplified using a custom designed amplifier, sampled at a rate of 50 kHz 
(NI PCI-6229, National Instruments), stored on a PC hard drive and filtered off-line (300–3,000 Hz 
Butterworth filter) for acoustically and optically ABRs (a/oABRs). a/oABRs were carried out with 
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the animal placed on a custom build heating plate (at 38 °C) on a vibration-isolation table within a 
soundproof chamber (Industrial Acoustics Company GmbH). Gerbils were anesthetized with 
isoflurane (4 % at 1 l/min for induction, 1-2 % at 0.4 l/min for maintenance) and appropriate 
analgesia was obtained with subdermal injection of buprenorphine (0.1mg/kg BW). Stimulus 
generation and presentation (acoustic and optic) as well as data acquisition were realized by 
custom written software in MATLAB (The MathWorks, Inc.) employing National Instruments data 
acquisition (NI-DAQ) cards in combination with custom build hardware to amplify as well as to 
attenuate audio signals, control laser drivers and to acquire data. For aABRs clicks of 0.3 ms length 
were presented near field via a single loudspeaker (Vifa, Avisoft Bioacoustics) placed 30 cm in 
front of the animal at the level of the animal’s head. Sound pressure levels were calibrated with a 
0.25 inch microphone (D 4039, Brüel & Kjaer GmbH) and measurement amplifier (2610, Brüel & 
Kjaer GmbH). For optical cochlear stimulation, a blue laser (473 nm, MLL-FN-473-100, 100 mW 
diode pumped solid state [DPSS]; Changchun New Industry Optoelectronics) was coupled to a 200 
µm optical fiber that was inserted into the cochlea either through the round window or a 
cochleostomy performed in the middle cochlear turn. The left cochlea was approached as 
described for intracochlear injections. Laser power was calibrated before every experiment with a 
laser power meter placed at a distance of 1 cm from the fiber tip (Gentec-EO Solo 2). Due to the 
unknown exact position of the optical fiber used in each experiment with respect to the SGNs to 
be stimulated we cannot assess the exact irradiance. However, based on a Monte Carlo ray 
tracing model (fig. S9) we estimate the irradiance to not exceed 3 mW/mm² at the site of neural 
stimulation (Rosenthals’ canal). The dynamic range of the stimulus intensity to ABR amplitude 
relationship was given in dB and defined as the range from threshold, identified by manual 
observation, to the point where either the slope of the stimulus-amplitude function is less than or 
equal to 5 % of the maximum slope or the maximum intensity employed. To compare the change 
in ABR amplitude and latency in dependence of stimulus repetition rates (Fig. 2) ABR data was 
normalized for each individual animal. For ABR amplitude, p1-n1 amplitudes in response to all 
stimulus conditions were divided by the p1-n1 amplitude of the 10 Hz stimulation rate condition 
(slowest stimulation rate tested). To normalize ABR latency (Fig. 2M), the p1 latency of the 10 Hz 
stimulation rate condition was subtracted from p1 latencies of all stimulus conditions. This was 
done to compensate for the different latencies observed in aABRs vs oABRs. 
 
Extracellular single auditory nerve fiber recordings 
Gerbils were anesthetized with Isoflurane (4 % at 1 l/min for induction, 1-2 % at 0.4 l/min for 
maintenance) and appropriate analgesia was obtained with subdermal injection of buprenorphine 
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(0.1mg/kg BW). The left auditory nerve was approached by removing parts of the left occipital 
bone and carefully aspirating the left hemisphere of the cerebellum (for more detail see (30)). 
Optical stimulation of the cochlea was performed as described for oABRs. During recordings in the 
auditory nerve the animal was placed on a heating plate (custom made, body temperature kept at 
38 °C rectal temperature) on a vibration-isolation table within a heated (30 °C) soundproof 
chamber (Industrial Acoustics Company GmbH). The animal’s head was fixed by a head post 
mounted with dental cement to the skull at the vertex. Pulled (P-1000, Sutter Instrument) glass 
micro electrodes (borosilicate, 1B100 F-4, world precision instruments) filled with 3 M NaCl (70 – 
80 MΩ tip resistance) were advanced through the auditory nerve by a single-axis inchworm 
micromanipulator (Burleigh EXFO 8200). Extracellular signals were amplified (ELC-03XS amplifier, 
NPI Electronics), band-pass filtered between 300 and 3000 Hz and digitized (National instruments 
card PCIe-6323) in custom written software (MATLAB, The MathWorks, Inc.). Phase-locking was 
quantified using the vector strength (31) according to the following equation : 
𝑣𝑣𝑣𝑣𝑣𝑣 𝑠𝑣𝑣𝑣𝑠𝑠𝑣ℎ =  
��∑ cos𝛳𝑖𝑛𝑖=1 �
2+ �∑ sin𝛳𝑖𝑛𝑖=1 �
2
𝑛
 , where ϴ1, ϴ2, ϴ3, …, ϴn are phases from spikes. 
This parameter varies from 0 to 1. The significance of phase-locking was tested with the Rayleigh 
test of circular data (32). The presence of two subpopulations was investigated by a k-means 
clustering analysis using Akaike's Information Criterion (criterion = 1.5 spike/pulse). In order to 
distinguish tonic vs phasic responses, we calculated an adaptation ratio as the ratio between the 
discharge rate during the first 50 ms and 900 ms for repetition rate ≥ 100Hz). 
 
Chronic oCI  
Anesthesia and analgesia were administered identical as for acute oABR recordings. An optical 
fiber (Thorlabs; 200 µm diameter, 30 mm length) coupled to a 2.5 mm steel ferrule was funneled 
through a custom bent stainless steel capillary (500 µm inner diameter; bent at the minimal long-
term bending radius of the optical fiber, i.e. 24 mm; ca. 29 mm length) for optimal shape and 
protection of the fiber. The skin overlying the parietal bones was removed and a fiber-holder 
(aluminum, 30 mm length) was fixed to the head of the animal using a self-etching UV-glue and 
dental cement. A blank metal wire (500 µm diameter; impedance < 1Ω) was implanted just left to 
the midline of the animal’s skull to serve as negative electrode for chronic oABR measurements. 
Care was taken to avoid touching the aluminum fiber-holder with the metal wire. Needle 
electrodes underneath the pinna and on the back of the animal were placed acutely whenever 
oABRs were recorded (recording procedure: see ABR recordings). The fiber implant was then 
placed in the round window of the animal (using the retroauricular approach described above) 
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while oABRs in response to blue light test pulses were constantly monitored online (12). As soon 
as a fiber position was found that reliably elicited oABRs, the implant was fixed at the cochlea of 
the animal using dental cement. For a second point of stabilization, the ferrule-coupled end of the 
implant was glued to the fiber-holder on the animal’s head. Finally, the skin of the animal was 
sutured and glued with histoacrylic glue. Animals were given subcutaneous injections of 
Carprofen (0.05mg/10g BW) immediately, 24h and 48h after the surgery. oABRs were then 
regularly measured under isoflurane anesthesia during the course of behavioral testing to confirm 
the presence of a physiological response. 
 
Shuttle box behavior 
For behavioral testing, a custom-built shuttle box located in a sound attenuated chamber 
(75x50x100 cm (WxDxH); IAC Acoustics) was used. The shuttle box consists of two platforms 
(25x25 cm; each assembled from 16 metal bars of 4 mm diameter, 15 mm spacing center to 
center), separated by a hurdle (4 cm height) and surrounded by plastic tubes (2.5 cm diameter, 
spaced 3.5 cm center to center; 35 cm height). Both platforms were mounted on an individual set 
of metal springs (4 per platform) and equipped with acceleration sensors (LIS344ALH; 
STMicroelectronics) to determine the position of the animal (fig. S10). Generation and 
presentation of stimuli as well as data acquisition was done using custom-written Matlab-scripts 
(The MathWorks, Inc) actuating NI-DAQ cards combined with custom build hardware for signal 
attenuation and amplification. Acoustic stimuli were delivered using a loudspeaker (ScanSpeak, 
Avisoft Bioacoustics) centered over the shuttle box and mounted to the ceiling of the chamber. 
For optogenetic stimulation, a blue laser (488 nm, LBX-488-100-CSB, Oxxius) was coupled to a 
200 µm optical fiber with an integrated rotary joint (Thorlabs) mounted to the ceiling of the 
chamber. The free end of the fiber could then be connected to the ferrule end of the animal’s 
implant to optically stimulate spiral ganglion neurons. For behavioral training, animals were 
placed in the shuttle box and given an adaptation time of 5 minutes before stimuli were 
presented. Both acoustic and optical stimuli (click or pulse trains) had durations of 250 ms and 
were presented with a repetition rate of 2 Hz during a response window of 6 seconds (60-80 trials 
per session with an inter-trial-interval randomized between 16 and 21 seconds). Upon perception 
of a stimulus the animal was expected to cross the hurdle of the shuttle box. If the animal crossed 
the hurdle within the response window, the trial was considered a hit and the stimulus was 
switched off. If the animal did not cross the hurdle in time, an aversive electric stimulus (0.2-
2 mA) was administered to the animal’s feet via the metal bars of the platform until the animal 
crossed the hurdle (or for a maximum of 6 seconds) and the trial was considered a miss. Per 
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session, 10 sham trials in which no stimulus was presented and accordingly no consequences for 
the reaction of the animal existed were randomly intermixed with regular target trials in order to 
determine the baseline activity of the animal. The hit (sham) rate of the animal for target (and 
sham) trials is reported as the fraction of target (or sham) trials in which the animal crossed the 
hurdle divided by the total number of target (or sham) trials. 
In the morning of the second day after fiber implantation animals were placed in the shuttle box 
and underwent one session of training using acoustic stimulation (250 ms click trains at 2s-1 with a 
click rate of 50 s-1; peak intensity: 91.5 dB SPL; calibrated with a 0.25 inch microphone [D 4039, 
Brüel & Kjaer GmbH] and measurement amplifier [2610, Brüel & Kjaer GmbH]) as cues for hurdle 
crossing. This training was necessary because after being placed in the shuttle box and receiving 
electrodermal stimulation for the first time, previously naïve animals showed unspecific 
locomotion (e.g. undirected, repetitive jumping or quick spurts across the hurdle) which was 
abandoned after a few trials. Thus, to avoid damage of the implant or injury of the animal, this 
session served to habituate animals to the setup. In the afternoon of the same day and of the five 
subsequent days animals underwent behavioral training using supra-threshold optogenetic 
stimulation (250 ms pulse trains with a repetition rate of 2 s-1 (10 ms pulses at 50 s-1, 25-30 mW at 
472 nm). In all sessions employing optogenetic stimulation animals were briefly anesthetized with 
isoflurane in order to connect the implant to the laser-coupled optical fiber for light delivery 
(adaptation time started once the animals were active again). In session no. 7 the laser beam path 
was blocked between the implant and the optical fiber in order to ensure that animals did not use 
any cues (especially visual) other than optogenetic stimulation to solve the task. Once the animals 
learned the task, behavioral thresholds of optogenetic stimulation were determined. For this, the 
stimulus structure of 250 ms pulse trains presented with a repetition rate of 2 s-1 was similar to 
the other sessions and pulses had 1 ms duration, a repetition rate of 10 s-1 and varying amplitude 
or varying pulse durations, a repetition rate of 2 s-1 and 25 mW intensity to determine amplitude 
or pulse duration thresholds, respectively. The repetition rate for pulse duration threshold 
determination was chosen to be lower in order to avoid cumulative effects of several pulses that 
would lead to a percept. In each session animals absolved 10 trials of each condition as well as 10 
sham trials and response rates were averaged across sessions. After determining behavioral 
thresholds, 3 sessions using acoustic stimulation (identical to the very first habituation session) 
were absolved to check whether animals, once they learned the task using optogenetic cues, can 
generalize these to acoustic stimuli. Finally, the control experiment in which the laser beam path 
was blocked was repeated to rule out that animals, after being trained on harder tasks 
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(thresholds) and generalizing the cues to acoustic stimulation will be able to use any kind of visual 
cue that might potentially originate from the laser stimulation. 
 
Recordings from primary auditory cortex neurons 
Recordings in the primary auditory cortex (AI) were performed in the same environment and 
conditions as described for ABR recordings. In addition, the animal’s head was fixed by a head 
post mounted with dental cement to the skull at the vertex. The bone above field AI of the right 
auditory cortex – contralateral to the intracochlear injection - was removed, leaving the dura 
intact. Multi- as well as single-unit recordings were realized by single tungsten electrodes (5 MΩ) 
positioned and advanced by a LN Junior 4RE micro manipulator (Luigs&Neumann). Amplification 
of signals, data acquisition as well as extracellular spike detection were implemented by a 
Neuralynx system (Digital Lynx 4S, Cheetah data acquisition hard and software, Neuralynx Inc.). 
For local field potentials (LFP) neuronal signals were bandpass filtered in a range of 0.1 – 300 Hz, 
for neuronal spikes between 600 and 6,000 Hz and after amplification recorded at a sampling rate 
of 32 kHz. Data analysis was performed off-line with custom software written in MATLAB (The 
MathWorks, Inc.) and Python (Python Software Foundation). Stimulus generation and 
presentation was obtained using the same hardware as described for ABR recordings also driven 
by custom written MATLAB software (The MathWorks, Inc.). Before driving a tangential, dorsal-to-
ventral track through AI – aiming at layer IV in 600 µm depth (33) – location and tonotopy of AI 
was determined by recording LFPs from several positions at the cortical surface while playing 
acoustic tone bursts from 0.25 – 32 kHz at 60 – 90 dB SPL in 9 logarithmic steps. Search stimuli for 
single unit activity consisted of acoustic sine bursts covering 0.25 – 32 kHz at 60 – 90 dB SPL in 
quarter octave steps. However, when encountering spontaneously firing neurons, we always 
attempted to drive them with auditory stimuli and/or light pulses. For neurons which were driven 
by light pulses we calculated a monotonicity index as the evoked firing rate at the highest light 
intensity divided by the maximum evoked firing rate (34). Neurons with a monotonicity index of 
0.5 or lower were considered “nonmonotonic” (34).  
 
Deafening 
Using the retroauricular approach as described for the virus injections, gerbils were deafened by 
bilateral intracochlear injections of 2-3 μl Kanamycin solution through the round window 
membrane (100 mg/ml, Kanamysel, Selectavet). After the injection, a small piece of gelatine 
sponge soaked in Kanamycin solution was placed in front of the round window (Gelita-Spon; 
Gelita medical) and the surgical site was covered with connective tissue. Animals were allowed to 
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recover for 7-10 days before deafness was confirmed by ABR recordings as well as shuttle box 
behavior. 
 
Histology  
Cochlear cryosections: Cochleae of both sides were taken out of the temporal bone immediately 
after death of the animal and fixed in 4 % paraformaldehyde (PFA) for 1 h. For cryosectioning 
cochleae were decalcified in Ethylenediaminetetraacetic acid (EDTA, 0.12 M for 3 – 4 days). 
Immunolabeling of calretinin, neurofilament and CatCh-eGFP was performed on 16 µm thin 
sections with calretinin CG1 (1:300, goat, Swant), Neurofilament 200 (1:300, mouse, Sigma) and 
Alexa Fluor 488-conjugated GFP (1:500, rabbit, Invitrogen) antibodies, respectively, and 
appropriate secondary antibodies (1:300, Invitrogen) in the case of calretinin and NF200. Images 
were acquired using a Leica SP5 confocal microscope. 
Whole-mount organ of Corti preparations: After decapitation, cochleae from adult wildtype-
control and pharmacologically-deafened gerbils were dissected, fixed in 4% formaldehyde 
solution (overnight, 4°C) and decalcified in 0.12 M EDTA solution (10 – 14 days at 4°C). 
Subsequently, organs of Corti were dissected in phosphate-buffered saline (PBS) and 
immunostainings performed essentially as described in Vogl, Panou, et al. 2016 (35). Briefly, 
specimens were incubated with goat serum dilution buffer (comprised of: 16% normal goat 
serum, 450 mM NaCl, 0.3% Triton X-100, 20 mM phosphate buffer, pH 7.4) to block non-specific 
binding sites and finally probed with a rabbit anti-calretinin primary antibody (1:300; Swant, 
CR7697). For immunolocalization, an Alexa Fluor 568-conjugated goat anti-rabbit secondary 
antibody (Thermo Fisher Scientific, A11011) was combined with an Alexa Fluor 633-coupled 
phalloidin (Thermo Fisher Scientific, A22284) to co-label F-actin-containing substructures within 
the sensory epithelium, such as hair cell stereocilia and cuticular plates, as well as the actin-
cytoskeleton of adjacent supporting cells. Finally, specimens were mounted in Mowiol mounting 
medium and imaged either on an (i) Axio Imager M2 System (5x objective, Zeiss) controlled by a 
Neurolucida system (Version 11, MBF Bioscience) or (ii) a Leica TCS SP2 laser-scanning confocal 
microscope with a 1.4 NA 63x oil immersion objective and HeNe 561 nm and 633 nm excitation 
laser lines. Images were processed for display in ImageJ (36) and Adobe Illustrator and presented 
as maximum projections of the acquired image stacks. 
  
X-Ray tomography 
After behavioral experiments the placement of the optical fiber was assessed with phase-contrast 
tomography (19). The customized cone-beam in-line tomography instrument was equipped with a 
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liquid-metal x-ray source (JXS D2, Excillum) operated at 70 kV acceleration voltage and combined 
with a 20 µm LuAG-scintillator-based fiber-coupled charge-coupled device (CCD) detector (6.5 μm 
pixel size, C12849-102U, Hamamatsu). The raw image data were fast Fourier-based transformed 
and finally reconstructed using the ASTRA toolbox (37, 38). Segmentation and 3D visualization of 
the reconstructed volume was realized with Avizo 3D 9 (Visualization Sciences Group, FEI 
Company). Automatic histogram-based segmentation was used to visualize bony structures, steel 
capillary and optical fiber. The basilar membrane and Rosenthal’s canal were traced with 
semiautomatic tools. 
 
Monte Carlo ray tracing 
To estimate the light spread in the gerbil cochlea, we conducted Monte Carlo ray tracing 
simulation using TracePro® Standard 7.8.1 (Lambda Research Corporation). The following cochlear 
structures were included and modelled as meshes of 7500 triangles reconstructed from x-ray 
tomography: 1) scala tympani, 2) scala vestibuli and scala media, 3) modiolus and 4) Rosenthal’s 
canal and peripheral processes. These volumes were embedded in a solid square prism to account 
for the cochlear bone. Mean optical properties for cerebrospinal fluid, brain tissue and bone 
taken from the literature were assigned to each mesh (39–48). The light sources were modeled as 
grid sources with a circular ray pattern of 1001 rings (3003001 rays, λ = 473 nm) with a symmetric 
Gaussian spatial and angular beam distribution and uniform total intensity of 10 mW. 
Two different light sources were modelled: the optical fiber used in the experiments (Thorlabs 
FT200UMT, 0.39 NA) and an optimal emitter (here approximated by the profile of the Thorlabs 
FG010LDA, 0.1 NA optical fiber). The properties of the optical fiber used in the experiments were 
defined in TracePro as follows: grid boundary radius: 100 µm; waist radius of Gaussian beam 
profile: 100 µm; half angle of angular profile of the beam: 16.79°. The properties of the optimal 
emitter were defined as follows: grid boundary radius: 5 µm; waist radius of spatial profile: 5µm; 
half angle of angular profile: 4.25°. The half angle for angular profiles were calculated using the 
formula: θ = sin-1 (NAfiber/nScala Tympani) (θ: half angle; NA, numerical aperture; n, refractive index). 
The surface of the experimental fiber was placed according to the model obtained from x-ray 
tomography, the optimal emitter was placed on the center line of scala tympani, facing 
Rosenthal’s canal at different tonotopic positions.  
Radiant flux was read from 300 query points (included as solid spheres with a 5 µm radius, with 
assigned optical properties of brain tissue) placed along the centerline of the Rosenthal’s canal 
using custom scripts. Irradiance was calculated as: Irradiance = Radiant Flux /4*pi*radius2. 
Irradiance values were scaled for the different intensities using the ratio between the simulation 
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intensity (10 mW) and the other investigated intensities (1, 5, and 30 mW) assuming a linear 
relationship (confirmed by initial simulations for all intensities). Intensities of the optimal sources 
were scaled so their maximal irradiance (peak of the profile) at the center of Rosenthal’s canal 
was equal to the maximal irradiance (peak of the profile) of the experimental fiber achieved with 
10 mW, and then scaled for the other intensities. Note that the required intensity of the optimal 
source was approximately 3 orders of magnitude lower than for the experimental fiber. 
Smoothed traces from the experiment fiber were obtained from the average between the higher 
and lower envelopes of the traces calculated by spline interpolation over local maxima separated 
by at least 5 points. These smoothed traces were used to determine the irradiance threshold 
(taken as the irradiance value at 10 kHz – the tonotopic position with the lowest auditory cortex 
response thresholds collected from the in vivo experiments – obtained with a total source 
intensity of 1 mW) and the suprathreshold frequency ranges/octaves. All the data processing and 
analysis were done in MATLAB R2016a (The Mathworks, Inc) with custom scripts. 
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Supplementary Figures 
 
 
 
Figure S1. Effects of postnatal transfection of SGNs in adult Mongolian gerbils using the opsins Chronos and CatCh. 
(A) Table of experiments summarizing the attempts to functionally express Chronos in SGNs of adult gerbils. (B) 
Comparative analysis of expression of Chronos vs. CatCh via immunohistology. A single line 7.5 µm long line was 
centered on the presumed cell membrane such that half of the line was inside the SGN while excluding the nucleus and 
the other half was located in the extracellular space sparing neighboring cells. (C) Quantification of the grey value as a 
proxy for expression strength along the line profile for randomly chosen transduced SGNs (animals: n=4, cells: n=20).  
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Figure S2. Spiral ganglion neuron (SGN) density of AAV-injected but CatCh-negative animals. (A) Quantification of SGN 
density in sections of the apical, middle and basal cochlear turn. Crossbars show mean and SEM, symbols raw data for 
investigated animals (n=4). Statisical analysis was performed with a standard tow sample t-test. (B) Cochlear 
immunostainings (exemplary section of a middle turn) in maximum projection with immunofluorescence for YFP (green, 
no positive SGNs were observed, hence “CatCh-negative”) and calretinin (staining SGNs, magenta), scale bar: 100 µm. 
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  Figure S3. Optical ABRs (oABRs): dependence on stimulus 
intensity, rate and duration – relationship to fraction of CatCh-
expressing SGNs. (A, B) relationship of oABR amplitude for p1-n1 
(A) and p2-n2 (B) and percentage of transduced SGNs analyzed by 
simple linear regression (n=8). (C, D) Mean amplitude (C) and 
latency (D) as a function of light intensity (1 ms duration at 10 Hz). 
(E, F) Mean amplitude (E) and latency (F) as a function of stimulus 
duration (16.3 mW at 10 Hz). (G, H) Mean amplitude (G) and 
latency (H) as a function of stimulation rate (21 - 32 mW for 1 ms). 
Vertical error bars in C, D, E, F, G and H indicate SD, horizontal error 
bars in C and D represent the area of binned light intensities for 
calculating the mean and SD.   
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Figure S4. Amplitude and latency comparison between acoustically and optically evoked auditory brainstem 
responses. (A) p1-n1 amplitudes evoked by optical stimulation with an intensity of ~30 mW in AAV-CatCh injected 
gerbils (blue) or by acoustic clicks of different intensity in wildtype gerbils (black). Errorbars indicate mean ± SD (optical: 
n = 19; 40 dB click: n = 11; all other clicks: n = 13). (B) Latency of the first wave (p1) evoked by optical stimulation with 
an intensity of ~ 30 mW in AAV-CatCh injected animals (blue) or by acoustic clicks of 80 dB in wildtype gerbils (black). 
Errorbars indicate mean±SD (optical: n = 20; click: n = 13). Stars indicate significance (*: p < 0.05; **: p < 0.01; ***: p < 
0.001; ****: p < 0.0001). 
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Figure S5 Single auditory nerve fiber (ANF) responses to acoustic click trains. (A) Exemplary unfiltered extracellular 
spikes of an ANF evoked by 0.1 ms acoustic clicks (20 dB above threshold). Blue trace corresponds to the acoustic 
stimuli. (B-F) Raster plots in response to 900 ms acoustic click trains at 5 different repetition rates (100, 200, 300, 400 
and 500 Hz). Panels to the right side of each raster plot show polar plots depicting the occurrence of spikes over the 
stimulation cycle. (G, H) Vector strength (G) and discharge rate (H) as a function of repetition rate for 40 units from 6 
gerbils. Different marker colors represent values from different units. Black traces represent the mean ± SEM. 
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Figure S6. oABR amplitudes and thresholds in chronically implanted gerbils. (A) p1-n1 amplitudes in chronically 
implanted animals on the day after surgery and on the last day of behavioral testing. Error bars indicate mean ± SD, 
colors mark individual animals (n = 7). (B) Thresholds of chronically implanted animals over time. Black markers are 
actually measured thresholds; grey markers are interpolated values for averaging. Solid lines indicate mean thresholds ± 
SD across all animals. (C) Thresholds of oABRs recorded in acute experiments (grey; n = 14) vs oABR thresholds of 
chronically implanted animals on the day after surgery and 3 weeks after surgery. A significant increase in threshold of 
implanted animals compared to animals from acute experiments was observed on the day after surgery, but vanished 3 
weeks after surgery. 
  
                                                                                  Chapter I: Optogenetic SGN stimulation in gerbils 
 
67 
 
Figure S7. Determination of fiber position with 3D X-ray tomography. (A) Reconstructed ear showing the opened bulla 
(bone edge, BU) and the landmarks stapedial artery (SA) and stapes (ST). Optical fiber (OF, blue) housed in a stainless 
steel capillary (CA) placed in the round window (RW). (B) Cochlea rendered transparent reveals basilar membrane (BM), 
Rosenthal’s canal (RC) and cochlear apex (star). (C) Distance from fiber tip to Rosenthal’s canal is about 750 µm with an 
angle of 34° which corresponds to the numerical aperture of the optical fiber, scale bar: 500 µm. 
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Figure S8. Optical thresholds for AI single units 
with high versus low best frequencies. Box plots 
show laser threshold of single units that could be 
driven by acoustic as well as optical stimuli. Single 
units are grouped in units with low (1-8 kHz) and 
high best frequencies (8-32 kHz). 
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Figure S9. Estimating the spread of excitation using Monte Carlo ray tracing. (A, B, C) Monte Carlo ray tracing 
simulation from a 200µm optical fiber in a gerbil cochlea (λ = 473nm), comparable to the one used in the in vivo 
experiments (Thorlabs FT200UMT, 0.39 NA). (A) Morphologically realistic 3D model reconstructed from X-Ray 
tomography. Purple: Rosenthal’s canal, neuronal peripheral processes; light purple: modiolus; Grey: Scala Tympani, 
Media and Vestibuli as well as semicircular ducts; Blue: Modelled optic fiber. For illustrative purposes, rays with an 
intensity 50% above minimum from 7351 rays (out of 3 million used for the simulation) are displayed. (B) Irradiance 
profile obtained from 300 query points placed along the centerline of the Rosenthal’s canal and their corresponding 
smoothed traces at four different intensities covering the range employed during in vivo experiments. Dashed line 
represents threshold, considered as the smoothed irradiance value at 10 kHz. (C) XY projection of the query points. 
Color of the query points is displayed as function of the irradiance normalized to the maximal value obtained at 30 mW 
for suprathreshold values. Black points represent positions with subthreshold irradiance. (D, E, F) Monte Carlo ray 
tracing simulation from a Thorlabs FG010LDA optical fiber (0.1 NA, λ = 473nm) at four different positions. These 
simulations show narrower spread of light using optimal conditions of position and beam divergence. (D) The origin of 
the source was placed at the centerline of the scala tympani facing the Rosenthal’s canal perpendicularly. The color 
code is the same as in panel A, with the exception of the light sources: FG010LDA optical fiber output at position A 
(slate blue), B (green), C (red) and D (blue). For illustrative purposes, rays with an intensity 50% above minimum from 
7351 rays (out of 3 million used for the simulation) are displayed for every position. (E) Irradiance profile obtained as in 
panel B in four independent simulations (one for each source position). For every source position, the maximum 
intensity was scaled to the maximum of panel B. The total source intensity needed to achieve comparable irradiances as 
in panel A is roughly 3 orders of magnitude lower. (F) Merged XY projection of the query points from the four 
simulations. For each source position, color of the query points is displayed as function of the irradiance normalized to 
the maximal value obtained at highest source output for suprathreshold values. Black points represent positions with 
subthreshold irradiance. 
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Figure S10. Shuttle box location detection algorithm. (A) Raw data of acceleration sensors (X-, Y- and Z-axis for each 
side, respectively). (B) Data of acceleration sensors after processing by the algorithm for location-detection (y-axis: 
standard deviations). Red lines indicate compartment changes detected by the algorithm, black areas mark the 
compartment in which the animal is currently located. 
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Table S1: Number of animals used for each experiment. In addition, 48 AAV-CatCh injected but negative animals have 
been used for the study, which have not been further analyzed. 
 
Experiment Number of Animals Figure 
Histology of Spiral Ganglion Neurons 9 CatCh-injected positive (intramodiolar, IM) 
4 CatCh-injected negative (IM) 
8 Chronos-injected (IM) 
3 Chronos-injected (scala tympani, ST) 
 
fig. 1 
fig. S2 
fig. S1 
fig. S1 
ABR Recordings 14 CatCh-injected acute  
7 CatCh-injected chronic 
13 Wildtype acute 
 
fig. 2, 3, fig. S4 
fig. 2, fig. S4 
fig. 2 
Auditory Nerve Fiber Recordings 7 CatCh-injected 
6 Wildtype  
 
fig. 3 
 
Chronic oCI – ABR Recordings 7 CatCh-injected 
2 PBS-injected 
 
fig. 4, fig. S7 
fig. 4 
Chronic oCI - X-ray Tomography 2 CatCh-injected 
 
fig. 4, fig. S8 
Chronic oCI - Shuttle Box Behavior 7 CatCh-injected 
2 PBS-injected 
 
fig. 5 
fig. 5 
Auditory Cortex Recordings 12 CatCh-Injected 
 
fig. 6 
Optical Stimulation of Deaf Gerbils 4 CatCh-injected fig. 7 
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recordings 
 
Data presentation: 
- Manuscript preparation (first draft and editing) under close supervision of Prof. Dr. T. Moser and   Dr. M. 
Jeschke 
- Preparation of figures 1, 2, 3 and 4 displayed in the manuscript and figures 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 
14 displayed in the supplementary information 
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Abstract 
 
Cochlear implants (CIs) electrically stimulate spiral ganglion neurons (SGNs) and partially restore 
hearing to half a million CI users. However, wide current spread from intracochlear electrodes 
limits spatial selectivity (i.e. spectral resolution) of electrical CIs. Optogenetic stimulation might 
become an alternative, since light can be confined in space, promising artificial sound encoding 
with increased spectral selectivity. We compare spectral selectivity of optogenetic, electric, and 
acoustic stimulation by multi-channel recordings in the inferior colliculus (IC) of gerbils. When 
projecting light onto tonotopically distinct SGNs, we observe corresponding tonotopically ordered 
IC activity. An activity-based comparison reveals that spectral selectivity of optogenetic 
stimulation is indistinguishable from acoustic stimulation for modest intensities. Moreover, 
optogenetic stimulation outperforms bipolar electric stimulation at medium and high intensities 
and monopolar electric stimulation at all intensities. In conclusion, we demonstrate better 
spectral selectivity of optogenetic over electric SGN stimulation, suggesting the potential for 
improved hearing restoration by optical CIs.  
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Introduction 
 
By stimulating spiral ganglion neurons (SGNs) electrically, cochlear implants (eCIs) provide the 
auditory system of profoundly hearing impaired and deaf with information on the surrounding 
acoustic scene1,2. eCIs are considered the most successful neuroprosthesis and enable open 
speech comprehension in the majority of approximately 500,000 users. Still, there is an unmet 
need for improvement: Wide spread of electric current from each electrode contact activates 
large subsets of SGNs, limiting the number of independent stimulation channels in eCIs to less 
than ten3–5. This major drawback of electric stimulation restricts the amount of spectral 
information that CIs can provide to the user, ultimately resulting in limited perception of acoustic 
signals such as speech, especially in noisy environments5,6.  
 
Optical stimulation of SGNs represents a novel approach to overcome this limitation of eCIs: Light 
can be better confined in space and, hence, optical cochlear implants (oCIs) could activate SGNs 
along the tonotopic axis of the cochlea with higher spatial selectivity. This promises improved 
spectral resolution of artificial sound coding and consequently an increased number of 
independent stimulation channels7–10. Studies of cochlear activation using infrared stimulation 
have indicated that spatial (and thus spectral) spread of SGN excitation in the cochlea is small for 
optical stimulation, comparable to pure tone acoustic stimulation7, while monopolar electrical 
stimulation led to spectrally broader SGN activation than infrared stimulation in a different 
study11. However, the energy requirement per pulse is very high for infrared stimulation (16-160 
µJ12), the exact mechanism of neural activation is still under debate and activation of the auditory 
pathway could not be verified in several studies on animal models of sensorineural hearing loss 13-
15.  
In contrast, optogenetic stimulation of SGNs expressing Channelrhodopsins (ChRs16,17) enables 
neural excitation by a well understood mechanism at lower light intensities. Indeed, stimulation 
of the auditory system using fiber-based oCI has greatly advanced in the past years: a proof of 
principle study employing cochlear optogenetics in transgenic mice demonstrated optical 
activation of the auditory pathway up to the inferior colliculus (IC), where current source density 
analysis indicated a smaller spread of SGN excitation for optical than for monopolar electrical 
stimulation8. Subsequent studies on mice in which SGNs were virally transduced during the first 
postnatal week using the fast-gating ChRs Chronos and f-Chrimson demonstrated high temporal 
fidelity of neural control up to several hundred Hertz by recording optogenetically driven auditory 
brainstem responses (oABRs) and spiking activity of individual SGNs in hearing and deaf 
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animals18,19. Finally, viral transduction of SGNs in adult Mongolian gerbils was recently established 
and optogenetic stimulation of the auditory nerve was studied by recordings of oABRs and 
individual SGNs20. Furthermore, stimulus perception upon optogenetic stimulation of the auditory 
nerve was demonstrated by single unit recordings from primary auditory cortex and behavioral 
experiments, the latter also involving deafened animals.  
 
However, despite the recent progress, a precise estimation of the spectral selectivity of 
optogenetic SGN stimulation and a rigorous comparison to acoustic and electrical stimulation is 
still lacking. Here, we perform multi-channel recordings of neuronal clusters (multi-unit activity) in 
the tonotopically organized central nucleus of the inferior colliculus (ICC) in Mongolian gerbils 
while stimulating SGNs optogenetically, electrically or acoustically. We demonstrate spatially 
selective optical activation of the auditory system in a tonotopic manner with a spectrally more 
confined SGN excitation than the one found upon monopolar and bipolar electrical stimulation. 
This indicates increased spectral resolution of artificial sound encoding when using optogenetic 
instead of electrical stimulation – and thus suggests that oCIs might overcome the major 
bottleneck of eCIs.  
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Results  
 
Mapping acoustic response 
properties in the central nucleus of 
the inferior colliculus (ICC): To 
characterize spectral response 
properties of the auditory system to 
optogenetic stimulation of SGNs we 
performed electrophysiological 
recordings of multi-unit activity in 
the ICC in isoflurane-anesthetized 
gerbils. The ICC was chosen because 
of its well-defined tonotopic 
organization, enabling estimation of 
the cochlear spread of excitation of 
acoustic electrical optogenetic 
stimulation (oCI). We used multiple 
laser-coupled optical fibers placed at 
three different positions along the 
tonotopic axis of the cochlea (Fig. 
1A-C) and recorded activity in the 
ICC using linear 32-channel silicon 
probes.  
 
After placing the silicon probe, 
frequency response areas were 
constructed for each recording site 
using acoustic stimulation. We then 
derived the characteristic frequencies (CFs) (Fig. 1D, E) and calculated tonotopic slopes for each 
animal by linearly fitting the CFs as a function of recording depth (Fig. 1E, Supplementary Figure 
1). The median tonotopic slope amounted to 4.58 octaves/mm (± 0.69 median average deviation, 
n = 46; Supplementary Figure 1, inset) and did not differ between animals that underwent 
cochlear surgeries and naïve animals (4.61± 0.70 octaves/mm, n = 38 vs. 4.58 ± 0.60 octaves/mm, 
n = 8; two-sample t-test: p = 0.69). However, in animals that underwent cochlear surgeries, 
 
Figure 1: Experimental layout and acoustic response properties. (A) 
Experimental design. (B) Optical fibers (blue dashed lines) inserted via 
cochleostomies at the apical and mid-turn of the cochlea (black dashed 
lines) as well as in the round window (from left to right). S: stapes, SA: 
stapedial artery. Scale bar: ~1 mm. (C) DiI-stained electrode track (red) 
in a DAPI-stained (cyan) coronal section of the inferior colliculus. Scale 
bar: 1 mm. (D) frequency response areas and characteristic 
frequencies (CFs; white stars) recorded at electrode 4, 16 and 24 (e4, 
16, 28) in one animal. (E) CFs as a function of recording depth. Solid 
line: linear fit of all CFs, according to Pearson’s correlation coefficient. 
Data is pooled from all animals (virus-injected as well as non-injected).  
Source data of (E) is provided as a source data file.   
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thresholds of acoustically 
driven multi-units in the 
ICC increased by 17.8 dB 
on average (30.3 ± 13.4 dB 
SPL standard deviation (n = 
246) in naïve animals, 48.1 
± 11.6 dB SPL (n = 208) in 
animals that underwent 
surgery, p < 0.001*10-35, 
two-sample t-test; 
Supplementary Figure 2). 
 
Artificial stimulation of 
spiral ganglion neurons: To 
prove stimulation of SGNs 
via oCI or eCI and 
determine time windows 
for potential responses, 
peri-stimulus time 
histograms (PSTHs) were 
constructed in response to 
the strongest optical and 
electrical stimuli 
(Supplementary Figure 3). 
Potential responses to 
various stimulus intensities 
were then evaluated 
during these time windows 
as well as during the 
presentation of tone bursts 
for acoustical stimulation. 
The majority of acoustically 
driven multi-units (98.1%) 
and all optically and 
 
 
Figure 2: Acoustic, optogenetic and electric activation of the auditory system. (A-
D) Monotonicity indices (MI) for acoustic stimulation in non-injected animals (A), 
optogenetic stimulation in virus-injected animals (B), monopolar (C) and bipolar 
electric stimulation in non-injected animals (D). Dashed lines mark a monotonicity 
index of 0.5, above which units are considered as monotonic. (E-H) Firing rates of 
multi-units as a function of stimulus intensity (thin, transparent lines) and average 
per animal and stimulus (solid lines) for acoustic (E), optogenetic (F), monopolar 
(G) and bipolar (H) electric stimulation. (I) Distribution of dynamic ranges (DRs) per 
multi-unit in dB (SPL), dB (mW) and dB (µA). (J) DRs of averaged multi-units per 
animal and stimulus, units as in (E). (K) Maximum strength of response that could 
be evoked by any stimulus modality. Data in (I), (J) and (K) is displayed as mean ± 
s.d.. Stars indicate statistical significance (one star: p < 0.05, two stars: p < 0.01, 
three stars: p < 0.001), based on one-way ANOVA and post-hoc pairwise 
comparison. Only significant differences are indicated. Source data of all 
panels is provided as a source data file.   
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electrically driven units showed a monotonic firing pattern, i.e. a rise in stimulus intensity led to a 
rise in firing rate (monotonicity index > 0.5; Fig. 2A-H). This observation allowed for estimation of 
the dynamic range (DR) based on stimulus-response functions both per individual multi-unit and 
per animal with a similar procedure. The DR was calculated as the range of stimulus intensities 
that led to a monotonic increase in firing rates in the range from 10% above baseline activity 
(average response to the three lowest stimulus intensities) to 10% below maximum response 
(averaged response to the three highest stimulus intensities). We note that saturation was not 
achieved for most of the optogenetically driven multi-unit responses (Fig. 2F), such that the 
apparent DR underestimates the true DR for optogenetic stimulation.  
 
The average apparent DR of individual multi-units in response to optical stimulation amounted to 
7.8 dB (mW; ± 3.7 s.d.; n = 762), which exceeded the DR in response to monopolar electrical 
stimulation (6.9 ± 4.2 dB [μA], n = 1515, p < 0.05; one-way ANOVA and post-hoc pairwise 
comparison) and was comparable to the DR in response to bipolar electrical stimulation (8.3 ± 5.1 
dB [μA], n = 572; p = 0.65; Fig. 2H). The DR in response to acoustic stimulation exceeded all 
modalities of artificial cochlear stimulation and amounted to 21.4 ± 10.1 dB (SPL) (n = 1531; p < 
0.001). The grand average DR (derived from the mean of the averaged multi-units per animal) was 
similar between responses to optical (10.7 ± 3.4 dB standard deviation, n = 34), monopolar (10.7 ± 
3.5 dB, n = 48; p = 0.99) and bipolar electrical stimulation (12.2 ± 3.9 dB, n = 18; p = 0.88), while 
the DR of acoustic stimulation amounted to 32.3 ± 10 dB (n = 73; Fig. 2J; one-way ANOVA and 
post-hoc pairwise comparison). Comparison of the maximal strength of cochlear excitation - 
measured in d’ values based on evoked firing rates - revealed that optical stimulation could drive 
neurons in the ICC as effectively as electrical stimulation (max. response: 4.4 ± 1.0 d’ values mean 
and SD, n = 34; compared to 4.5 ± 0.7 d’ values for monopolar stimulation (n = 48; p = 0.99) and 
4.9 ± 0.6 d’ values for bipolar stimulation (n = 18; p = 0.79), respectively), whereas acoustic 
stimulation of non-injected animals yielded stronger activation (9.0 ± 2.9 d’-values; one-way 
ANOVA and post-hoc pairwise comparison; Fig. 2K).  We note that no responses to optical 
stimulation of SGNs were observed in non-injected control animals, excluding excitation unrelated 
to the optogenetic mechanism such as opto-acoustic or -thermal effects and thus proving the 
specificity of optogenetic SGN stimulation (Supplementary Figure 4). 
 
Spectral spread of fiber-based cochlear optogenetics: To thoroughly characterize the spread of 
excitation upon optical stimulation, we used a multi-site approach to project light onto SGNs at 
three distinct tonotopic positions. For this purpose, optical fibers were inserted into the cochlea i) 
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via the round window (high-frequency base) and via cochleostomies in the ii) middle (mid-
frequency) and iii) apical cochlear turn (low-frequency), (Fig. 1B).  
 
For comparing the optogenetic spread of excitation to that of acoustic and electrical stimulation, 
we also performed recordings while stimulating naive animals that did not undergo any surgical 
manipulation of the cochlea using pure tones and stimulating non-injected animals with a 4-
channel eCI using monopolar electrical stimulation, where the return electrode was placed 
outside of the bulla tympanica and bipolar electrical stimulation where the electrode next to the 
stimulation electrode (in basal direction) served as the return electrode. Neuronal activity was 
recorded in response to a given modality of varying stimulation intensity (pure tones, optically via 
one of the fibers, or electrical stimulation via one of the four eCI electrodes Fig. 3).  
 
 
Figure 3: Exemplary spatial tuning curves (STC) for different stimulus modalities. (A) STCs in response to pure tones of 
different frequencies in naive animals. (B) STCs in response to laser pulses delivered via optical fibers placed at different 
positions in the cochlea of virus-injected animals. (C) STCs in response to electric current delivered via different 
electrodes (e1, e2 and e3) of an electrical cochlear implant in non-injected animals in the monopolar configuration. (D) 
STCs in response to electric current delivered via the same electrodes in bipolar configuration. White stars indicate the 
best electrode (BE) of each STC. The color scale in (A) applies to all panels displayed in this figure. 
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To characterize the change in multi-unit firing rates to changing stimulation levels across different 
modalities we employed a method based on signal detection theory21. A cumulative d´-value 
based on multi-unit spike rates in response to increasing stimulation intensities was calculated, 
starting in the absence of stimulation (i.e. zero intensity). Cumulative d´-values for increasing 
stimulus intensities were then sorted into a response matrix according to the electrode they were 
recorded from and iso-d’-contour-lines were drawn at integer d´-values in order to construct 
spatial tuning curves (STC; Fig. 3 and 4). As in previous studies on eCI, a d´ value of 1 was defined 
as the threshold and the recording electrode with the lowest threshold was defined as the best 
electrode (BE; 16, 25). Average thresholds amounted to 2.67 mW for optical, and 45.8/52.8 μA for 
mono-/bipolar electrical stimulation (Supplementary figure 5). 
 
In order to quantify the cochlear spread of excitation, we measured the distance between all 
active electrodes (d´ > 1) at the stimulus intensity at which the BE reached a given d´ value (i.e. 
1.5, 2, 2.5 or 3; Fig 4A). In some cases, more than one peak (defined as electrodes below 
threshold separating electrodes above threshold) has been observed for each stimulus modality 
(acoustic: 33/304; optogenetic: 27/101; monopolar electric: 25/192; bipolar electric: 7/72). In 
these cases, the dorsal- and ventral-most electrodes with a significant response (d´ > 1) have been 
considered as the boundaries of the STC to avoid underestimation of the spread of excitation 
(Supplementary Figure 6). Using the tonotopic slopes calculated above, spatial spread in each 
animal (measured in distance between the electrodes) could then be translated into spectral 
spread of cochlear excitation (measured in octaves). Measuring at fixed significance of response 
strengths – i.e. at identical levels of activation – rather than at fixed stimulus intensities, the 
estimation of the spread of excitation becomes independent of the stimulus’ nature and makes 
neural activation by different modalities more comparable.  
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Figure 4: Quantification of spatial tuning curves (STCs). (A) Quantification of STCs: STC in response to a 2 kHz pure tone 
in a non-injected gerbil. Cumulative d-prime values are color-coded in a matrix sorted according to electrode number 
(ordinate) and stimulus intensity (abscissa). The electrode with the lowest threshold (d’ = 1) is defined as the best 
electrode (BE, white star) and the spread of excitation (SoE) is measured at different activation strengths (exemplary 
shown for a d’ of 3 at the BE). (B) BEs as a function of stimulation frequency recorded from non-injected gerbils. Solid 
line: linear fit of tonotopic slope. Different symbols mark different animals. (C) BEs as a function of optical stimulation 
site in virus-injected animals, including mean and standard deviation for each stimulation site. Symbols mark different 
animals. (D) BEs as a function of stimulation electrode for monopolar electrical stimulation in non-injected animals, 
including mean and standard deviation for each electrode. (E) BEs as a function of stimulating electrode pair for bipolar 
electrical stimulation in non-injected animals, including mean and standard deviation for each electrode pair. Pearson’s 
correlation coefficient r and the corresponding p-values were calculated for panel B-E. (F-I) Spectral spread has been 
quantified at different d’-values for acoustic (F), optogenetic (G), monopolar (H) and bipolar electric stimulation (I). Box 
plots indicate minimum (lower) and maximum (upper) whisker, median (center line) as well as 25- and 75-percentiles. 
(J) Mean and SEM for the spread of excitation upon acoustic, optogenetic, monopolar and bipolar electric stimulation. 
Stars indicate statistical significance (one star: p < 0.05, two stars: p < 0.01, three stars: p < 0.001), according to 
repeated-measures ANOVA and post-hoc pairwise comparison tests. Only significant differences have been indicated. 
Source data of panels B-J is provided as a source data file. 
 
Plotting the focus of activation (i.e. BE) as a function of stimulation frequency visualizes the 
natural tonotopic axis of the ICC with an average tonotopic slope of 4.48 octaves/mm (Pearson’s 
correlation coefficient r = 0.80, p < 0.001; Fig. 3A, also see Fig. 1 and Fig. 4B). Similarly, neuronal 
responses could be shifted systematically from the dorsal to the ventral ICC when stimulating 
optically at the apex, mid or base of the cochlea in AAV-injected animals (p < 0.001; Fig. 3B, Fig. 
4C, Supplementary Figure 7A). A systematic shift of activation was also apparent for eCI 
stimulation via different electrodes upon monopolar electrical stimulation (p < 0.001; Fig. 3C, also 
see Fig. 4D) but was not significant when stimulating in bipolar configuration (p = 0.18). 
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Nonetheless, when probing tonotopy of stimulation by correlating stimulating electrode (pairs) 
with the CF recorded at the best electrode it was significant for both mono- and bipolar electrical 
stimulation (r = 0.31, p < 0.05 and r = 0.6, p < 0.01, respectively; Supplementary Figure 7B-C). Note 
that the layout of the eCI might have contributed to the less pronounced tonotopic activation, as 
the 4 electrodes only covered 1.8 mm in the case of monopolar and 1.2 mm in the case of bipolar 
electrical stimulation and thus were not distributed along the whole cochlea, whereas optical 
fibers have been placed in a way to cover large parts of the cochlear spiral. 
 
In order to better understand the spread of light upon optical stimulation and the variance 
introduced by fiber-positioning, we modelled ~3,000,000 optical rays in a Monte-Carlo simulation 
where optical fibers were placed at the corresponding positions within a model of the gerbil 
cochlea reconstructed from x-ray phase-contrast tomography (Supplementary Figure 8). Peak 
illumination of the spiral ganglion in Rosenthal’s canal was observed at tonotopic places 
corresponding to 1.01, 6.9 and 22.89 kHz, spanning a total of 4.43 octaves. Varying the angle of 
light projection shifted the peak of illumination at the spiral ganglion, which (just as precise axial 
positioning of the fiber aperture) contributes to the variance of the experimentally observed BEs 
and CFs upon optical stimulation.  
 
Spread of excitation at increasing d´ values grew for all stimulus modalities (Fig. 4F-I). At a d´ of 
1.5 and 2, the spread of excitation of optogenetic stimulation was indistinguishable from that 
upon pure tones suggesting that near physiological frequency resolution might be achievable in 
future oCI for modest stimulation strength (Repeated-measures ANOVA and post-hoc pairwise 
comparison tests; Fig 4J). At higher activation levels (d´ of 2.5 and 3) the spread of excitation was 
significantly higher for optogenetic stimulation (p < 0.05) as compared to acoustic stimulation. 
However, optogenetic stimulation outperformed monopolar eCI stimulation at all activation 
strengths (p < 0.05 at a d’ of 1.5; p < 0.001 at all other activation strengths). Furthermore, 
optogenetic stimulation performed significantly better than bipolar electrical stimulation at 
medium (d’ of 2; p < 0.05) and high activation levels (d’ of 2.5/3; p < 0.001), while no difference 
was found at low activation levels (d’ of 1.5; p = 0.77). These findings were identical when the 
spectral spread of excitation was not normalized by the tonotopic axis of each animal, i.e. when 
measuring the spread of excitation in terms of spatial activation in the ICC (Supplementary Figure 
9). For optical stimulation via the round window we also compared the fiber orientation 
projecting light onto SGNs of i) the high-frequency base (used in the present comparison (Figs. 3 
and 4) and ii) the orientation pointing towards the cochlear apex and thus projecting light along 
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the modiolar axis (used in our previous study 20), which led to a rather broad activation of the 
spiral ganglion (Supplementary Figure 10). Thus, the precise projection of light to the spiral 
ganglion is of critical importance to achieve high spectral resolution by oCI stimulation. 
 
These findings suggest that optical excitation of SGNs happens in a more spatially confined 
manner than electrical stimulation and hence can achieve better spectral resolution, provided 
appropriate projection of the light.  
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Discussion  
 
In this study, we scrutinized the spectral spread of excitation for optogenetic stimulation of SGNs 
and compared it to physiological hearing and hearing with eCI employing monopolar stimulation, 
used in the majority of clinical eCIs23, as well as bipolar stimulation. We could demonstrate a 
major advantage of optogenetic over monopolar and bipolar electrical stimulation for this highly 
relevant parameter of artificial sound encoding. In fact, the study indicates that optogenetic 
stimulation can achieve near physiological frequency selectivity at low to modest levels of 
activation. We attribute this primarily to the spatial confinement of optical stimulation even with 
the rather crude oCI implementation in our current study. 
 
A prerequisite for quantifying cochlear spread of excitation based on ICC measurements is reliable 
and reproducible positioning of electrode arrays along the tonotopic axis of the ICC. Hence, we 
placed the array under guidance of neuronal responses to acoustic stimuli. The expected 
correlation of electrode CF and depth in the ICC was observed for each animal in this study. The 
median tonotopic slope amounted to 4.58 octaves/mm based on CFs and to 4.48 octaves/mm 
based on the BEs, which compares well to literature (4.08 and 4.37 octaves/mm, respectively24,25). 
A few units in ventral ICC regions were found to be responsive to low frequency tones, indicating 
that recording sites for these units were likely outside the ICC 24. However, since these were only 
30 out of 1340 units, 97.76 % of multi-units recorded in this study can be considered to primarily 
originate from the ICC. As the external cortex, covering the ICC dorsally and laterally, is thin (less 
than 150 µm26,27) we have not attempted to separate the expectedly few cortical neurons 
contributing to the data set. 
 
Optogenetic stimulation of SGNs at different positions of the cochlear spiral evoked neural activity 
in tonotopically corresponding ICC regions: apical stimulation evoked activity in the dorsal, low 
frequency regions of the ICC while baso-cochlear stimulation excited ventral, high frequency 
parts. Tonotopic ICC activation was less obvious when using electrical stimulation. We note that 
appropriate positioning of the oCI/eCI within the cochlea is critical for its tonotopic activation: 
Optical fibers were placed in 3 spatially distinct positions to cover a large tonotopic range (see fig. 
1B, 4C, Supplementary Figure 5A; i.e. regions coding centred around 0.6, 3.6 and 13.3 kHz from 
apical, mid and basal stimulation, spanning a total of 4.5 octaves, i.e. 56% of the gerbils hearing 
range). This was confirmed by modelling optical rays from the fiber aperture placed in a 
reconstructed gerbil cochlea (Supplementary Figure 8). In contrast, electrodes of the eCI spanned 
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1.8 mm (monopolar) and 1.2 mm (bipolar) of the scala tympani, covering only 16.4 % and 10.9 % 
(i.e. 0.29 and 0.19–fold of optical stimulation) of the cochlear length28. Experimentally, average 
best electrode IDs in response to optical stimulation upon apical and basal stimulation were 6.7 
and 27.9, whereas in response to electrical stimulation the electrode IDs for apical- and basal-
most mono- or bipolar stimulation were 16.5/ 21.8 or 17/ 20.7 (i.e. 0.25-fold of 0.17-fold optical 
stimulation, respectively). These ICC estimates agree well with cochlear tonotopic ranges 
estimated above for optical and electrical stimulation, suggesting that tonotopic activation was 
achieved in a comparable manner.  
 
The spread of cochlear excitation determines the spectral resolution of artificial sound coding 
which is limited with current eCIs. A previous study on cats (where the spread of excitation was 
quantified by measuring the width of ICC activation 6 dB above threshold) reported 2.55 and 4.94 
octaves of neural activation for bi- and monopolar stimulation, compared to 0.6 octaves for pure 
tones21. Electrical stimulation via an intra-neural electrode array (penetrating the auditory nerve) 
outperformed eCIs conventionally placed in the scala tympani, activating only 1.4 octaves in the 
same study. When analyzing our data as done in this study (6 dB above threshold, corresponding 
to a mean/SD d´ of 3.02 ± 0.64), the spread of excitation in our study amounted to 1.81 ± 0.7 (SD; 
n = 71), 2.91 ± 1.6 (n = 20), 6.36 ± 2.3 (n = 44) and 6.07 ± 2.6 (n = 16) octaves for acoustic, 
optogenetic, monopolar and bipolar electric stimulation, respectively (Supplementary Figure 11).  
 
Since the species used in these studies differ both in physiology and anatomy, we suggest 
normalizing the spread of excitation to the corresponding spread of excitation upon pure tone 
stimulation employed in each study to facilitate a better comparison. By doing so, the spread of 
excitation with the penetrating array of the above-mentioned study corresponds to 2.33-fold of 
the acoustic one, while bi- and monopolar stimulation of eCI in the scala tympani amounted to 
4.16 and 8.23-fold spread. The spread of excitation evoked by optical stimuli in our study 
amounted to 1.61-fold, while the ones of monopolar and bipolar electrical stimulation amounted 
to 3.51 and 3.35-fold spread, respectively. Another study, performed in guinea pigs reported 3.9-
fold and 1.8-fold spread of excitation upon mono- and bipolar electrical stimulation, respectively 
(measured 6 dB above threshold; compared to acoustic stimulation 20 dB above threshold)22. 
Comparing our data in this way, we found 0.74-fold spread of excitation upon optogenetic and 
1.61-/1.53-fold excitation upon mono- and bipolar electrical stimulation, respectively 
(Supplementary Figure 11). 
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Not finding the previously reported advantage of bipolar electrical stimulation over monopolar 
stimulation in our study is most likely explained by the fact that the majority of STCs upon 
electrical stimulation have been underestimated. The boundaries of recorded STCs exceeded the 
limits of the electrode array in many cases (i.e. neural activity was evoked at all recording sites). 
Since the supposedly more focused bipolar stimulation already evokes activity in most parts of the 
cochlea (and thus the ICC), less selective stimulation in the monopolar configuration could not be 
demonstrated. Therefore, we found bipolar stimulation to be more selective than monopolar 
stimulation only for weak stimuli (d’ of 1.5). We attribute this finding primarily to the model 
system we used: since the gerbil cochlea is roughly 2.5 times smaller than the cat cochlea and 
~1.6 time smaller than the guinea pig cochlea, a physically similar current spread from the eCI 
electrode will lead to activation of a larger SGN population in the gerbil than in the cat21,28–31. 
Thus, the advantage of bipolar, and importantly, even more so of optical stimulation, over 
monopolar electrical stimulation – especially at high activation strengths – is expected to be 
greater in species with larger cochleae, e.g. cats or even humans (even in the guinea pig, 60% and 
93% of the STCs upon mono- and bipolar electrical stimulation exceeded the boundaries of the 
recording electrode array and thus might have been underestimated22). Despite the limited size of 
the gerbil cochlea, however, we could still demonstrate spatially selective SGN activation upon 
optogenetic stimulation, approaching the frequency resolution of natural acoustic stimulation.  
 
Taken together, these results suggest that optical stimulation of cochlear neurons is indeed more 
confined in space than electrical stimulation, despite the non-optimal projection of light from a 
fiber aperture placed at an opening of the cochlear capsule (Supplementary Figure 8). We 
suppose that the spread of excitation upon optogenetic SGN stimulation might be even lower 
when placing light sources into the scala tympani (i.e. closer to the target tissue), using emitters 
with a lower numerical aperture or by combining light emitters with focusing lenses. Indeed, ray 
modeling studies indicate narrow tonotopic ranges of activation under these conditions 
(Supplementary Figure 8C/D). 
 
The output dynamic range of individual multi-units in response to sound (21.4 dB) and electrical 
stimulation (6.9 dB and 8.3 dB for mono- and bipolar stimulation) are in good agreement with 
literature values: an average DR of 20 dB per single unit in response to sound has been reported 
for the gerbil IC and DRs between 6.7-7.6 dB have been reported upon stimulation with different 
kinds of eCIs in the rat IC31–33. DR comparison of optogenetic to electrical stimulation is 
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confounded by the fact that we did not find saturation for most multi-units at the light intensities 
amenable to our set-up (Fig. 2E, Supplementary Figure 12).  
 
The resulting apparent DR of 7.8 dB (mW) was only slightly larger than the DR in response to 
monopolar, and comparable to bipolar electrical stimulation. We note that our DR estimation for 
optical stimulation refers to dB (mW), i.e.  DR =  10 ×  log10 𝑝𝑝𝑝𝑝𝑝 (90%)
𝑝𝑝𝑝𝑝𝑝 (10%)
, while that of electrical 
stimulation was based on current amplitudes, i.e. DR =  20 ×  log10 𝑎𝑎𝑝𝑎𝑎𝑎𝑎𝑎𝑝 (90%)
𝑎𝑎𝑝𝑎𝑎𝑎𝑎𝑎𝑝(10%)
. Future 
studies involving behavioural analysis should provide psychophysical estimates of DR as well as of 
the intensity discrimination. Furthermore, optimized opsins conferring increased light sensitivity 
might lower the threshold of SGN activation and thus increase the DR at the lower end. Biosafety 
studies of long term exposure to light illumination need to be done in order to determine safe 
margins for light stimulation that might limit the DR at the upper end. 
 
An obvious limitation of our study is the use of multiple laser-coupled optical fibers 
placed near the cochlear lateral wall at variable distance to SGNs (Supplementary Figure 
8). This approach is not feasible for clinical translation. Due to the spatial flexibility of 
placing optical fibers at arbitrary cochlear positions, it was possible to access the 
tonotopic axis of the spiral ganglion throughout the whole cochlea, from the round 
window up to the apex. Even though the technical feasibility of oCIs, e.g. in the form of 
miniaturized LEDs on a flexible substrate34, has been demonstrated, chronic translational 
experiments requiring stable multi-channel oCIs have not yet been reported to our 
knowledge. A second – apparent – limitation of the current study is that artificial 
stimulation of SGNs was done in the presence of inner hair cells, i.e. in normal hearing 
animals. We can assume that the presented results would not differ in deaf animals since 
we have shown in a previous study that opsin expression is absent in inner hair cells due 
to the choice of the promotor (human synapsin) and furthermore optogenetic excitation 
of SGNs is feasible in a model of sensorineural hearing loss20. Also, we showed that there 
was no effect of optical stimulation in non-injected animals, ruling out the contribution of 
non-optogenetic neural excitation by light. 
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Methods 
 
Animals: Data was recorded from 46 adult (> 8 weeks of age) Mongolian gerbils (Meriones 
unguiculatus) of either sex. For each surgery, gerbils were anesthetized with Isoflurane (4 % at 
1 l/min for induction, 1-2 % at 0.4 l/min for maintenance) and appropriate analgesia was achieved 
by subcutaneous injection of Buprenorphine (0.1mg/kg BW) 30 minutes prior to surgery. Depth of 
anesthesia was monitored regularly by the absence of reflexes (hind limb withdrawal) and 
adjusted accordingly. During all experiments, animals were placed on a heating pad and body 
temperature was maintained at 37°C. All experimental procedures were done in compliance with 
the German national animal care guidelines and approved by the local animal welfare committee 
of the University Medical Center Göttingen as well as the animal welfare office of the state of 
Lower Saxony, Germany (LAVES).  
 
Virus purification: Adeno-associated viruses (AAVs) were generated in HEK-293T cells (ATCC) using 
polyethylenimine transfection (25.000 MW, Polysciences, USA) 35,36. In brief, triple transfection of 
HEK-293T cells was performed using pHelper plasmid (TaKaRa/Clontech), trans-plasmid providing 
viral capsid PHP.B (generous gift from Ben Deverman and Viviana Gradinaru, Caltech, USA). The 
cell line was regularly tested for mycoplasma. We harvested viral particles 72 h after transfection 
from the medium and 120 h after transfection from cells and the medium. Viral particles from the 
medium were precipitated with 40 % polyethylene glycol 8000 (Acros Organics, Germany) in 
500 mM NaCl for 2 h at 4°C and then after centrifugation at 4,000 g for 30 min combined with cell 
pellets for processing. The cell pellets were suspended in 500 mM NaCl, 40 mM Tris, 2.5 mM 
MgCl2, pH 8, and 100 U mL-1 of salt-activated nuclease (Arcticzymes, USA) at 37°C for 30 min. 
Afterwards, the cell lysates were clarified by centrifugation at 2,000 g for 10 min and then purified 
over iodixanol (Optiprep, Axis Shield, Norway) step gradients (15 %, 25 %, 40 % and 60 %) 37,38 at 
350,000 g for 2.25 h. Viruses were concentrated using Amicon filters (EMD, UFC910024) and 
formulated in sterile phosphate-buffered saline (PBS) supplemented with 0.001 % Pluronic F-68 
(Gibco, Germany). Virus titers were measured using AAV titration kit (TaKaRa/Clontech) according 
to manufacturer’s instructions by determining the number of DNase I resistant vg using qPCR 
(StepOne, Applied Biosystems). Purity of produced viruses was routinely checked by silver staining 
(Pierce, Germany) after gel electrophoresis (Novex™ 4-12 % Tris-Glycine, Thermo Fisher Scientific) 
according to manufacturer’s instruction. The presence of viral capsid proteins was positively 
confirmed in all virus preparations. Viral stocks were kept at -80 °C until injection. 
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Virus injections: Viral vectors used in this study were either AAV-2/6 or the recently engineered 
AAV-PHP.B 36. Vectors carried plasmids that code for the Channelrhodopsin-2-variant CatCh linked 
to the reporter-protein eYFP under control of the human synapsin promotor (titer: AAV2/6: 
3.2x1012 -2.7x1013 GC/ml; PHP.B: 4.57x1012 GC/ml). Injections were performed using 
micropipettes (20 µm tip diameter) pulled from quartz capillaries on a P-2000 laser puller (Sutter 
Instruments) connected to a pressure microinjector (100 – 125 PSI, PLI-100 pico-injector, Harvard 
Apparatus). 2-3 μl of virus suspension were injected directly into the left spiral ganglion of adult  
gerbils under general anesthesia using a recently developed intramodiolar approach 20,39. After 
making an incision behind the ear, muscles and connective tissue covering the bulla tympanica 
were displaced and a bullostomy was performed in order to access the cochlea. Using a KFlex 
dental file, a small hole was then drilled into the basal part of the modiolus via the dorsal part of 
the round window niche to directly access the spiral ganglion. After injection, muscles and 
connective tissue were repositioned and the skin was sutured. Animals were allowed to recover 
for at least 4 weeks after surgery before continuing experiments. Positively transfected animals 
showed no significant differences in both thresholds (AAV2/6: 3.49 ± 3.03 mW, PHP.B: 1.70 ± 0.99 
mW, mean/SD, p = 0.073, two-sample t-test) and maximal strength of responses (AAV2/6: 4.27 ± 
0.80 d’ values, PHP.B: 4.55 ± 1.11 d’ values, mean/SD, p = 0.57, two-sample t-test) that could be 
evoked in the inferior colliculus dependent on the virus they were injected with (Supplementary 
Figure 13). 
 
Stimulation: Stimuli were generated and presented via a custom-made system based on NI-DAQ-
Cards (NI PCI-6229; National Instruments; Austin, US) controlled with custom-written MATLAB 
scripts (The MathWorks, Inc.; Natick, US). Acoustic stimuli were presented near field via a 
loudspeaker (Scanspeak Ultrasound; Avisoft Bioacoustics, Glienicke, Germany) centered 30 cm in 
front of the animals’ head. A 0.25-inch microphone and measurement amplifier (D4039; 2610; 
Brüel & Kjaer GmbH, Naerum, Denmark) were used to calibrate sound pressure levels. For optical 
stimulation, access to the cochlea was achieved using the surgical approach described for virus 
injections. An optical fiber (200 µm diameter, 0.39 NA; Thorlabs, Dachau, Germany) coupled to a 
blue laser (473 nm, 100 mW DPSS; Changchun New Industry Optoelectronics) was then inserted 
into the cochlea either via the round window (for basal stimulation) or via cochleostomies in the 
middle or apical cochlear turn, respectively (stimulation sites in which the cochleostomy resulted 
in bleeding have been excluded from analysis; 3/29 STCs). Radiant flux from the fiber aperture 
was calibrated with a power meter before each experiment (Solo-2; Gentec-EO; München, 
Germany). Biphasic pulses (100 μs phase duration) of varying electric current were generated with 
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a custom-made current-source stimulus isolator and delivered via 4-channel (600 μm electrode 
spacing) rodent eCI, provided by Roland Hessler, MED-EL Innsbruck (for details see 40). The 
implant was inserted into the scala tympani via the round window, such that the most apical 
electrode was approximately 5-6 mm within the cochlea. Implant positioning was confirmed by 
our physiological results: Considering 11 mm length of the gerbil basilar membrane and a hearing 
range of ~0.2-50 kHz, the eCI would cover approx. 5.5/11 mm (= 50%) of the cochlear length, 
which corresponds – according to the Greenwood function – to a CF at the cochlear location at 
the tip of the eCI of approximately (𝑓 = 0.39(102.1𝑥 − 0.5) = 4.18 kHz 28,41. The mean CF 
recorded in response to electrical stimulation at electrode 1 (which is located at the very tip of the 
implant) was 3.72 kHz in response to monopolar and 4.5 kHz in response to bipolar stimulation 
(Supplementary Figure 7). The return electrode for monopolar electrical stimulation was placed 
between connective tissue and the bone outside of the bulla tympanica. The return electrode for 
bipolar stimulation was chosen as the neighboring electrode to the stimulation electrode in basal 
direction. 
 
Recording of Multi-Unit Activity (MUA): To access the inferior colliculus (IC), an incision was made 
in the animal’s scalp along the midline of the skull. After cleaning the bone, a thin layer of self-
etching UV glue (Orbi-Bond; Orbis Dental, Münster, Germany) was applied and a head post was 
mounted rostrally to bregma using dental cement (Paladur; Kulzer, Hanau, Germany). The 
animal’s head was fixed and bregma and lambda were aligned stereotactically. A low impedance 
(< 1Ω) metal wire was implanted between the skull and the cortical surface on the left 
hemisphere to serve as a reference electrode. Using a dental drill, a craniotomy (~1 mm diameter; 
centered 2 mm lateral and 0.5 mm caudal to lambda) was performed on the right hemisphere of 
the animal’s skull in order to access the IC contralateral to the injected ear. After removing the 
dura over primary visual cortex (which partly covers the gerbil’s IC 42) with a sharp needle, a linear 
32-electrode silicon probe (177 µm² electrode surface, 50 µm electrode spacing, 1-3 MΩ 
impedance measured at 1 kHz; Neuronexus, Ann Arbor, US) was positioned above the brain ~2 
mm lateral to lambda and as close as possible to the transverse sinus (which also covers the IC in 
this species) as possible. Initially, the probe was slowly inserted ~3.3mm into the brain (measured 
from the surface of visual cortex) using a LN Junior 4RE micromanipulator (Luigs & Neumann; 
Ratingen, Germany). After waiting for one hour in order to obtain a stable preparation, a first 
mapping of recording sites was done using acoustic stimuli at 60-80 dB ranging from 0.5-32 kHz. 
Based on the measured neuronal activity the probe was then further advanced (or retracted) in 
order to optimally access the tonotopic axis of the central nucleus of the IC (ICC; 24,43) and to be 
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able to compare neuronal responses to optogenetic/electrical stimulation across animals later on. 
Once the silicon probe was positioned, activity of multi-neuronal clusters was amplified, filtered 
(0.1-9,000 Hz) and recorded at a sampling rate of 32 kHz using the Digital Lynx 4S recording 
system (Neuralynx; Dublin, Ireland). Data was stored on a hard drive and analyzed off-line. 
 
Event extraction: All data was analyzed using custom-written MATLAB scripts. To obtain time 
stamps of neuronal events, thresholds were set manually on 0.6-6 kHz bandpass-filtered (4th order 
Butterworth-filter) data traces, usually at the level of three times the median absolute deviation 
of the whole data trace. Each crossing of this threshold was considered a time stamp of a 
neuronal event and a refractory time of 1 ms was implemented after each time stamp. For 
electrical stimulation, a linear interpolation was performed from the sampling point just before 
trigger onset to the sampling point 3 ms after trigger onset before thresholding in order to 
remove the electrical artefact from the data trace (Supplementary Figure 14A-C). The artefact 
removal has subsequently been verified with data recorded from dead animals where no 
neuronal component could be observed in addition to the artefact (Supplementary Figure 14D-H).  
Frequency tuning: Frequency response areas were constructed in response to pure tones (100 ms 
duration, 5 ms sine squared ramps for stimulus on- and offset, 150 ms inter-stimulus interval) 
ranging from 0.5-32 kHz in quarter octave steps at sound pressure levels ranging from 10-80 dB 
SPL in 10 dB steps. 20-30 repetitions of each frequency-intensity combination were presented in a 
pseudo-random order, where each stimulus was presented once before presenting the next 
iteration of trials. The characteristic frequency (CF) and its corresponding threshold at each 
recording site was determined as the frequency that elicited responses at the lowest sound 
pressure level during the period of stimulus presentation 44,45.  
 
Responses to artificial SGN stimulation: To determine a time window in which potential responses 
to optical or electrical stimulation can be evaluated, a peri-stimulus time histogram (PSTH; 0.05 
ms bin size) was constructed from pooled multi-unit activity recorded at all recording sites in 
response to a 1 ms laser pulse or a biphasic pulse of electrical current (100μs phase duration) with 
the maximal stimulus intensity presented (~35 mW, 500 µA). The response was defined as MUA 
exceeding the mean spike rate plus 3 standard deviations 20 ms before stimulus onset and was 
observed 2.25-24.5 ms after stimulus onset for optical stimulation and 2.45-13.25 ms after 
stimulus onset for electrical stimulation (Supplementary Figure 2). Based on these results, the 
response windows were set to 0-25 ms after stimulus onset for optical and to 0-14 ms after 
stimulus onset for electrical stimulation.  
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Spatial spread of excitation: To quantify response thresholds and the spread of excitation, spatial 
tuning curves (STC) based on the cumulative discrimination index (d-prime; d´) of spike rates were 
constructed 7,21,22: For each electrode, the distribution of spikes during 20-30 trials in response to 
one stimulus was compared against the distribution of spikes during each trial in response to the 
subsequent (higher intensity) stimulus, where stimuli are sorted according to their intensity, 
starting with an intensity of zero (no stimulus condition). A receiver operating characteristic (ROC) 
curve was constructed from these distributions. The area under the ROC curve, which depicts the 
Z-score (measured in standard deviations), was then multiplied by √2 in order to obtain the d´ 
value. D´ values of successively increasing stimulus intensities were finally summed up in order to 
calculate the cumulative discrimination index. In the next step, a matrix was constructed by 
sorting cumulative d´ values according to the electrode position they were obtained from in one 
dimension and the stimulus intensity they were evoked by in the other dimension. Iso-d´-contour-
lines were then interpolated by using MATLABs built-in contour function and thresholds of 
neuronal activation were determined as the stimulus intensities that correspond to isolines at the 
cumulative d´ level of 1. The best electrode (BE) was defined as the electrode which showed the 
lowest threshold (d´ = 1). The spread of excitation was accessed as the distance between the most 
dorsal and the most ventral electrode with a d´ >=1 at the stimulus intensity that elicited a d´ 
value of 1.5, 2, 2.5 or 3 at the best electrode.  
 
Monte Carlo ray tracing: Monte Carlo ray tracing simulation was performed using TracePro® 
Standard 7.8.1 (Lambda Research Corporation) to validate the experimentally used fiber 
stimulation. Briefly, different cochlear compartments were reconstructed from x-ray tomography 
and embedded in a solid cube to simulate bone enclosure. Each of the structures was assigned 
with mean optical properties from cerebrospinal fluid, brain tissue and bone, respectively46. All 
the light sources were modelled as the optical fiber used in the experiments (Thorlabs FT200UMT, 
0.39 NA) and defined in TracePro as grid sources with the following parameters: circular pattern 
of 3003001 rays (1001 rings, λ = 473 nm, uniform total intensity of 10 mW); grid boundary radius: 
100 µm; symmetric Gaussian spatial and angular beam distribution (waist radius of Gaussian 
beam profile: 100 µm; half angle of angular profile of the beam: 16.79°). Emitter surfaces were 
calculated for every position: First, the tonotopic axis was defined along the center line of 
Rosenthal’s canal, where 300 query points were extrapolated and the corresponding frequency 
positions were calculated by the Greenwood function for a hearing range of 50-0.25 kHz 
(𝑓 = 0.39(102.1𝑥 − 0.5), where x is the cochlear length normalized from 0 to 1 in baso-apical 
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direction). Second, coordinates for the tips of optical fibers were placed in anatomically 
meaningful positions corresponding to fiber placement in our in vivo experiments. These 
coordinates were then translated following a straight line to Rosenthal´s canal to a given distance 
from the query point (400, 700 and 900 µm for apical, mid-cochlear and basal stimulation, 
respectively). The newly calculated coordinate was defined as the origin of the light source and 
the straight line as its normal vector. To account for variability in fiber placement during our 
experiments, two models were calculated. In the rotation model, the normal vector was  rotated 
± 15 degrees in two perpendicular. In the translational model, the normal vector was coaxially 
translated ± 100 and 200 µm. The origin and the normal vector of all five sources (initial position 
plus 4 rotations or four translations) at the three positions were imported to TracePro. Radiant 
flux was read from the 300 query points (included as solid spheres with a 5 µm radius, with 
assigned optical properties of brain tissue). Irradiance was calculated as radiant flux /4*pi*radius2. 
Irradiance values were linearly scaled to 2.67 mW, which was the mean threshold for optogenetic 
stimulation observed in our experiments (Supplementary Figure 5). The mean irradiance profile 
was calculated for every position using the irradiance profile of all five sources, and the tonotopic 
location the fiber was facing was then calculated as the peak of the mean irradiance profile.  
 
IC histology: After each experiment the silicon probe was retracted with the micromanipulator 
and a tungsten electrode covered with DiI (DiIC18(3); Thermo Fisher Scientific, Darmstadt, 
Germany) was inserted into the IC at the same site in order to stain the electrodes’ position. 
Afterwards brains were explanted and fixed in 4% PFA in phosphate buffered saline (PBS) for 
several days before they were moved to 30% sucrose in PBS for cryoprotection. Coronal slices of 
50 μm thickness were obtained using a Leica CM3050 Cryostate (-25°C object temperature). Slices 
were mounted on microscope slides using Fluoroshield mounting medium (Sigma Aldrich, 
Darmstadt, Germany), which contains DAPI in order to stain the cell nuclei.  
 
Data Availability: Data generated and analyzed during the current study is available from the 
corresponding author upon reasonable request. Numerical source data underlying figures 1e, 2a-
k, 4b-j, as well as supplementary figures 1, 2, 5, 7, 9, 11, 12, 13 are provided as a source data file. 
Code Availability: Analysis code – written in MATLAB 2016a – is available from the corresponding 
author upon reasonable request.  
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Supplementary Figure 1: Linear fit of tonotopic slopes. The 
tonotopic slope of each animal was calculated by a linear fit of 
the characteristic frequencies at given recording depths. The 
steepest and shallowest slopes are depicted in black lines. Inset: 
Distribution of tonotopic slopes in 46 gerbils contributing to this 
study. Source data is provided as a source data file. 
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Supplementary Figure 2: Auditory thresholds of  
multi-units in the central nucleus of the inferior 
colliculus (ICC). (A) Thresholds of acoustically driven 
multi-units in non-injected animals without cochlear 
surgery (black) and in AAV-injected animals upon fiber 
insertion (blue). Solid lines show the mean threshold 
for each octave band. In animals that underwent 
cochlear surgery, thresholds of ICC multi-units were 
elevated by ~20 dB SPL on average. For each octave 
band, p-values are below 0.001, at least (two-sample 
t-test). Source data is provided as a source data file. 
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Supplementary Figure 3: Response window of artificial auditory nerve 
stimulation. (A) Peri-Stimulus-Time-Histogram (PSTH; normalized to 1) in 
response to optical stimulation via the round window. (B) PSTH (normalized to 
1) in response to electrical stimulation via a cochlear implant inserted into the 
scala tympani via the round window. Both PSTHs are compiled across all multi-
units that have been recorded upon optical or electrical stimulation. Blue and 
orange lines indicate stimulus on- and offset, respectively. Solid and dashed 
black lines indicate mean firing rate as well as the mean firing rate plus 3 
standard deviations, respectively. The detected times of response on- and 
offsets ared epicted in the corresponding panel. 
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Supplementary Figure 4: Intracochlear optical stimulation of non-injected gerbils. (A-C) Peri-Stimulus-Time-Histogram 
(normalized) in response to optical stimulation via the round window (A; n = 6 gerbils) and cochleostomies in the middle 
(B; n = 3 gerbils) and apical (C; n = 3 gerbils) cochlear turn. Blue lines indicate stimulus on- and offset, respectively. Solid 
and dashed black lines indicate the mean firing rate as well as the mean firing rate plus 3 standard deviations, 
respectively. (D-F) Averaged spatial tuning curves (STCs) in response to basal (D) mid-turn (E) and apical (F) cochlear 
stimulation in non-injected animals. No responses (d’ >= 1) were observed in any individual STC. 
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Supplementary Figure 5: Thresholds for 
artificial auditory nerve stimulation. (A) 
Thresholds of the best electrode (BE) for 
optically driven multi-units in the inferior 
colliculus (IC): Data is displayed as mean ± s.d.. 
(B) Thresholds of the BE for electrically driven 
multi-units in the IC for monopolar (red) and 
bipolar (orange) stimulation (p < 0.01, two-
sample t-test).  Data is displayed as mean ± s.d.. 
Source data is provided as a source data file. 
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Supplementary Figure 6: Multi-peak spatial tuning curves (STCs). Few STCs with more than one peak have been 
observed for acoustic (left), optogenetic (center left), monopolar (center right) and bipolar (right) electrical 
stimulation. In these cases, the most dorsal and most ventral electrodes with significant responses have been 
considered as the boundaries of the STC in order not to underestimate the spread of excitation.  
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Supplementary Figure 7: Tonotopy of artificial auditory nerve stimulation. Characteristic frequencies (CFs) as a 
function of optical stimulation site in AAV-injected animals (A), stimulation electrode for monopolar electrical 
stimulation (B) and electrode pair for bipolar electrical stimulation (C) in non-injected animals. Data is displayed as 
mean and standard deviation for each stimulation site. Symbols mark different animals. Pearson’s correlation 
coefficient r and the corresponding p-values were calculated. The two low-frequency units in response to optical 
stimulation from the cochlear base most likely were positioned at the border – or even outside – of the central nucleus 
of the inferior colliculus (ICC), where low-frequency units typically are found. However, the neural excitation upon 
basal cochlear stimulation always had a focus in the ventral inferior colliculus (as shown when plotting best electrodes 
(BEs) in dependence of stimulation site; see Fig. 4C). The discrepancy in number of data points for apical and basal 
optical stimulation when compared to Fig. 4C is explained by an increase in auditory thresholds upon cochlear surgery 
(see fig. S2), so that acoustically driven activity could not be evoked at all BEs and thus the CFs could not be 
determined. This primarily affected multi-units coding for frequencies at the edge of the audiogram, which typically 
have higher thresholds than the ones in the mid-frequency range. Source data is provided as a source data file. 
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Supplementary Figure 8: Verifying fiber positions by Monte-Carlo ray tracing. 3D model reconstructed from x-ray 
tomography including fiber positions (Pos. 1-3), roughly corresponding to the ones used in physiological experiments. 
In the model, original positions as well as their respective rotation in two orthogonal planes (A and B, panel A) and 
four different coaxial translations (C) have been used to account for variability in fiber placement. Light grey: Bone; 
Grey: Scala media, vestibuli and tympani, as well as semicircular canals; Purple: Peripheral processes and Rosenthal’s 
canal that houses the spiral ganglion neuron’s somata; Fiber position and their corresponding rotations and 
translations, respectively, are indicated by different colors (see legend). (B/D) Irradiance profiles obtained from 300 
query points located along the tonotopic axis, defined in the centerline of the Rosenthal’s canal, upon Monte-Carlo ray 
tracing from the three different fiber positions using a source radiant flux of 2.67 mW. Peak irradiances of the mean 
traces indicate that fibers from these different positions were stimulating areas around 1.01, 6.9 and 22.89 kHz, 
according to the rotation model in panel B, and 1.02, 6.34 and 21.81 according to the translational model in panel D. 
Source data of panel B and D is provided as a source data file. 
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Supplementary Figure 9: Spatial spread of excitation. Mean and s.e.m. for the spatial spread 
of excitation upon acoustic, optogenetic, monopolar and bipolar electric stimulation. Stars 
indicate statistical significance (one star: p < 0.05, two stars: p < 0.01, three stars: p < 0.001), 
according to a repeated-measures Anova and post-hoc pairwise comparison tests. Only 
significant differences have been indicated. Source data is provided as a source data file. 
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Supplementary Figure 10: Effect of fiber angle on spread of excitation. (A) Scheme of fiber 
placement and (B) resulting spread of excitation when the fiber aperture points towards the 
cochlear apex. (C) Positioning of the fiber aperture towards the cochlear base lead to more 
restricted spread of excitation (D). 
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Supplementary Figure 11: Spectral spread x dB above 
threshold. Spectral spread in octaves, measured 6 dB above 
threshold of the best electrode, as done in a different study by 
Middlebrooks and Snyder(Middlebrooks and Snyder, 2007) as 
well as 20 dB above threshold for acoustic stimulation, as done 
by Snyder, Bierer and Middlebrooks(Snyder et al., 2004). Data is 
depicted as mean ± s.d.. Source data is provided as a source 
data file. 
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Supplementary Figure 12: Saturation of stimulus-response functions. 
Dynamic range (DR) of individual multi-units for optical (A), monopolar (B) 
and bipolar (C) electrical stimulation as a function of their respective 
thresholds (10% intercept). Solid lines mark the largest DR possible at the 
respective threshold, limited by the setup’s highest stimulus intensity. While 
optically driven units with higher thresholds (> 2 mW) seem to be mainly 
limited by hardware restrictions, this was not the case for electrically driven 
units. (D) Difference of saturated responses (90% intercept) and the highest 
achievable DR (in dB). While optically driven multi-units tend to approach the 
highest achievable DR, electrically driven units typically were saturated at 
lower intensities. Source data is provided as a source data file. 
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Supplementary Figure 13: Comparison of AAV2/6 and AAV-php.b 
injected animals. (A) Thresholds (d´ = 1) of individual animals at the 
best electrode(two-sample t-test; n = 7 (AAV2/6)/n = 12 (php.b)(. 
(B) Strongest response that could be evoked in each animal (two-
sample t-test;n = 7 (AAV2/6)/n = 12 (php.b)). Data is depicted as 
mean ± s.d.. Source data is provided as a source data file. 
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Supplementary Figure 14: Artefact removal of electrical stimulation. (A) “raw” data trace (hardware-filtered from 0.1-
9 kHz) including the electrical artefacts before linear interpolation. (B) The same data trace after linear interpolation of 
a 3 ms window around the stimulation artefact. (C) 0.6-6kHz band-pass filtered data of the trace shown in (A) and (B) in 
order to extract multi-unit activity. (D-E) Data display as in (A-C), but here measured post-mortem in a sacrificed animal. 
No waveforms were observed after artefact removal. (G-H) Peri-Stimulus-Time-Histograms of detected waveforms 
upon electrical stimulation without clipping of the artefact (G) and with clipping of the artefact (H). Spike counts per bin 
are summed across all animals and stimulation intensities. Orange lines indicate stimulus on- and offset. Insets show a 
zoom-in of the y-axis. 
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Abstract 
 
Electrical cochlear implants (eCIs) restore hearing and enable speech comprehension to half a 
million implantees, thereby re-connecting deaf patients to the auditory scene surrounding them. 
Yet, eCIs suffer from limited spectral selectivity, resulting from current spread around each 
electrode contact and causing poor speech recognition in background noise. Optogenetic 
stimulation of the auditory nerve might overcome this limitation, as light can be conveniently 
confined in space. Here, we combined virus-mediated optogenetic manipulation of cochlear 
neurons and microsystems technology to establish acute multi-channel optical cochlear implant 
(oCI) stimulation in adult Mongolian gerbils. 16-channel µLED-based oCIs evoked activation of the 
auditory pathway with high spectral selectivity and modest power requirements in hearing and 
deaf gerbils. These results prove the feasibility of µLED-based oCIs for spectrally selective 
activation of the auditory nerve. 
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Introduction 
 
According to the World Health Organization, 6.1% of the human population suffers from disabling 
hearing loss, with an economic impact of 750 billion dollar spent on treatment development. 
Approximately 90% of the cases suffer from sensorineural hearing loss resulting from dysfunction 
of the cochlea and/or the auditory nerve. As of today, causal therapies for sensorineural hearing 
loss do not exist. Hence, the methods of choice for hearing restoration are hearing aids and the 
electrical cochlear implant (eCI). When hearing loss is profound or complete, eCIs are used to 
bypass dysfunctional or lost sensory hair cells and electrically stimulate spiral ganglion neurons 
(SGNs). eCIs utilize the intrinsic place-frequency-map (known as tonotopy) of the SGNs to provide 
the patient with spectral information1. However, while open speech comprehension is achieved in 
most of the 500,000 eCI users, there is a major unmet clinical need for improvement of hearing 
restoration. Current spread in the electro-conductive cochlear fluids limits the spatial – and thus 
spectral – selectivity of SGN activation by eCIs and thus the resolution of electric sound encoding. 
This ultimately compromises signal perception, especially in noisy environments2–4. While efforts 
are being undertaken towards more spectrally selective electrical SGN activation, e.g. via 
multipolar stimulation5 or direct electrode-neural interfacing6, it seems that the spread of 
excitation remains the bottleneck of the eCI.  
Recently it has been suggested that optical stimulation, which – opposed to electric current – can 
be conveniently confined in space, could activate SGNs with higher spectral selectivity. Thus, 
optical cochlear implants (oCIs) could increase the frequency resolution of artificial sound 
encoding7,8. Two approaches have been proposed for optical activation of SGNs: i) direct infrared 
neural stimulation7 and ii) optogenetics8. While infrared stimulation has remained controversial9–
11,  the use of light-gated ion channels (channelrhodopsins, ChRs) for optogenetic SGN stimulation 
has been reported by at least two laboratories8,12. Establishing optogenetic hearing restoration is 
a challenging, interdisciplinary task13–16. Two major objectives must be met: First, optogenetics 
must render SGNs light sensitive and enable neural coding at good temporal fidelity. Second, 
multi-channel oCIs must allow for spectrally more selective SGN stimulation as eCIs. Temporally 
precise optical SGN control has been established with fast gating ChR variants17–19. Furthermore, 
spatially confined SGN stimulation by individual optical fibers has been shown to elicit neural 
responses with higher spectral selectivity than electrical stimulation8,20. Thus, studies on the 
biomedical prerequisites to enable optical sound encoding are very promising.  
Towards the development of multi-channel optical cochlear implants, oCIs have been fabricated 
both with commercially available LEDs and with gallium-nitride-based, custom-developed thin-
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film LEDs in the micrometer range (µLEDs)21–24. While LED-based implants23,24 typically carried 10-
15 LEDs with emitters sizes from 0.22-1 mm, µLED-based implants were manufactured with up to 
144 emitters of 60x60µm22. µLEDs of these implants achieve an optical power output of up to 0.82 
mW (corresponding to a power density of 407 mW/mm²), with a maximum temperature increase 
of 1 °C (driven at 10 mA), and are thus efficient enough to drive most ChRs and safe enough for in 
vivo application22. Peak intensity and light extraction of these µLEDs could further be increased 
(by 95% and 83%, respectively) by the implementation of conical concentrators and spherical 
micro-lenses on the emitter surface25. However, to our knowledge optogenetic SGN activation in 
vivo by such implants have not been demonstrated yet.  
In this study, we combined viral gene transfer of the ChR-variant CatCh into SGNs of adult 
Mongolian gerbils with optical stimulation by 16-channel, µLED-based oCIs. We demonstrate 
µLED-mediated activation of the spiral ganglion by 32-channel recordings of multi-neuronal 
clusters in the auditory midbrain in hearing and deaf gerbils. SGN activation was achieved with 
individual µLEDs, and the strength of responses increased when recruiting additional emitters. 
Finally, µLED-based optogenetic stimulation achieved increased spectral selectivity as compared 
to electrical stimulation via clinical-style eCIs. This proof of increased frequency selectivity by 
µLED-based, multi-channel oCIs raises hopes that optogenetic hearing restoration might indeed 
overcome the major limitations of eCIs, and one day might increase the quality of artificial sound 
encoding for deaf patients. 
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Results  
 
Multi-channel optical control of the auditory 
nerve: To render SGNs light sensitive, we 
intramodiolarly injected a suspension of 
adeno-associated virus (AAV-php.b26) 
carrying the calcium translocating 
channelrhodopsin CatCh, fused to eYFP 
under control of the human synapsin 
promoter, into the cochlea of adult 
gerbils18,20. Functional expression of CatCh 
was probed by recordings of auditory 
brainstem activity upon illumination of the 
cochlea with a laser-coupled optical fiber 
earliest four weeks after virus-injection 
(Suppl. Fig. 1). A subset of animals has been 
deafened by intracochlear application of 
kanamycin, which leads to loss of hair cells 
and hence creates a model of sensorineural 
hearing loss18. Deafening was confirmed by 
recordings of auditory brainstem activity in 
response to acoustic clicks. Mean thresholds 
of click-evoked auditory brainstem responses 
amounted to 30 ± 0 dB SPL before deafening 
(n = 4) and no responses were observed with 
clicks up to 100 dB SPL 5-10 days after kanamycin application (Suppl. Fig. 2A). Optogenetic 
activation of the auditory nerve was still possible in deafened animals (Suppl. Fig. 2B). For multi-
channel optical stimulation, we used oCIs housing 16 individually addressable µLEDs (60x60 µm) 
with a center-to-center pitch of either 100 or 250 µm embedded in biocompatible epoxy material 
(Fig. 1A)22. The maximum power output mounted to 0.76 mW for individual µLEDs and 2.94 mW 
when all emitters of an oCI were activated (Suppl. Fig. S3). Using a retroauricular approach, the 
oCIs were inserted into the cochlea of isoflurane-anesthetized gerbils via the round window or 
cochleostomy (Fig. 1B). Electrophysiological recordings of multi-unit activity have been performed 
 
 
Figure 1: μLED-based oCI. (A) Picture of an optical CI 
carrying 16 individually addressable µLEDs with a pitch of 
100 µm on a flexible substrate, µLEDs #5 and #14 (from the 
tip) are active. Scale bar: 500 μm. (B) 3D X-ray tomography 
reconstruction of a 16-channel optical CI implanted in a 
gerbil cochlea. Cables and μLEDs are marked in blue; the 
basilar membrane is marked in green. 
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in the central nucleus of the inferior colliculus (ICC) using linear 32-channel multi-electrode arrays. 
Since both the spiral ganglion and the ICC are characterized by a remarkably conserved tonotopic 
organization, the frequency range of SGN activation in the cochlea can be inferred from neural 
activation in the ICC. 
 
Acoustic calibration: To interpret neural activation in response to oCI stimulation and compare 
data across animals, electrode positioning along the tonotopic axis of the ICC was physiologically 
confirmed by acoustic stimulation using pure tones of varying frequency and intensity. 
Characteristic frequencies were derived for each responsive electrode, and tonotopic slopes were 
calculated for each animal by a linear fit of characteristic frequencies as a function of recording 
depth (Suppl. Fig. 4). Median tonotopic slopes amounted to 4.34 octaves/mm (± 0.47 median 
average deviation, n = 9), which is consistent with previous studies (tonotopic slopes were 
reported between 4.08 and 4.58 octaves/mm)20,27,28. In deafened animals, the recording probe 
was stereotactically inserted and the median tonotopic slope of regular hearing animals was 
assigned since acoustic mapping could not be performed. 
 
ICC activation with oCI stimulation: ICC activation by oCI stimulation of SGNs was evaluated based 
on peri-stimulus time histograms in response to maximum stimulus parameters (i.e. 16 active 
µLEDs at maximum intensity, ~2.9 mW; Suppl. Fig. 5) and neural responses were found to occur 
3.4 –18.8 ms after stimulus onset. Since a transient stimulus artefact was observed in some traces 
at stimulus onset, the time window to quantify potential responses was set to 3 – 20 ms in order 
to avoid the artefact but not discard neural responses. During this time window, multi-unit 
activity in response to a given stimulus of increasing intensity was sorted in a two-dimensional 
response matrix according to the corresponding recording site and stimulus intensity. From this 
matrix, the cumulative discrimination index (d-prime, d´) was calculated based on spike rates in 
response to increasing stimulation intensities, starting with a zero intensity condition (i.e. no 
stimulation, baseline6,7,20. The cumulative d´ quantifies the change in response strength as 
standard deviations from baseline, i.e. a d´ of one is equal to a rise in firing rates by one standard 
deviation. To estimate the patterns of ICC activation, spatial tuning curves (STCs) were 
constructed based on iso-contour-lines at integer d´-values (Fig. 2A). 
 
When stimulating SGNs with individual µLEDs of the oCI at maximum intensity, approximately one 
third of the µLEDs (127/352) evoked neural responses in the ICC (i.e. d´ values greater or equal to 
1 at least at one recording site), and an average d´ value of 2.1 (± 0.78 SD) was obtained from 
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responsive multi-units (fig. 2B). Responses increased when recruiting additional µLEDs: Upon 
maximal stimulation with four neighboring µLEDs, approximately 60% (55/88) of µLED blocks 
evoked neural responses in the ICC with an average d’ value of 2.99 (± 0.93 SD), and maximal 
stimulation with all 16 µLEDs on the oCI achieved average response strengths of 3.29 (± 0.59 SD, 
at ~ 2.9 mW; fig. 2B). For comparison, SGN stimulation with a laser-coupled optical fiber delivering 
light of ~35 mW evoked average response strengths of 4.36 (± 0.53 SD). The strength of neural 
responses did not differ between hearing and deafened animals (p = 0.11/0.44/0.83/0.89 for 
individual/block/all/fiber stimulation, post-hoc corrected two-sample t-test for multiple 
comparisons). 
 
 
 
Figure 2: μLED-evoked neural responses in the ICC. (A) Exemplary STCs in response to SGN illumination with a single 
(most basal) μLED, a block of four neighboring μLEDs and all μLEDs in a CatCh-transduced gerbil and with all µLEDs in a 
wildtype gerbil (from left to right). μLEDs were spaced by 100 μm. (B) Maximum strength of ICC responses evoked by 
oCI stimulation with 1, 4 and 16 active µLEDs, and with a laser-coupled optical fiber (~35 mW) in CatCh-transduced 
gerbils. oCI stimulation with all µLEDs has also been performed in wildtype animals and in sacrificed CatCh-transduced 
animals. Brown dots indicate data recorded from deafened animals. (C) Active electrodes (d´ > 1) upon oCI stimulation 
with 1, 4 and 16 µLEDs, and with optical fiber stimulation. oCI stimulation with all µLEDs has also been performed in 
wildtype animals. (D Thresholds (d´ = 1, measured at the best electrode) for ICC activation evoked 16 active µLEDs on 
an oCIs and with a laser-coupled optical fiber, respectively (p = 0.12, two-sample t-test).  
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Weak responses (d´ = 0.68 ± 0.63) were also observed in two out of eight measurements from 
non-injected, hearing control animals (probably due to an opto-acoustic effect), but responses 
have never been observed in deafened control (no AAV-CatCh injection) or in sacrificed animals. 
Only ~3.0 multi-units (located in dorsal ICC regions (i.e. tonotopically not corresponding to the 
illuminated regions in the basal cochlea) were responsive to light in hearing control gerbils. 
Responses had longer latencies (7.5 vs 3.4 ms) and shorter duration (3.3 vs 15.8 ms) as compared 
to neural responses in CatCh-injected animals (Suppl. fig. S6). Besides increasing response 
strengths of individual multi-units, recruitment of additional µLEDs also activated broader regions 
of the ICC: While individual µLEDs drove on average 12.4 ± 9.0 (out of a maximum of 32 
electrodes, limited by the silicon probe design) units per animal, blockwise stimulation evoked 
activity in 16.9 ± 8.5 units, and oCI stimulation with all µLEDs recruited 19.7 ± 5.4 units (Fig. 2C). 
To demonstrate that these spatially restricted activation patterns originate from confined 
illumination by the oCI and not, for example, from spatially limited opsin expression in the spiral 
ganglion, we employed SGN stimulation with an optical fiber in a less selective manner20: The 
fiber was placed to broadly illuminate the whole cochlea rather than confining laser at a given 
cochlear region, and the intensity was set to ~35 mW, the highest possible laser output and by far 
exceeding the thresholds for CatCh-mediated SGN activation. Stimulating with these settings, 
multi-unit activity was observed at 30.22 ± 3.2 recording sites per animal, indicating that almost 
all units could potentially be driven by light. Thus, the selective activation of SGNs by more ideally 
placed oCIs ad modest stimulation intensities indeed originates from spatially limited spread of 
light (Fig. 2C). As for response strengths, also the number of recruited multi-units did not differ 
between hearing AAV-injected and non-injected animals (p = 0.61/0.21/0.63/0.74 for 
individual/block/all/fiber stimulation, two-sample t-test). Thresholds for optical activation were 
similar for SGN illumination with oCIs and optical fibers (0.52 ± 0.45 mW vs. 0.82 ± 0.53 mW; p = 
0.12, two-sample t-test; Fig. 2D). The mean electrical threshold for optical activation amounted to 
4.80 mA. 
 
SGN activation with high frequency selectivity: In order to estimate activation patterns in 
the cochlea, the spatial extent of ICC activity has been quantified by an activity based 
analysis. From STCs, the iso-contour-line corresponding to a d´ of one was taken as the 
threshold of neural activation, as previously done in other studies on electrical and optical 
auditory nerve stimulation6,7,20,29. The recording site with the lowest threshold, i.e. the 
focus of neural activation, was defined as the best electrode. The spatial extent of neural 
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activation, i.e. the spread of cochlear excitation, was defined as the range in the ICC 
covered by electrodes that recorded optically responsive multi-units at the stimulus 
intensity at which responses of a fixed d´ value were obtained from the best electrode 
(Fig. 3A). This activity-based quantification allows for an estimation of neural excitation 
independent of the nature and absolute intensity of a stimulus, and thus allows for 
comparison across different modes of stimulation at comparable stimulus strengths. 
Since neural responses did not differ between hearing and deafened animals, the data of 
both groups was pooled for subsequent analysis.To demonstrate tonotopic activation of 
the auditory nerve by oCIs, SGNs have been stimulated both with individual µLEDs and 
with blocks of four neighboring µLEDs. The 16 µLEDs on oCIs were spaced either by 100 
and 250 µm, and thus covered a cochlear length of 1.5 and 3.75 mm, respectively. Since 
the length of the scala tympani (where oCIs have been inserted) amounts to 
approximately 11 mm in gerbils, only 13.6 and 34.1% of the cochlear length could be 
covered by the oCIs, respectively30. To overcome this limitation and demonstrate 
tonotopic activation over larger parts of the cochlea, some implants have been inserted 
via a cochleostomy in the middle cochlear turn rather than via the round window. Indeed, 
SGN illumination at different locations along the cochlear spiral led to spatially confined 
neural activation of tonotopically corresponding ICC regions (Fig. 3A).  
 
To correct for different locations of oCI insertion (round window vs cochleostomy), 
different insertion depths (due to varying implant lengths), and different µLED-pitch, 
µLED-locations in the cochlea were normalized to the apical-most µLED on each implant 
which elicited neuronal responses in the ICC. Hence, the best electrode of each STC has 
been normalized to the best electrode which was evoked by the apical-most µLED in the 
cochlea. In other words, for each implant and animal, µLED-dependent shifts in neural 
activation have been normalized to the most apical µLED in the cochlea and the focus of 
neural activation evoked by this µLED. Upon SGN illumination with different µLEDs, a 
(non-significant) trend for stimulus-location-dependent ICC activation was observed 
which amounted to 1.92 electrodes (i.e. 96 µm) in the ICC per millimeter stimulus location 
in the cochlea when stimulating with individual µLEDs (Pearson’s r = 0.073) and 1.21 
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electrodes (i.e. 61 µm) when stimulating with blocks of four neighboring µLEDs (Pearson’s 
r = 0.068; Fig. 3B).  
 
 
 
Figure 3:  Spectral features of oCI coding. (A) Exemplary STCs in response to SGN stimulation with the four apical- and 
four basal-most μLEDs of an oCI inserted via a mid-turn cochleostomy (left, center left) and via the round window 
(center right, right). Definitions of the best electrode (BE) and spread of excitation (SoE) are indicated in the left panel. 
(B) Relative best electrode as a function of stimulus location, normalized to the apical-most μLED evoking a response. 
The black line indicates the tonotopic axis as expected based on literature values. (C) Spectral spread of excitation upon 
SGN stimulation with µLED-based oCIs (solid lines; mean ± SEM), laser-coupled optical fibers, as well as mono- and 
bipolar electrical stimulation with a clinical-style eCI (dashed lines). Data of stimulation via optical fibers and electrical 
CIs is reprinted from20. 
 
Intracochlear spread of excitation (SoE) was estimated at different levels of response 
strength in the ICC. Since the average strength of neural responses to optical stimulation 
with individual µLEDs did not exceed a d´ of two (Fig. 2B), blockwise stimulation with four 
neighboring µLEDs at a time was performed for estimating the spatial extent across a 
larger range of activation levels. Generally, the spread of neural excitation in the ICC upon 
intracochlear oCI stimulation increased with growing response strengths at the best 
electrode (Fig. 3C). The spatial extent of neural excitation was then transferred to spectral 
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spread by using the tonotopic slope of each animal (in case of deaf animals, this 
transformation was done by using the median tonotopic slope of hearing animals). The 
spread of excitation was similar when stimulating with a µLED pitch of 100 µm (0.95 ± 
0.12/1.72 ± 0.21/2.11 ± 0.16/3.08 ± 0.31 octaves at d´ of 1.5/2/2.5/3; mean ± SEM) 
compared to a pitch of 250 µm (1.02 ± 0.15/1.76 ± 0.28/2.26 ± 0.16/3.34 ± 0.26 octaves; p 
= 0.68/0.90/0.60/0.69, repeated measures ANOVA and post-hoc pairwise comparison; 
Fig. 3C). These findings were identical when the spread of ICC activation was not 
normalized by the tonotopic slope, i.e. is reported as physical space in the ICC (Suppl. fig. 
7). 
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Discussion  
 
In this study we have applied multi-channel, µLED-based optical cochlear implants to activate the 
optogenetically modified auditory nerve, successfully combining the biomedical and 
optoelectronic work towards optogenetic hearing restoration. We demonstrated in vivo 
functionality and high spectral selectivity of optogenetic SGN stimulation by µLED-based oCIs in a 
rodent model of cochlear optogenetics.  
 
oCI implantation: For two of the implants, x-ray tomograms have been reconstructed. 
Interestingly, light-emitting surfaces of the µLEDs were facing Rosenthal’s canal in both cases and 
hence achieve ideal illumination of the spiral ganglion – a fact of critical importance for the 
functionality of optogenetic hearing restoration. However, in both cases, the implant pierced 
through the basilar membrane at the base of the cochlea, crossing from scala tympani to scala 
media (Fig. 1B, Suppl. Fig. 8). This might be due to the limited flexibility of the implant: Both the 
planar structure of the µLEDs and the parallel power lines to address µLEDs limit oCI flexibility to 
the plane of emitter surfaces. We speculate that the current oCIs were not flexible enough to be 
maintained in the gerbil scala tympani, respecting the basilar membrane. To overcome this 
problem, oCIs could be implanted via a basal cochleostomy which optimizes the insertion angle in 
future studies.  
 
oCI-mediated neural activation: The average threshold of neural activation in the ICC upon oCI 
stimulation of SGNs was found to be 0.52 mW (4.8 mA driving current). Thresholds tended to be 
lower (even though the difference was not significant, p = 0.12) for stimulation by µLEDs as 
compared to fiber-based stimulation, which amounted to 0.82 mW. In a previous study using the 
same settings, the average threshold of fiber-based stimulation was reported to be 1.7 mW20. As 
expected and demonstrated by Monte Carlo modelling, optical power needed for SGN excitation 
is lower when reducing the emitter deistance from the spiral ganlgion20. Since the intracochlear 
µLEDs used in this study are located closer to the neural target tissue as optical fibers positioned 
at the round window, the trend of lower thresholds most likely results from improved emitter 
placement. The maximum d’ values of neural responses in the ICC amouned to a d´ of 2.1, 2.99 
and 3.29 for oCI stimulation via 1, 4, and 16 active µLEDs, respectively. This compares to a d´ of 
4.36 upon fiber-based stimulation in the same animals and a maximum d´ of 4.4 reported in a 
previous study, when driving SGNs with an optical power of up to 30 mW20. µLED stimulation 
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reached ~75 % of the response strength evoked by optical fibers, with 90% less optical power (2.9 
mW vs 30 mW).  
  
Spectral selectivity of cochlear optogenetics: The average spatial spread of excitation in the ICC 
upon SGN stimulation with blocks of four neighboring µLEDs with a pitch of 100µm amounted to 
0.95/1.72/2.11/3.08 octaves at a d´ of 1.5/2/2.5/3 at the BE, respectively. A previous study 
reported a spatial spread of 1.07/1.89/2.96/3.57 octaves upon confined fiber-based optogenetic 
stimulation, supporting our finding of spectrally precise neural activation of the auditory nerve20. 
While it might seem surprising that the SoE with a block of 4 µLEDs, i.e. Lambertian emitters, is 
comparable to that of a 200 µm optical fiber, we suspect that this reflects the closer proximity of 
µLEDs to the target tissue. The spread of excitation upon mono- and bipolar stimulation in the 
same study amounted to 2.06/4.92/6.91/7.29 and 0.67/3.90/5.89/6.96 octaves20. Thus, oCI-
mediated activation of the auditory system is feasible with higher spectral selectivity then when 
using clinical-style eCIs, where even bipolar stimulation was less selective for all, but near 
threshold intensities. Since we were only able to assess the spatial selectivity upon SGN 
stimulation with groups of four µLEDs, we expect that the spatial selectivity of optogenetic SGN 
stimulation can be further improved by increased light efficacies of µLEDs, the implementation of 
micro-lenses, or the implementation of opsins with a higher light sensitivity, which would allow 
for robust SGN stimulation with individual µLEDs25.  
 
Non-optogenetic neural activation: Upon oCI stimulation in non-injected wildtype gerbils, weak 
neural responses were observed with 2 out of 8 implants. These responses differed from neural 
responses in CatCh-transduced animals (Suppl. Fig. 3). We suggest that an opto-acoustic effect 
might have evoked these responses11, as the longer latency might result from the delay of 
synaptic transmission between the inner hair cell and the SGN, and responses could not evoked in 
wildtype animals without hair cells. Furthermore, these responses vanished after some time and 
were not stable over the course of the experiment, most likely due to degradation of the 
endocochlear potential upon oCI implantation. In contrast, optically evoked responses in CatCh-
transduced animals were highly stable over the whole experiments. However, even if there was 
minor contribution to neural excitation by an opto-acoustic effect in the case of CatCh-transduced 
gerbils (which is unlikely given the comparable patterns of activation in regular hearing and 
deafened CatCh-injected animals), we have rather over- than underestimated the spread of 
excitation in this study, since such combined SGN excitation was most likely broader than for 
exclusive optogenetic stimulation.  
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Limitations: Obviously, this study is only contributing one step in the effort to develop optical 
cochlear implants. Since individual µLEDs have a limited power output, neural responses in the IC 
could not be evoked with all individual µLEDs and evoked responses were far away from 
saturation (Fig. 2B, individual µLEDs vs optical fiber). Hence, one major objective of future µLED 
development is increased power output, which might be achieved by the implementation of 
micro-lenses. Besides the power efficacy, also the number of optical emitters and their pitch 
should be optimized for the model system used in future experiments. oCIs in this study housed 
16 µLEDs with a maximum pitch of 250 µm, covering at most 3.75 mm, i.e. one third, of the gerbil 
cochlear length. To optimally access the tonotopic axis of the auditory nerve with high resolution, 
the number of emitters – ideally spaced by a pitch of 100 µm – should be increased, in order to 
cover larger regions of the cochlea. Furthermore, the depth of implantation in this study was 
mainly limited by the implant length, which should also be increased for future experiments, 
especially when considering studies in other animal models such as the common marmoset, 
which have larger cochleae as compared to rodents. A tapered oCI tip might further increase the 
implantation depth in order to maximize the access to the tonotopic axis of the cochlea. Finally, 
biocompatibility and long-term stability of optical cochlear implants need to be evaluated in 
longitudinal studies upon chronic implantation, ideally by performing behavioral studies involving 
more complex stimulation patterns in order to determine the perceptual frequency resolution 
limit of optical sound encoding.  
  
  Chapter III: µLED-based optical cochlear implants  
 
133 
Methods 
 
Animals: Data was obtained from 13 Mongolian gerbils (Meriones unguiculatus) between 6-14 
months of age. For each surgical procedure, gerbils were placed on a heating pad and 
anesthetized with Isoflurane (induction: 4% at 1 l/min; maintenance: 1-2% at 0.4 l/min). 
Anesthetic depth was monitored by the absence of reflexes and adjusted if necessary. Analgesia 
was achieved by injections of Buprenorphine (0.1 mg/kg BW s.c.). All experiments were 
performed in compliance with the German national animal care guidelines and approved by the 
animal welfare office of the state Lower Saxony, Germany (LAVES), and the local animal welfare 
committee of the University Medical Center Göttingen.  
 
Gene transfer to SGNs: Virus suspension of the recently engineered AAV-variant php.b 
carrying plasmids that code for the calcium permeable Channelrhodopsin-2-variant 
CatCh, linked to the reporter eYFP, under control of the human synapsin promoter, has 
been injected into the spiral ganglion of adult Mongolian gerbils (> 3 months of age) as 
described before (6.99x1012 GC/ml)18,20,26,31. In summary, access to the cochlea was 
achieved via a retroauricular approach, and a small hole was drilled into the basal 
modiolus with a dental file to access the spiral ganglion18,20,32. After intramodiolar 
pressure injections of 2-3 µl virus suspension via micropipettes, muscles and connective 
tissue were repositioned to close the surgical site and the skin was sutured. Animals 
recovered for at least four weeks after surgery before electrophysiological measurements 
were performed.  
 
Deafening: Animals were deafened by bilateral, intracochlear injections of Kanamycin 
solution (~3 µl, 100 mg/ml, Kanamysel, Selectavet) as described before18. Briefly, the 
cochlea was accessed by the retroauricular approach described for virus injections, 
Kanamycin solution was injected via the round window membrane, and a kanamycin-
soaked gelatin sponge was placed in the round window niche before closing the surgical 
site with connective tissue and suturing the skin. 
 
Implant fabrication: Multi-channel optical cochlear implants were fabricated as described 
elsewhere22. Briefly, 16 Gallium-Nitride-based µLEDs of 60x60 µm with a pitch of 100 or 
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250 µm were integrated in a flexible, highly transparent, and biocompatible epoxy 
material. µLEDs are individually addressable via a 4 x 4 matrix interconnection with 4 n- 
and 4 p-contacts. Light emission and the µLED n-side contact are realized via a circular 
aperture (50 µm diameter) in the n-metallization on top of the emitting surface. A wafer-
level process was established to achieve a high process yield: In summary, µLEDs were 
fabricated from epitaxial grown Gallium Nitride on sapphire substrates. Furthermore, the 
contacts on the p-side were realized by a high reflective nickel, gold, silver contact and 
laterally defined by chlorine-based plasma etching. An epoxy-resin-based polymer 
substrate was then deposited on a sapphire wafer equipped with a sacrificial aluminum 
layer (to allow for peel-off from the wafer) via a spin-coating process. Subsequently, the 
µLED-wafer was bonded on the polymer-wafer via an Indium-gold inter-diffusion bonding 
process, and the µLED sapphire wafer was released by laser-lift-off. Gold-based n-
contacts were then metallized on the µLED surface and an additional layer of epoxy-resin 
was applied for passivation. Finally, the polymer stack was trenched down to the wafer by 
oxygen plasma to separate the individual probes. Probes were then released by 
electrochemical dissolution of the sacrificial aluminum layer below.  
 
Auditory brainstem recordings (ABRs): Acoustic or optogenetic stimulation of the auditory 
pathway was verified by recordings of compound activity from the auditory nerve and 
(see next section for details). Evoked potentials were recorded via subdermal, low 
impedance needle electrodes at the vertex and the mastoid bone, amplified with a 
custom made amplifier and stored on a hard drive at a sampling rate of 50 kHz for offline 
analysis. A third needle placed at the back of the animals served as an active shielding 
electrode.  
 
Auditory midbrain recordings: Activity of multi-neuronal clusters (multi-unit activity, 
MUA) was recorded with a linear 32-channel silicon probe (177 µm² surface, 1-3 MΩ 
impedance, 50 µm pitch; Neuronexus, Ann Arbor, US) from the central nucleus of the 
inferior colliculus (ICC) and was described in detail before20. Briefly, the ICC was 
stereotactically accessed via a craniotomy contralateral to the stimulated ear, and the 
silicon probe was inserted ~2 mm lateral and ~0.5 mm caudal to lambda to an initial 
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depth of ~3.3 mm (measured from the surface of visual cortex, which partially covers the 
auditory midbrain in gerbils33) using a micromanipulator (LN Junior 4 RE, Luigs & 
Neumann; Ratingen, Germany). After initial mapping of MUA with acoustic tones, the 
silicon probe was re-positioned as needed in order to optimally access the tonotopic axis 
of the ICC27,34. An epidural low-impedance metal wire (< 1Ω) served as a reference 
electrode on the contralateral hemisphere. Using the Digital Lynx 4s System (Neuralynx; 
Dublin, Ireland), multi-unit responses were amplified, filtered (0.1-9,000 Hz), digitized (32 
kHz sampling rate) and stored on a hard-drive for offline analysis. Once the preparation 
was done, stimuli were designed with custom-written Matlab-scripts (The MathWorks, 
Inc.; Natick, US) and generated with a custom-made system based on NI-DAQ-Cards (NI 
PCI-6229; National Instruments; Austin, US). Near field acoustic stimulation was 
performed with a loudspeaker (Scanspeak Ultrasound; Avisoft Bioacoustics, Glienicke, 
Germany) calibrated with a 0.25-inch microphone (4039; Brüel & Kjaer GmbH, Naerum, 
Denmark), pre-amplifier (2670) and measurement amplifier (2610) positioned 30 cm in 
front of the animal’s head. For optical SGN stimulation, access to the inner ear was 
realized with the retroauricular approach described for virus injections18,20,32. µLEDs were 
inserted into the scala tympani via the round window, with µLEDs facing the center of the 
cochlea. µLEDs were then driven individually or blockwise with current pulses of 1 ms 
between 0-10 mA delivered from a custom-made current source. For fiber-based 
stimulation, a laser-coupled (473 nm, 100 mW DPSS; Changchun New Industry 
Optoelectronics) optical fiber (200 µm diameter, 0.39 NA; Thorlabs, Dachau, Germany) 
was inserted to the cochlea via the round window and directed towards the apex to 
broadly illuminate the cochlea.  
 
Data analysis: All data analysis was performed with custom-written Matlab-scripts. Time 
stamps of multi-units were extracted as peaks exceeding a threshold (median plus three 
median absolute deviations) from filtered data traces (0.6-6 kHz, 4th order Butterworth-
filter). After each time stamp, an artificial refractory period of 1 ms was implemented to 
avoid overestimating the spike rates. Frequency tuning of multi-units was assessed by 
presenting 100 ms pure tones (5 ms sine ramps) of frequencies between 0.5-32 kHz 
(quarter octave steps) and varying sound pressure level in a pseudo-random order at a 
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repetition rate of 4 Hz. Frequency response areas were constructed from 20-30 
repetitions of each frequency-intensity combination, and the frequency that evoked 
neural activity at the lowest intensity was defined as the characteristic frequency35,36. For 
optical stimulation, multi-unit responses occurring 3-20 ms after stimulus onset (1 ms 
light pulses of varying intensity) were sorted into a response matrix according to stimulus 
intensity and recording site. Spatial tuning curves have then been constructed based on 
the cumulative discrimination index of response rates in response to increasing stimulus 
intensity as described previously6,7,20,29. Iso-contour lines were subsequently calculated by 
the contour function provided by Matlab. The iso-contour line at a d´ of 1 was then 
defined as the threshold for neural activation, and the recording site with the lowest 
threshold was defined as the best electrode. The spread of neural excitation, i.e. the 
distance spanned by electrodes that recorded a d´ greater or equal to 1, was then 
calculated at the stimulus intensity that evoked a d´ of 1.5/2/2.5 or 3 at the best 
electrode. If electrodes which recorded responsive multi-units were separated by 
electrodes with multi-units below threshold (d´ = 1), the distance between the dorsal- and 
ventral-most electrodes with a d´ greater or equal to 1 were used to calculate the spread 
of excitation in order to avoid underestimation.  
 
X-ray tomography: After acquisition of electrophysiological data, some oCIs have been 
mounted into the scala tympani with dental cement. Positioning of the implant and 
direction of the µLEDs light emitting surface was assessed with x-ray tomography as 
described previously18,37. Data acquisition was achieved with a customized imaging 
system for cone-beam in-line phase contrast tomography based on a liquid metal x-ray 
source and a LuAG-scintillator-based detector with a pixel size of 6.5 µm, and a fast 
Fourier-based phase reconstruction procedure. Segmentation and visualization of 
reconstructed structures were achieved with the Avizo 3D 9 software and cochlear 
structures as well as oCI components were traced semi-automatically.  
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Supplementary figure 4: Tonotopy in the auditory midbrain. 
Supplementary figure 5: Response window of oCI evoked neural responses. 
Supplementary figure 6: Neural responses in wildtype animals 
Supplementary figure 7: Spatial spread of excitation 
Supplementary figure 8: Tomogram of the oCI-implanted cochlea. 
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Supplementary Figure 1: Optically evoked auditory 
brainstem responses. Functional opsin expression was 
verified by recordings of optically evoked activity in the 
auditory nerve and brainstem at the start of each 
experiment before stimulating SGNs with oCIs for IC 
recordings. Optical stimulation occurred with laser 
pulses of ~35 mW intensity and 1 ms pulse duration at a 
stimulation rate of 10 Hz. Each trace represents the 
average of 1000 stimulus presentations in one animal. 
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Supplementary Figure 2: Deafening by intracochlear kanamycin application 
(A) Auditory brainstem responses (average of 1000 stimulus presentations at a 
stimulation rate of 10 Hz) upon click stimulation from 10-100 dB SPL before 
(left) and after deafening (right). The star indicates the threshold of acoustic 
stimulation. (B) Optically evoked auditory brainstem responses before (left) and 
after deafening (right), elicited by ~35 mW pulses of 1 ms duration, delivered 
by a laser-coupled fiber (1000 stimuli presented at 10 Hz). Optogenetic 
activation of the auditory system was still possible after deafening. Differences 
in amplitude and waveform before and after deafening are likely due to 
different positioning of recording electrodes and the optical fiber. 
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Supplementary Figure 3: Optical power of µLED based 
oCIs. The optical power of individual µLEDs (top) and all 
µLEDs on the oCI (bottom) has been measured before 
each experiment when driving the implant with up to 
10/40 mA, respectively. The power of four neighboring 
µLEDs was estimated from the power of individual 
µLEDs (up to 2.5 mA * 4; center), since the driving 
current of 10 mA was distributed over all four µLEDs. 
Non-functional µLEDs (which did not emit light) have 
been excluded from analysis (numbers of 
functional/tested µLEDs are indicated in each plot). 
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Supplementary Figure 4: Tonotopy in auditory midbrain. (A) Characteristic 
frequencies as a function of recording depth (normally distributed jitter of 0.05 
octaves was added to each unit to reduce overlay of dta points for better 
visualization). Tonotopic slopes (dashed lines) were calculated by linearly fitting 
characteristic frequencies at given recording depths for each animal. Data from 
different animals is indicated by different colors. Inset: Distribution of 
tonotopic slopes of the 9 animals contributing to this study. (B) Electrode 
position in deafened animals. The silicon probe was placed as in normal 
hearing animals, but tonotopy of the ICC could not be mapped. 
  
 
146 
 
 
Supplementary Figure 5: Response window of oCI evoked 
responses. Peri-stimulus time histogram in response to SGN 
stimulation with 16 active µLEDs of an oCI at maximum intensity 
(~2 mW), composed of multi-units recorded from all recording 
sites. Stimulus presentation is indicated in blue. Solid and dashed 
red lines indicate the mean firing rate plus 3 standard deviations, 
respectively. Bin size was set to 0.1 ms, and the detected neural 
response is indicated in black.  
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Supplementary Figure 6: oCI responses in non-
injected gerbils. (A) PSTH in response to SGN 
stimulation with 16 active µLEDs of an oCI at 
maximum intensity (~2.9 mW), composed of multi-
units recorded from responsive recording sites. 
Stimulus presentation is indicated in blue. Solid and 
dashed red lines indicate the mean firing rate plus 3 
standard deviations, respectively. Bin size was set to 
0.1 ms, and the detected neural response is 
indicated in black. Responses have longer latencies 
when compared to oCI stimulation in virally 
transduced animals (compare to supplementary 
figure 2). (B) Exemplary STCs in response to SGN 
illumination with all μLEDs in a non-injected gerbil. 
Responses are much weaker as compared to 
injected animals and do not correspond to the 
pattern of SGN illumination, as responses occur in 
the dorsal, low frequency regions of the ICC, even 
though basal, high frequency regions of the cochlea 
were stimulated (compare to figure 2A, B).  
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Supplementary Figure 7: Spatial spread of excitation. Spread of ICC activity 
upon SGN stimulation with µLED-based oCIs (solid lines; mean ± SEM), laser-
coupled optical fibers, as well as mono- and bipolar electrical stimulation with a 
clinical-style eCI (dashed lines). Data of stimulation via optical fibers and 
electrical CIs is reprinted from20. 
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Supplementary Figure 8: Tomogram of the oCI-
implanted cochlea. X-ray based 3D reconstruction of a 
gerbil cochlea implanted with a 16-channel µLED-based 
oCI. Blue: µLEDs; yellow: Polymer carrier substrate of 
oCI; green: basilar membrane. 
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Discussion 
Cochlear optogenetics – current status 
 
The development of cochlear optogenetics as an alternative to electrical hearing restoration is a 
challenging, interdisciplinary task and multiple objectives must be met before considering clinical 
translation. A first requirement for optogenetic SGN stimulation is light sensitivity of the auditory 
nerve. Towards this end, potential molecular mediators for optogenetic stimulation have been 
identified and optimized for the auditory system using mice as a model system (Hernandez et al., 
2014; Keppeler et al., 2018; Mager et al., 2018). Furthermore, temporal properties of optogenetic 
sound encoding have been characterized in these animals. Second, the technology to enable 
spatially confined illumination of the auditory nerve needs to be developed. First versions of 
multi-channel oCIs have been engineered and their mechanical, thermal, and optical properties 
have been characterized (Goßler et al., 2014; Klein et al., 2018, 2019; Schwaerzle et al., 2016). 
Even though molecular as well as technological prerequisites are already advanced, both require 
further optimization. Moreover, the integration of both aspects and a thorough characterization 
of optical sound encoding in the auditory system, as well as behaviorally relevant perception 
remained important tasks to be performed. In this thesis, some of these aspects have been 
addressed:  
 
First, a fiber-based single-channel oCI has been developed and implanted to the cochlea of adult 
Mongolian gerbils whose auditory nerve has been virally transduced to express the ChR-variant 
CatCh (Wrobel et al., 2018). By optogenetically stimulating the auditory nerve with this implant, 
the perception of optogenetic SGN stimulation has been demonstrated on the behavioral level 
(Wrobel et al., 2018). Furthermore, restoration of auditory function has been demonstrated on 
the physiological and behavioral level in a gerbil Model of sensorineural hearing loss (Wrobel et 
al., 2018). Both the perception of optogenetic SGN stimulation and the functionality of cochlear 
optogenetics in the absence of hair cells are important aspects when considering artificial sound 
encoding by optogenetics in humans suffering from sensorineural hearing loss.  
 
Second, improved spectral selectivity of optogenetic over electric auditory nerve stimulation has 
been demonstrated (Dieter et al., 2019). An activity-based analysis of multi-unit recordings in the 
auditory midbrain enabled comparison of the spectral selectivity upon acoustic, optogenetic and 
electric stimulation. It was shown that optogenetic SGN stimulation outperforms monopolar 
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electrical stimulation at all activation levels, while it was spectrally more specific than bipolar 
electrical stimulation for SGN stimulation beyond threshold values (Dieter et al., 2019). At low 
stimulus intensities, the spread of excitation upon optogenetic SGN stimulation was even as 
narrow as the spread of excitation upon pure tone acoustic stimulation in wildtype animals 
(Dieter et al., 2019). This improvement of spectral selectivity is of uttermost importance, since the 
challenging development of oCIs and their implementation in a clinical setting is only justified if a 
fundamental improvement of artificial sound encoding is to be expected. 
 
Third, functional activation of the auditory system by 16-channel µLED-based optical cochlear 
implants has been demonstrated in Mongolian gerbils. Multi-channel recordings in the auditory 
midbrain of anesthetized animals revealed optogenetic SGN stimulation by individual µLEDs, and 
the strength of midbrain activation positively correlated with the recruitment of additional µLEDs 
in the cochlea. The spectral selectivity of µLED-mediated optogenetic SGN stimulation 
outperformed electrical stimulation. These results demonstrate that µLED-based oCIs can achieve 
increased spectral selectivity as compared to eCIs and are an important milestone towards the 
development of cochlear optogenetics for hearing restoration. 
 
Even though these results promise improved hearing restoration by cochlear optogenetics in the 
future, a long way remains to be gone before considering clinical application. The following 
sections will briefly summarize the experimental evidence for improved sound encoding by 
cochlear optogenetics, before discussing remaining tasks towards clinical translation. Finally, 
optogenetic activation of the auditory system will be discussed in a broader context of auditory 
neuroscience.  
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Sound encoding by cochlear optogenetics 
 
Most real-world acoustic signals are complex, and the auditory system relies on multiple 
mechanisms to encode these signals. Spectral information is primarily encoded via tonotopic SGN 
activation, but a spike time code of neural activity contributes to coding of low frequencies. Sound 
intensity is encoded both on the single neuron and on the population level: When stimulus 
intensities are increased, this raises the firing rate of individual neurons, while additional neurons 
are recruited to code intensity on the population level. Finally, the temporal structure of sound is 
encoded by precise timing of action potentials. Thus, in order to enable restoration of most 
natural hearing, cochlear optogenetics needs to be spectrally selective (to encode sound 
frequency), enable a broad modulation of response strengths (to encode sound intensity), and be 
temporally precise (to not miss out on temporal and spectral properties of the acoustic stimulus). 
 
Frequency resolution: Spectral selectivity of cochlear optogenetics was first shown by local field 
potential recordings and current source density analysis in the inferior colliculus of transgenic 
mice expressing ChR2 (Hernandez et al., 2014). While illuminating the cochlear base – which is 
coding for high frequencies – via the round window, neural activity was observed in high 
frequency regions of the auditory midbrain. The spread of neural activation was statistically 
indistinguishable from acoustic stimulation (31 kHz pure tone, 80 dB SPL), and 1.74-fold more 
restricted than monopolar electric stimulation (Hernandez et al., 2014). In this thesis, spectral 
selectivity of cochlear optogenetics has been analyzed by multi-unit recordings from the ICC in 
Mongolian gerbils while stimulating the cochlea via three optical fibers at low, mid and high 
frequency regions. Upon illumination at a given site in the cochlea, activity has been observed in 
tonotopically corresponding ICC regions (Dieter et al., 2019). The breadth of neural activation in 
the ICC, which allows for the inference of the spread of excitation in the cochlea, was 2.04- and 
1.94-fold as narrow as upon mono- and bipolar stimulation with a 4-channel clinical cochlear 
implant. The spread of excitation upon cochlear illumination with four neighboring optical 
emitters (100 µm pitch) of a 16-channel, µLED-based optical CI was estimated to be 2.37 and 2.26 
fold as narrow as the spread of excitation upon mono- and bipolar electrical stimulation (values 
for electrical stimulation are taken of a comparable study using the same methods (Dieter et al., 
2019)). While these estimates of spectral selectivity are highly promising and prove that optical 
sound encoding can indeed overcome the limitation of electrical cochlear implants, these results 
should be confirmed also in other model organisms, ideally in the awake state. Furthermore, 
future experiments should involve optical cochlear implants with larger numbers of independent 
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emitters. A higher density of emitters along the cochlear axis will be important to determine the 
frequency resolution limit of optical cochlear implants, and might demonstrate the advantage 
over eCIs even stronger, since a similar implant design enables better comparison of the two 
stimulation modes. If the resolution limit of oCIs would overcome the ones of eCIs also in these 
settings, and the number of independent stimulation sites can be substantially increased, the 
objective of clinical translation of cochlear optogenetics would seem justified.  
 
Modeling studies (based on X-ray imaged gerbil cochleae, literature values of optical parameters 
of biological tissues, and optical fiber properties identical to the experimental setup reported in 
this thesis) corroborated the high spectral selectivity of optical sound encoding: Monte Carlo ray 
tracing confirmed the feasibility of spatially precise auditory nerve stimulation, given appropriate 
positioning of the light emitters and adequate illumination intensities (Dieter et al., 2019; Wrobel 
et al., 2018). Modelling furthermore suggested that spectral selectivity might be improved even 
further by optimizing various aspects of SGN illumination: On the engineering level, the surface of 
the light emitter might be further decreased, which consequently would lead to a decrease in the 
illuminated area at the level of the spiral ganglion. In addition, lower numerical apertures of the 
light emitters could improve the confinement of the beam path. Since the geometry of the light 
emitting surface relative to the neural target structure is of critical importance for spatially 
selective neural activation, improvements might also be achieved on the experimental side: First, 
the distance of the stimulators to the target tissue should be decreased, which can be done by 
intracochlear emitters wrapping around the modiolus. Second, the emitter surface should be 
directed as orthogonal as possible to the spiral ganglion. Illumination should target the somata of 
SGNs rather than the peripheral neurites, since the preservation of the latter upon hearing loss 
might be reduced. By optimizing the emitter placement in these ways, the illuminated area at the 
level of the spiral ganglion can be minimized (Dieter et al., 2019; Wrobel et al., 2018). Finally, the 
implementation of opsins with a red-shifted action spectrum might increase spectral resolution of 
optical sound encoding, since light scattering by biological tissues is less pronounced for red light 
as compared to blue light and thus the confinement of the light beam might be more narrow 
(Jacques, 2013). 
 
Together these results demonstrate increased spectral selectivity of optogenetic over electric SGN 
activation and thus suggest that oCIs can indeed overcome the major limitations of eCIs and 
hence increase frequency resolution of hearing restoration. 
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Dynamic range: Besides frequency information, also intensity information is limited in electrical 
sound encoding. Since SGNs have an intrinsically low dynamic range in response to electric 
current (1-2 dB  (Miller et al., 2006)), and large SGN populations are activated at similar 
thresholds, the output dynamic range of electrical cochlear implants is limited to typically 10-20 
dB (Miller et al., 2006; Rubinstein, 2004), as compared to ~120 dB that can be coded by acoustic 
stimuli (Viemeister, 1988). Based on the stimulus-response function of oABR wave I amplitudes, 
several studies on cochlear optogenetics have reported dynamic ranges of 10-20 dB (Keppeler et 
al., 2018; Mager et al., 2018; Wrobel et al., 2018). On the level of the auditory midbrain, the 
dynamic range of optogenetic SGN stimulation has been estimated to be 7-8dB (and ~11 dB on 
the population level, which was comparable to the dynamic range of mono- and bipolar electrical 
SGN stimulation), based on the activity of multi-neuronal clusters (Dieter et al., 2019). These 
values slightly exceeded the dynamic range reported from eCI stimulation in the rat (also based 
on multi-unit activity in the inferior colliculus) which have been reported to be between 6-8 dB 
(Allitt et al., 2012, 2016). Two notions should be taken when interpreting these results: First, it is 
likely that the true output dynamic range of optogenetic SGN stimulation has been 
underestimated. This is evident from the fact that most neural responses did not reach saturation, 
even at the highest stimulation intensities tested (Dieter et al., 2019). Second, adequate 
comparison between optogenetic and electrical stimulation is not straightforward: The dynamic 
range of electrical SGN activation was calculated based on current amplitude, while the dynamic 
range of optogenetic SGN activation was calculated based on optical power. Calculating the 
dynamic range based on power versus amplitude leads to a difference by the factor of two. The 
power-based calculation is likely to be appropriate for optogenetic stimulation, since the optical 
power directly relates stimulation intensity to membrane depolarization of SGNs. However, the 
unit that relates stimulus intensity to SGN depolarization when stimulating electrically is likely to 
be electric charge rather than current amplitude. With this assumption, the dynamic range of 
electrical stimulation has been overestimated by a factor of two, and hence the dynamic range of 
optogenetic stimulation might outperform electrical stimulation. The maximum output dynamic 
range that can be coded optically will further be influenced by additional factors: The 
implementation of future opsins with increased light sensitivity, as well as optimized emitter 
positioning, might lower the light thresholds for SGN activation and hence increase the dynamic 
range at the lower end of coding. However, long-term safety limits for tissue illumination to avoid 
heating and phototoxicity might limit the maximum stimulus intensity, and hence the dynamic 
range at the upper end of coding. To finally answer the question regarding the output dynamic 
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range of cochlear optogenetics, and furthermore to address the question how many intensity 
steps might be discriminable, also behavioral experiments are needed.  
  
 
Temporal coding: Coding of acoustic stimuli in the auditory system heavily relies on spike timing, 
since SGN typically have firing rates up to several hundreds of Hertz with sub-millisecond 
precision (up to ~100 Hz spontaneous activity and up to ~400 Hz sustained rates of acoustically 
evoked responses) (Heil and Peterson, 2015; Liberman, 1978; Schmiedt, 1989). Therefore, 
optogenetic SGN stimulation must facilitate action potential generation in SGNs with great 
temporal fidelity even at high stimulation rates. Temporal fidelity of optogenetic neural activation 
depends on the kinetics of the expressed opsin, and the high frequency cut-off for light-induced 
spiking is mainly governed by the time constant τoff for channel closing after illumination is 
terminated. Since optogenetic tools with improved kinetics are of broad interest in the 
neuroscience community, quite some effort was put on the identification of faster opsin, both by 
screening of naturally occurring opsins (Klapoetke et al., 2014) and by directed mutagenesis of 
previously described opsins (Gunaydin et al., 2010; Mager et al., 2018). The temporal fidelity of 
optogenetic SGN stimulation has been approximated on the population level by oABR recordings 
and on the single unit level by auditory nerve fiber recordings for the ChRs ChR2 (τoff =10 ms at 
room temperature (Hernandez et al., 2014)), CatCh (τoff = 16 ms (Kleinlogel et al., 2011; Wrobel et 
al., 2018)), Chronos (τoff =3.6 ms (Keppeler et al., 2018; Klapoetke et al., 2014)), and f-Chrimson 
(τoff = 5.7 ms (Mager et al., 2018)). However, with increasing temperature, closing kinetics of ChRs 
are scaled by a temperature coefficient (Q10 = scaling factor for a temperature change of 10 °C). 
In the case of Chronos, the Q10 amounts to 2.7 (τoff = 0.76 ms at body temperature), and a Q10 of 
2.4 has been reported for ChR2 (τoff = 3 ms at body temperature (Keppeler et al., 2018)). Assuming 
similar Q10 values (e.g. 2.5) for CatCh and f-Chrimson, their closing kinetics would be as fast as 4.6 
ms and 1.6 ms at physiological temperature. 
 
Since ABRs are compound potentials whose amplitude is determined both by the amount of 
activated neurons and by their synchronization, the amplitude and temporal jitter of oABR wave I, 
which originates from activity in the auditory nerve, serves as a proxy for temporal fidelity of 
optogenetic SGN activation on the population level (Henry, 1979; Land et al., 2016). Typically, the 
amplitude of oABR wave I decreases and latency as well as its jitter rise with increasing 
stimulation rates, indicating the limitation of temporal fidelity of coding (Hernandez et al., 2014; 
Keppeler et al., 2018; Mager et al., 2018; Wrobel et al., 2018). In ChR2-mediated responses, 
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oABRs could not be evoked at stimulation rates greater than 80 Hz (Hernandez et al., 2014), while 
stimulation rates of up to 200 Hz still were able to evoke responses in CatCh- and f-Chrimson 
expressing animals (Mager et al., 2018; Wrobel et al., 2018). Using Chronos, responses could be 
evoked even with stimulation rates up to 1 kHz, although the signal propagation along the 
pathway could not be validated given the brief averaging time window (Keppeler et al., 2018).  
 
On the level of individual SGNs, temporal fidelity of cochlear optogenetics was estimated by the 
spike probability and the vector strength – a measure for the quality of phase-locking – of light-
induced action potentials. In CatCh-transduced gerbils, both spike probability and vector strength 
decreased substantially at stimulation rates beyond 100 Hz (Wrobel et al., 2018), while f-
Chrimson- and Chronos-transduced mice facilitated spike probabilities of ~0.3 even at stimulation 
rates up to 200 Hz and substantial vector strength up to rates of a few hundred Hertz (and even 
up to 1 kHz in some Chronos-expressing SGNs) (Keppeler et al., 2018; Mager et al., 2018).  
 
Even though the implementation of opsins with improved kinetics enables reliable and precise 
spike generation up to few hundreds of Hertz, the temporal fidelity of natural sound encoding is 
not yet reached. However, it has been shown that speech recognition mainly relies on temporal 
cues in the range of 50-160 Hz, which would be covered by both Chronos and f-Chrimson 
(Shannon et al., 1995). Furthermore, some portion of the temporal limitation might be 
compensated by the auditory nerve on the population level, since several SGNs jointly encode 
information (Liberman, 1978). Nevertheless, the search for faster opsins should further continue 
in order to identify even more suitable opsins for future applications in hearing restoration. 
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Cochlear optogenetics for hearing restoration 
Besides encoding acoustic stimuli on the physiological level, cochlear optogenetics must meet 
some further requirements to qualify as an alternative method for the treatment of hearing loss: 
First, opsin expression must be stable over time, in order to enable SGN activation by light over 
decades, and ideally over the whole lifespan of the patient. Second, in order to allow for cognition 
of optically coded auditory information, optogenetic SGN stimulation must not only drive the 
auditory system physiologically, but must also evoke a percept. Third, optogenetic SGN 
stimulation must be functional in the absence of hair cells, i.e. in the deafened cochlea, since 
most patients suffer from hearing loss due to dysfunction of inner hair cells. Finally, optical sound 
encoding should happen at reasonable thresholds, minimizing the energy requirements and thus 
increasing battery lifetime of future oCIs. 
 
Long term stability of opsin expression:  
By chronic implantation of optical fibers into the cochlea and weekly recordings of oABRs, this 
thesis demonstrates that cochlear optogenetics can elicit stable physiological responses over 
more than 110 days, which was the longest period observed in these experiments (Wrobel et al., 
2018). Long term stability of acutely recorded oABRs has also been shown in different studies in 
mice: One study demonstrated that optogenetic stimulation of SGNs which express f-Chrimson 
evoked comparable oABRs in young mice and in mice were expressing the opsin for nine months 
(Mager et al., 2018). A second study reported similar opsin expression levels and comparable 
oABRs 6-18 weeks after transduction of the auditory nerve of mice with Chronos (Duarte et al., 
2018). However, studies that analyze functional opsin expression over years, or ideally over the 
whole lifespan of an animal, are still pending. 
 
Perception of cochlear optogenetics:  
An optogenetically evoked percept strong enough to guide avoidance behavior in Mongolian 
gerbils has been demonstrated in this thesis (Wrobel et al., 2018). By chronically implanting 
optical fibers into the cochlea and training implanted animals in the shuttle-box paradigm of 
negative reinforced learning, animals could demonstrate the perception of optogenetic SGN 
stimulation via locomotion. Minimal energy thresholds required to evoke a percept were as low 
as 1.3 µJ, which still exceeds the energy requirements for electrical cochlear implants (~0.2 µJ for 
a pulse of 80 µs)(Zierhofer et al., 1995). After learning the behavioral task with optogenetic cues, 
gerbils could generalize and transfer that knowledge to acoustic cues, suggesting some degree of 
similarity between perception of optogenetic and acoustic stimuli (Wrobel et al., 2018). A 
 Discussion 
 
159 
different study confirmed the behaviorally relevant perception of optogenetic stimulation at a 
different stage in the auditory system: Upon virus injection (with constructs coding for ChR2 or 
Chronos) and fiber implantation in the inferior colliculus of mice, animals were successfully 
trained in the shuttlebox and could indicate the perception of optogenetic stimulation of the 
auditory midbrain (Guo et al., 2015).  
 
Optogenetics in the deafened cochlea:  
This thesis demonstrates optogenetic activation of the auditory nerve independent of hair cell 
function (Wrobel et al., 2018). As a model of sensorineural hearing loss, gerbils have been 
pharmacologically deafened by local application of aminoglycosides to the inner ear, and deafness 
has been proven both behaviorally and by ABR recordings. Even though hair cells were lost after 
deafening, as demonstrated by post-mortem histological analysis, optogenetic SGN stimulation 
was still able to evoke oABRs, and animals were successfully trained to solve the task by using 
optogenetic cues. Re-activation of the deafened cochlea by optogenetics was already 
demonstrated before for different models of deafness: As proven by recordings of oABRs, 
cochlear optogenetics could activate the auditory nerve in a ChR2-expressing mouse model of 
human deafness (Hernandez et al., 2014), in which transmitter release from inner hair cells is 
severely impaired (Pangrsic et al., 2010). Furthermore, optogenetic auditory nerve activation was 
demonstrated after the injection of furosemide (Hernandez et al., 2014), which prohibits 
mechanotransduction by hair cells due to the abolishment of the endocochlear potential (Sewell, 
1984). A different study reported optogenetic SGN stimulation (Mager et al., 2018) in a mouse 
model of age related hearing loss (Shnerson et al., 1981): oABRs recorded from nine months old 
C57BL/6J mice, whose aABR amplitudes only amount to one third of the aABR amplitude found in 
young mice, and whose aABR thresholds are elevated by almost 40 dB SPL, were still comparable 
to the oABRs recorded in young mice (Mager et al., 2018). Taken together, these studies 
convincingly demonstrate the feasibility of optogenetic SGN stimulation in various rodent models 
of deafness, including genetic, drug-induced, and age-related loss of inner hair cells. 
 
Thresholds of neural activation:  
A further consideration for hearing restoration by optogenetics is the energy required for optical 
sound encoding. Activation thresholds must be minimized to enable safe stimulation and avoid 
phototoxicity or heating in the cochlea, but also to achieve reasonable battery lifetimes when 
using future oCIs in daily life. Thresholds of optogenetic SGN activation generally depend on 
multiple aspects, such as the expression level of the opsins, their open channel lifetime, and 
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emitter placement, while the light sensitivity of the chosen channelrhodopsins seems relatively 
constant. In this thesis, SGNs have been optogenetically modified to express CatCh, and 
thresholds for neural activation have been determined with multiple methods: multi-unit 
recordings in the ICC revealed thresholds of 2.67 mW for 1 ms pulses, which corresponds to an 
energy of 2.67 µJ (Dieter et al., 2019), while activation thresholds of single units in the auditory 
cortex (recorded in high frequency regions, and thus matching the fiber placement in the cochlea 
cochlea) were as low as 1.4 µJ (1.4 mW at 1 ms pulse duration) (Wrobel et al., 2018). Population 
potentials (oABRs) were reported to have higher activation thresholds (on average 4.6 µJ), while 
behavioral thresholds were as low as 1.8 µJ (Wrobel et al., 2018). Studies on SGNs expressing 
different opsins have reported oABR thresholds of 6-9 µJ (Chronos (Duarte et al., 2018; Keppeler 
et al., 2018)), 4.6 µJ (Chronos-ES/TS (Keppeler et al., 2018)), 2.2 µJ (ChR2 (Hernandez et al., 
2014)), and even as low as 0.5-1 µJ when transducing the auditory nerve with f-Chrimson (Mager 
et al., 2018). From these estimates, f-Chrimson is a promising candidate for optogenetic hearing 
restoration, since it enables safe SGN activation not only due to low thresholds, but also due to its 
red-shifted action spectrum (Mager et al., 2018). However, even the energy required to optically 
excite auditory neurons expressing f-Chrimson still exceeds the energy requirements for electrical 
SGN stimulation (~0.2 µJ for a pulse of 80 µs) (Zierhofer et al., 1995). Fortunately, the optogenetic 
toolbox is under active investigation, and tools with optimized characteristics are frequently 
discovered, raising the hope that opsins with increased light sensitivity might be available soon. 
As stated earlier, also more ideal placement of the light sources (Dieter et al., 2019; Wrobel et al., 
2018) and higher levels of opsin expressions (Keppeler et al., 2018) might contribute to further 
lower the energy requirements for optogenetic sound encoding.  
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Engineering of multi-channel optical cochlear implants 
 
While considerable progress has been made on the biological side of cochlear optogenetics in 
recent years, also the engineering of multi-channel optical stimulators for cochlear illumination 
reported great advancements. The design and technical realization of oCIs is very demanding, and 
heavily restricted by the cochlear anatomy: Implants must be scaled to fit into the limited 
intracochlear space, and flexible enough to follow the cochlear turns without causing trauma due 
to implantation. Large numbers of optical emitters should be integrated on this carrier, and the 
implant must be embedded in a biocompatible encapsulation that guarantees long-term stability 
over decades, while being both transparent and electrically insulating (in the case of µLED-based 
oCIs). Furthermore, the design and optimization of the emitter itself is very challenging: light 
sources should have a narrow beam profile to allow for confinement of the light, while providing 
sufficient power output at minimal energy consumption. Two general designs can be considered 
(Dombrowski et al., 2018; Jeschke and Moser, 2015): passive implants, which consist of 
intracochlear waveguides coupled to external light sources (Balster et al., 2014), and active 
implants, whose optoelectronic components are integrated on the carrier and placed in the 
cochlea close to the neural target tissue (Goßler et al., 2014; Klein et al., 2018; Schwaerzle et al., 
2016; Xu et al., 2018). Passive implants have the advantage to spatially separate the light source 
from the cochlea. Optoelectronic components could be placed in a hermetically sealed housing, 
which would have several advantages. Spatial separation of optoelectronics and tissue would 
decrease the risk of tissue damage due to heating, which is a big advantage in terms of patient 
safety. Furthermore, the encapsulation of the intracochlear part would be less critical, the size of 
light sources is less limited, and light sources could potentially be exchanged in case an emitter 
would fail. On the other hand, oCIs based on active emitters would be favorable in terms of 
energy consumption, since passive stimulators face loss of light at the interface between the light 
source and the waveguide, as well as along the waveguide (Alt et al., 2017). 
 
Passive optical cochlear implants:  
So far, only one passive oCI has been developed, which is composed of eight silicone-embedded 
glass fibers of 25 µm diameter (Balster et al., 2014). This implant has successfully been inserted 
into explanted human temporal bones, without causing any trauma due to implantation. 
Furthermore, insertion forces for this oCI have been assessed in a 2D cochlea model and were 
comparable to the forces observed when inserting conventional electrical CIs (Balster et al., 
2014). While this device is already very promising, it is not yet functional, since it was not coupled 
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to optical emitters, and the number of waveguides must be substantially increased. The latter 
might be achieved by the implementation of single-mode optical fibers, which typically are 
thinner (2-10 µm diameter (Alt et al., 2017)) than the multi-mode fibers used in this study 
(typically tens to hundreds of µm (Balster et al., 2014)). A second advantage of single mode fibers 
is the lower numerical aperture, which narrows the beam of out coupled light and would thus 
enable neural stimulation with greater spatial selectivity (Alt et al., 2017). Unfortunately, single-
mode fibers come at the cost of more challenging light coupling at the emitter-waveguide-
interface (Alt et al., 2017). Alternatively, fibers made from polymers might serve as waveguides 
for passive optical CIs, since they can be manufactured with diameters below 10 µm (Alt et al., 
2017; Xu et al., 2018; Zorzos et al., 2010). Furthermore, polymer-based waveguides, even though 
being less light efficient than glass fibers, might be beneficial in terms of their mechanical 
properties, since they are more flexible than glass fibers, which could be of advantage when 
winding along the cochlear spiral.  
 
Active optical cochlear implants:  
Active oCIs based on LEDs have been developed in various versions during the past few years 
(Goßler et al., 2014; Klein et al., 2018, 2019; Schwaerzle et al., 2016; Xu et al., 2018). In one 
approach, ten commercially available LEDs (220 x 270 µm; 460 nm emission peak; Cree Europe 
GmbH) have been flip-chip bonded on a flexible polyimide substrate with a pitch of either 350 or 
500 µm (Schwaerzle et al., 2016). The oCI of 20 mm length and 0.24 mm width allowed for a 
bending radius of 1 mm, while still being functional. Individually addressable LEDs had an output 
power of 0.3 mW (when driven at 5 mA), which amounts to a power density of ~5 mW/mm² 
(Schwaerzle et al., 2016), which is sufficient to drive most opsins (Deisseroth and Hegemann, 
2017). When placed on agarose and driven at a duty cycle of 10%, the implant led to a maximum 
temperature increase of 1.67 °C. In a different approach, 15 LEDs (1 x 0.6 mm, 470 nm emission 
peak) with a maximum output of 34 mW have been embedded in biocompatible silicone and 
inserted into models of the human cochlea (Xu et al., 2018). Insertion forces have been assessed 
and were comparable to forces observed upon implantation of electrical cochlear implants. 
Besides cochlear application, wireless controlled LEDs have been engineered for optogenetic 
experiments with emission peaks in the red, yellow, green, blue (220 x 270 µm each) and 
ultraviolet (100 x 100 µm) spectrum (Shin et al., 2017). Even though these designs are important 
steps towards the development of optical cochlear implants, commercially available LEDs are still 
relatively large, and thus the number of emitters on the implant is limited.  
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To further miniaturize optical emitters, Gallium Nitride (GaN) based thin film µLEDs as small as 50 
x 50 µm have been developed and integrated on flexible substrates (Goßler et al., 2014; Klein et 
al., 2018). GaN depicts the ideal material for µLED fabrication since it is biocompatible (Jewett et 
al., 2012) and highly stable (lifetimes of up to 100,000 hours have been reported)(Alt et al., 2017; 
Laubsch et al., 2010). Furthermore, the emission spectrum of GaN-based µLEDs ranges from green 
to ultraviolet light, and power efficiencies as high as 60 % can be achieved (Alt et al., 2017; 
Laubsch et al., 2010).   First developments of µLED-based oCIs for animal experiments resulted in 
two different designs (Goßler et al., 2014): One oCI, with dimensions of 0.23 x 5 mm, carried four 
µLEDs of 50 x 50 µm. A second oCI of 0.38 x 5 mm size carried 15 µLEDs of 150 x 150 µm. µLEDs 
had an emission peak of 405 nm and a maximum output of 60 µW when driven with a current of 1 
mA, corresponding to a power density of 6 mW/mm². While the second implant was successfully 
inserted into the model of a rat cochlea, the smaller design of the first implant even allowed 
implantation into an explanted mouse cochlea via the round window (Goßler et al., 2014). Further 
advancement of these oCIs led to an implant which houses 144 individually addressable µLEDs of 
50x50 µm (emission peak: 462 nm; max. power 0.82 mW, = 4.07 mW/mm²) at a total size of 0.35 
x 15 mm (Klein et al., 2018). A fully epoxy-based, biocompatible carrier substrate of these 
implants minimized thermomechanical bending, and maximum temperature increases of 1 °C 
when driving the implant at 10 mA for 20 ms, enabling safe in vivo application of this implant 
(Klein et al., 2018). Indeed, functional activation of the auditory nerve by oCIs of this kind has 
been successfully demonstrated in this thesis. Follow-up efforts to improve the optical properties 
of oCIs employed conical concentrators and spherical micro-lenses made from 
polydimethylsiloxane (a transparent, flexible and biocompatible material), which were placed on 
the light emitting surface of µLEDs (Klein et al., 2019). Concentrators and micro-lenses increased 
light extraction by 83 % and peak intensity by 95 %, promising more robust opsin activation, but 
also lowering energy consumption and temperature increase during illumination, as compared to 
identical SGN illumination without micro-lenses (Klein et al., 2019). 
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The roadmap towards clinical translation of optogenetic cochlear implants 
 
Despite the enormous progress both in animal experiments and in oCI engineering, lots of work 
remains to be done before considering clinical translation of cochlear optogenetics. This section 
will outline the major objectives that should be addressed in future studies in order to pave the 
way for clinical translation. 
 
Rendering the auditory nerve light sensitive 
 
Choosing the ideal opsin for cochlear optogenetics:  
To facilitate optogenetics-based artificial sound encoding with high temporal fidelity, at low 
thresholds, and with minimal risk for phototoxicity, the ideal opsin would combine a red-shifted 
action spectrum, fast opsin kinetics, large ion conductance, and high light sensitivity. The red-
shifted action spectrum is desired because red light is reportedly less phototoxic than blue light 
(Kerstein et al., 2014; Mager et al., 2018). Furthermore, due to reduced absorption, red light 
penetrates deeper into biological tissue, lowering the light thresholds needed for opsin activation 
(Jacques, 2013). Both the reduction in phototoxicity and the lower illumination intensities would 
increase the biosafety of cochlear optogenetics. Finally, also the scattering in biological tissue is 
less pronounced for red than for blue light, which potentially enables improved spatial 
confinement of the beam path, enhancing spatial selectivity of neural activation and thus 
increasing frequency resolution of oCIs (Jacques, 2013). As discussed previously, temporal fidelity 
of optogenetics-mediated action potential generation is mainly limited by the closing constant 
τoff of a channel. Even though the fastest opsins known to date are approaching physiological 
firing rates of SGNs, some improvement is still needed. This might be achieved by directed 
mutagenesis: helix 6 mutations in the red-shifted opsin Chrimson considerably sped up τoff and 
resulted in the versions f-Chrimson and vf-Chrimson (τoff  = 3.2 ms and 1.6 ms at body 
temperature, respectively, as compared to ~10 ms in regular Chrimson) (Mager et al., 2018). 
These mutations could in principle also be done in other opsins, such as the fastest natural 
occurring opsin, Chronos, to speed up their channel kinetics (Klapoetke et al., 2014). 
Unfortunately, shorter lifetimes of opened channels due to faster closing reduce photocurrents in 
the target cell, which leads to decreased light sensitivity of the cell. Consequently, light sensitivity 
and channel kinetics must be balanced. Increasing the ion conductance of the opsin should be 
considered in order to mediate strong and stable depolarization of transduced cells and thus 
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facilitate reliable responses to neural illumination.. Thus, the amount of foreign protein necessary 
to mediate responses could be reduced, consequently reducing stress on the target cell. Finally, it 
might be worth to consider light-activated ion pumps, such as Xenorhodopsin, in order to 
decouple the ion conductance and thus the depolarization of the cell from ion gradients across 
the cell membrane (Shevchenko et al., 2017). However, ion pumps with sufficiently fast pump 
rates not yet available in the optogenetic toolbox.   
 
Improving opsin expression:  
In order to facilitate stable light-induced neural responses, the opsin needs to be expressed at 
high levels and integrated into the plasma membrane. Previous studies have shown that 
trafficking of microbial opsins in mammalian neurons and proper membrane integration can be 
limited (Gradinaru et al., 2010; Keppeler et al., 2018; Wrobel et al., 2018). To improve opsin 
export from the endoplasmic reticulum, an export signal naturally occurring in inward rectifying 
potassium channels was added to the construct, resulting in enhanced export from the 
endoplasmic reticulum and improved opsin integration into the cell membrane (Gradinaru et al., 
2010; Ma et al., 2001). A second trafficking signal derived from the same family of ion channels 
was reported to further increase localization of the expressed opsin to the cell membrane 
(Gradinaru et al., 2010; Stockklausner et al., 2001). In combination, these export and trafficking 
signals improved opsin targeting to the cell membrane not only in SGNs, but also in primary 
hippocampal cultures and HEK cells (Keppeler et al., 2018). In SGNs, improved membrane 
localization halved illumination intensity needed to evoke oABRs and increased the success rate of 
opsin expression after virus injection from 50 % to 95 % (Keppeler et al., 2018). 
 
Choosing the viral vector:  
Various viral vectors, including adeno-, adeno-associated-, lenti-, and rabies viruses – which all 
have their individual advantages and drawbacks – have been used for gene transfer to neural 
tissue. Out of this toolbox, AAVs are the most promising candidates for gene therapy, since they 
have an intrinsically high neural tropism, provide long-term protein expression at high levels, and 
have little potential for virus-related immune reactions or toxicity in the target tissue (Ahmed et 
al., 2017; Hudry and Vandenberghe, 2019; Lotfinia et al., 2019; Willett and Bennett, 2013). 
Various clinical trials for AAV-mediated gene therapy have been and are currently performed, 
including the treatment of retinal dysfunction (Askew et al., 2015; Hudry and Vandenberghe, 
2019; Landegger et al., 2017; Lotfinia et al., 2019; Pan et al., 2017; Suzuki et al., 2017). Two 
recently approved clinical trials even involve optogenetic tools for vision restoration 
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(NCT02556736 and NCT03326336). Furthermore, Luxturna – an AAV-mediated gene therapy for 
the treatment of vision loss due to Lebers congenital amaurosis – has recently been FDA-
approved (Keeler and Flotte, 2019). No adverse reactions against AAVs were reported except 
mild, transient inflammatory responses. Transgene expression and vision restoration was stable 
for several years (Simonelli et al., 2010), and AAV-injection into the second eye has been 
approved and successfully performed (Bennett et al., 2012). For hearing restoration, gene 
therapies have not reached clinical trials yet. However, quite some studies have shown to restore 
auditory function in animals by AAV-mediated gene transfer (Ahmed et al., 2017; Al-Moyed et al., 
2019; Askew et al., 2015; Landegger et al., 2017; Pan et al., 2017). In addition to naturally 
occurring AAVs, novel AAVs have been engineered recently in order to enhance their potential to 
transduce neural tissue. Both by targeted evolution (Deverman et al., 2016) and by in silico 
reconstruction (Chan et al., 2017; Zinn et al., 2015), transduction efficiency for various tissues, 
including hair cells and SGNs, could be greatly increased. 
 
Administration route:  
Several methods have been developed to optogenetically transduce the auditory nerve of 
different rodent species (Hernandez et al., 2014; Keppeler et al., 2018; Mager et al., 2018; Wrobel 
et al., 2018). In general, robust expression of optogenetic tools across all cochlear turns is desired 
for efficient optical coding, since oABR amplitudes have been shown to positively correlate with 
the amount of opsin expressing SGNs in the cochlea (Duarte et al., 2018; Hernandez et al., 2014; 
Wrobel et al., 2018). Furthermore, the method of virus administration should be minimally 
invasive and as atraumatic as possible. In this thesis, virus suspension has directly been injected 
into the modiolus, which houses the spiral ganglion, via a posterior tympanotomy (Wrobel et al., 
2018). While this method of transduction resulted in homogeneous expression of opsins across 
the whole cochlea, the transduction efficiency was relatively low (~30%). Furthermore, only half 
of the injected animals were expressing the opsin, and SGN density was decreased by ~25% across 
all cochlear turns, probably due to the pressure injection (since SGN reduction has also been 
observed in PBS-injected animals). In contrast, early postnatal injections of viral suspension into 
the cochlea of mice transduced 60-90% of SGNs, which were evenly distributed along the cochlear 
axis (Duarte et al., 2018; Keppeler et al., 2018; Mager et al., 2018). However, cochleae of early 
postnatal mice are weakly ossified, and the immune system of these animals not yet fully 
developed (Kraus and Aulbach-Kraus, 1981). In contrast, the human cochlea is highly ossified and 
almost fully developed at birth (Haith, 1986), raising the need for an efficient administration 
 Discussion 
 
167 
strategy tailored to the human inner ear. Future studies should thus include the development of 
an atraumatic method for reliable and efficient virus delivery to the auditory nerve in man. 
 
 
Evaluating the biosafety of cochlear optogenetics 
 
Specificity of opsin expression:  
While the expression of optogenetic tools should be robust and efficient in the auditory nerve, 
opsin expression in off-target tissues beyond the inner ear should be excluded. Upon early 
postnatal virus injections into the mouse cochlea, substantial opsin expression has also been 
reported in the contralateral, non-injected ear (Keppeler et al., 2018; Mager et al., 2018). Most 
likely, viral particles reached the contralateral ear via the temporal bone marrow space or via the 
cochlear ducts, since the cochlea of early postnatal mice is not yet ossified(Kho et al., 2000). In 
contrast, opsin expression upon intramodiolar injections of virus suspension directly into the 
spiral ganglion of mature gerbils, as performed in this thesis, was restricted to SGNs in the 
injected ear (Wrobel et al., 2018). This raises hope that local virus application in the human 
cochlea will largely contribute to specific transduction, since the human inner ear is almost fully 
developed at birth (Haith, 1986). In addition to local virus administration, also the implementation 
of SGN-specific promoters will contribute to the specificity of opsin expression. Even though 
specific SGN promoters are not yet known, molecular profiling of SGNs is ongoing, and the results 
of these studies will likely enable the identification of adequate promoters to target the auditory 
nerve in future studies (Shrestha et al., 2018; Sun et al., 2018).  
 
Immune reactions:  
Before virally transducing a neural system and expressing alien proteins over extended periods of 
time in man, possible immune reactions of the host system should be carefully evaluated. 
Unfortunately, long-term studies of virus-mediated opsin-expression are relatively limited, since 
the application of optogenetic tools in neuroscience is a relatively novel method. Regarding the 
auditory system, two studies have reported the absence of cytotoxic effect in opsin-expressing 
tissue: While expression of f-Chrimson in the auditory nerve did not cause obvious cell loss over 
nine months (Mager et al., 2018), no cytotoxic effects have been identified in auditory brainstem 
neurons expressing ChR2 and halorhodopsin even for up to 18 months (Shimano et al., 2013). 
Additional studies, performed in the retina, reported the absence of cytotoxic effects in rodents 
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up to one year after virus application (Bi et al., 2006; Busskamp et al., 2010; Doroudchi et al., 
2011). In contrast, two studies have reported opsin aggregates due to overexpression, 
highlighting the importance to carefully evaluate any given construct for optogenetic transduction 
in preclinical studies, before considering its application in humans (Diester et al., 2011; Gradinaru 
et al., 2008). Besides harmful effects of the opsin itself, also possible immune responses against 
the viral vector must be taken into consideration. After retinal AAV-injections to cure vision loss 
with the FDA-approved gene therapy Luxturna, no virus-related harmful effects were observed 
except a mild and transient inflammatory response (Bennett et al., 2012; Simonelli et al., 2010). 
However, neutralizing antibodies, which might be present in the host organism, might hinder 
successful viral transduction of the target tissue. Antibodies might on the one hand result from 
natural AAV exposure before the gene therapy, and thus exclude some patients from the therapy 
(Hudry and Vandenberghe, 2019; Mendoza et al., 2017). On the other hand, neutralizing 
antibodies might be produced by the patient upon first administration of the virus, and 
consequently affect a second virus injection if needed (Hudry and Vandenberghe, 2019; Mendoza 
et al., 2017). Luckily, strategies to combat neutralizing antibodies are currently developed and 
include shielding of viral capsids, engineered capsids with reduced sensitivity to antibodies, or the 
use of empty capsids that bind neutralizing antibodies (Lotfinia et al., 2019; Mingozzi and High, 
2013). Furthermore, local virus application might avoid global immune responses, since the 
cochlea is considered immune privileged due to the blood-labyrinth barrier. Taken together, 
currently available data of longitudinal studies in animals and humans raise the hope for AAV-
based optogenetic transduction without severe damage to the target tissue. This is also 
highlighted by the fact that two clinical trials (NCT02556736 and NCT03326336) for optogenetic-
mediated vision restoration have recently been approved by the FDA. However, two preclinical 
studies on non-human primates (Hinderer et al., 2018; Hordeaux et al., 2018) and piglets 
(Hinderer et al., 2018) have reported adverse effects upon systemic application at high dosages. 
Consequently, careful evaluation of gene therapy safety for optogenetic hearing restoration – 
including virus, gene dosage, administration route, promoter, opsins, and potential trafficking 
signals – are inevitable before considering human application. These studies should include non-
human primates, since their immune system is more similar to humans than the immune system 
of rodents, which have so far been used to develop cochlear optogenetics. 
 
Phototoxicity:  
Another important aspect to evaluate before translating cochlear optogenetics is the cellular 
response to chronic illumination of neural tissue, since light interatcts with cells in various ways. 
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Illumination over extended periods of time might have phototoxic effects, especially when using 
blue light, or lead to heating and changes in neural properties, such as long-term potentiation 
(Delbeke et al., 2017; Senova et al., 2017; Zhang and Oertner, 2007). So far, longitudinal data is 
not available for chronic illumination of neurons expression optogenetic tools. However, few 
studies have evaluated adverse light-induced effects, and irradiances up to 75 mW/mm² are 
generally considered to be safe for in vivo application of optogenetics (Cardin et al., 2010). One 
study used irradiances up to 600 mW/mm², and even though mild tissue heating (0.1°C with blue 
light, 0.3°C with red light) has been observed upon illumination at 200 mW/mm², neither 
phototoxic effects nor apoptosis or even cell loss have been observed upon illumination with up 
to 600 mW/mm² (Senova et al., 2017). Even though the safety limits of chronic SGN illumination 
must still be defined, they will strongly depend on the action spectrum of the opsin of choice. 
Safety limits defined for the retina (European commission directive 2006/25/EC, and International 
Commission on Nonionizing Radiation Protection) are three orders of magnitude lower for blue 
light as for orange light, since blue light has a higher potential of phototoxicity – which is probably 
also true for cells in the inner ear (Duebel et al., 2015; Sengupta et al., 2016). Thus, a red-shifted 
action spectrum of opsins for hearing restoration is desirable, since it would increase the safety 
for patients substantially.  
 
 
Remaining technological developments 
 
Medical device:  
Even though first optical cochlear implants have been developed in the previous years, the need 
for optimization still remains (Balster et al., 2014; Goßler et al., 2014; Klein et al., 2018; 
Schwaerzle et al., 2016; Xu et al., 2018): To take maximal advantage of the improved spectral 
selectivity of optical sound encoding, the number of independent light sources of a future oCI 
needs to substantially surpass the number of channels employed by eCIs. State of the art eCIs 
house between 12-24 electrodes, of which typically less than ten are independent (i.e. are 
actually available for sound encoding by the coding strategy and processor)(Friesen et al., 2001). 
As the frequency resolution of optical sound encoding has been estimated to be at least two-fold 
higher than the resolution of electrical sound encoding (which might even be an 
underestimation), oCIs should contain double as much stimulation sites at a minimum, ideally 
even more, which would be in the range of 50 to more than 100 light sources (Dieter et al., 2019). 
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Even though one of the recently engineered oCIs fits these requirements, functionality and long-
term stability of this implant in chronic experiments need to be demonstrated (Klein et al., 2018). 
Regarding implant stability, encapsulation of the oCI will be of critical importance, since this 
barrier protects both the inner ear and the optoelectronic device. By physically separating the 
light source from biological fluids and tissue, the barrier provided by the encapsulation avoids 
leakage of alien molecules from the optoelectronic implant. Conversely, optoelectronics of the 
implant are protected from intracochlear fluids, which might lead to emitter damage or 
shortcutting of the current supply. Hermetically sealed light sources in a passive oCI easily meet 
the stability requirements, since the light sources are heavily protected and might even be 
exchanged in case of failure. However, properly encapsulated active optoelectronics in the 
cochlea might also be feasible, since the life expectancy of state of the art LEDs is reported to be 
as high as 11 years, which, when driven with a lower duty cycle, promise optical auditory nerve 
stimulation over decades (Laubsch et al., 2010). In any case, the long-term stability of eCIs, which 
typically is stable over several decades, is a tough benchmark for future oCIs to meet. To 
guarantee more safety to the patient and maximize the possibilities of successful hearing 
restoration, hybrid implants could be employed for first clinical trials. Combining optical emitters 
with electrode contacts in one implant, the CI would offer increased coding capabilities due to 
optical sound encoding, but still provide the possibility of conventional electric stimulation as a 
backup. Should optical sound encoding fail, state of the art electrical sound encoding would still 
be possible.  
 
Coding strategy:  
Besides gene therapy and innovative multi-channel stimulators, hearing restoration by 
optogenetics also requires a tailor-made strategy for optical sound encoding. This strategy 
depends both on the channel kinetics of the implemented opsin, and on the number of light 
emitters on the oCI. Optical sound encoding will take advantage of the increased number of 
stimulation channels, which will independently deliver pulses of varying energy and repetition 
rate. The strength of neural responses increases with increasing optical energy which will thus be 
implemented for the coding of sound intensity (Dieter et al., 2019). Both illumination intensity 
and pulse duration determine the energy of a pulse, and hence the coding strategy must balance 
intensity and pulse duration in a way that avoids phototoxic effects at high intensities but also 
enables sufficiently short pulse durations to facilitate stimulation at high repetition rates. Based 
on experimental data, pulse durations between 0.1-1  ms seem reasonable, since no activity could 
be evoked with shorter pulses, and oABR amplitudes decreased for pulses longer than 1 ms 
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(probably due to channel inactivation) (Keppeler et al., 2018; Mager et al., 2018; Wrobel et al., 
2018). However, by taking advantage of temporal integration of photocurrents, it might be 
possible to compose stimulation from pulses below 100 µs if stimulation rates are sufficiently 
high. This might have the advantage to avoid channel interaction, as inspired by the continuous 
interleaved sampling strategy employed in modern eCI coding (Wilson et al., 1991). In contrast to 
the increased amount of independent stimulation channels, stimulation rates of optogenetic 
sound encoding will most likely be lower than for electrical sound encoding.  Current eCIs employ 
stimulation rates reaching from few hundred up to 3,000 Hz (Zeng et al., 2008). This is due to the 
fact that spike jitter in response to electrical stimulation is very low, and overly synchronized 
activation of large SGN populations seems to reduce speech understanding (Rubinstein, 2004). 
Increasing the stimulation rates beyond the maximum firing rate of auditory neurons induces 
jitter to neural responses (Litvak et al., 2003), which improves the coding of temporal fine 
structure, dynamic range, and inter-aural time differences in bilaterally implanted patients 
(Goupell et al., 2009; Hong et al., 2003; Rubinstein, 2004). As opposed to electrical stimulation, for 
which the jitter of auditory nerve firing is as low as 10-30 µs (van den Honert and Stypulkowski, 
1984), opsin-dependent spike jitter in the range of 200-300 µs has been reported for optogenetic 
SGN activation (Hernandez et al., 2014; Keppeler et al., 2018; Mager et al., 2018; Wrobel et al., 
2018). Because of this larger jitter, lower stimulation rates already de-synchronize the auditory 
nerve sufficiently in response to optical stimulation, and hence allow for decreasing stimulation 
rates. Furthermore, studies have shown that the enormous increase in stimulation rates in eCIs 
does not substantially improve speech recognition, and vocoded noise stimuli which were 
modulated with the envelope of human speech signals did not increase word recognition when 
modulated with frequencies higher than few hundred Hz (Shannon et al., 1995, 2011). Thus, 
optical sound encoding with stimulation rates of few hundreds of Hz should be sufficient to 
intelligibly encode human speech. Nevertheless, the development of a coding strategy for oCIs 
will largely depend on the final choice of opsin and stimulator design.  
 
Translation to non-human primates: 
Hearing restoration by optogenetic cochlear implants combines gene therapy in the auditory 
nerve with the implantation of multi-channel optical stimulators and real-time sound processors 
with a coding strategy optimized for opsin kinetics and channel number of future molecular tools 
and implantable devices. Before clinical translation, these different approaches should be 
integrated and thoroughly tested in non-human primates. Regarding anatomy, physiology, and 
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behavior, non-human primates are much more similar to humans than mice are, and thus provide 
a valuable model for preclinical studies of biomedical developments (Ahmed et al., 2017; 
Sengupta et al., 2016). In these studies, efficiency and safety of viral vectors and molecular tools 
should be demonstrated, and the insights from rodent work should be corroborated. 
Furthermore, functionality and long-term stability of multi-channel oCIs must be demonstrated. 
The efficiency of optical sound encoding via multi-channel implants driven by sound processors 
with a tailor-made coding strategy must be benchmarked against state of the art electrical sound 
encoding. A suitable model for non-human primate studies would be the common marmoset: 
Marmosets have a rich vocal repertoire, a comparable hearing range to humans, and a similar 
cortex structure. Due to these aspects, marmosets received increasing attention as a model in 
auditory neuroscience (Eliades and Miller, 2017), and more recently became an important model 
for cochlear implant research (Johnson et al., 2016). Furthermore, marmosets can be trained in 
complex behavioral tasks on stimulus detection and discrimination, both using acoustic 
(Remington et al., 2012) and electrical sound encoding (Johnson et al., 2016). A comparison of 
behaviorally relevant artificial sound encoding by electrical and optical CIs in marmosets would 
thus depict the ideal model for preclinical benchmarking of oCI technology. These experiments 
should subsequently be complemented by post-mortem studies, which screen for unwanted side 
effects of optogenetic gene therapy such as opsin expression beyond the target tissues, cytotoxic 
or phototoxic effects and local as well as global immune reactions, in order to guarantee the 
highest level of safety for clinical translation. Inspired by the development of optogenetics for 
vision restoration, longitudinal studies in non-human primates could be complemented by 
experiments involving human tissue or even inner ear organoids, to optimally prepare the way for 
clinical translation of cochlear optogenetics (Garita-Hernandez et al., 2018; Koehler et al., 2017; 
Landegger et al., 2017; Sengupta et al., 2016). 
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5.3 Cochlear optogenetics as a tool for auditory neuroscience 
 
Besides promising improved capabilities of artificial sound encoding for hearing restoration, 
cochlear optogenetics will help to innovatively address open questions in the field of auditory 
neuroscience. Acoustic sound encoding by the organ of Corti is inherently entangled with the 
micromechanics of the cochlea: For example, the amplitude of the cochlear traveling wave, which 
is thought to mainly encode sound intensity, to some degree determines the location at which the 
travelling wave maximally deflects the basilar membrane, resulting in an intensity-dependent 
tonotopic shift (Johnstone et al., 1986). Hence, the place-frequency code of the cochlea to some 
degree depends on sound intensity, both on a physiological  and on a psychophysical level (Tao et 
al., 2017). The travelling wave also deflects the basilar membrane surrounding the region of 
maximum deflection in a stimulus-level dependent manner, and furthermore it resonates for 
some time after stimulus-off (especially after short, transient stimuli, such as acoustic clicks), 
limiting the precision of acoustic hair cell activation both in space and in time (Chatterjee and 
Zwislocki, 1998; Johnstone and Boyle, 1967; Zhang et al., 2018a). In addition, the pitch of low 
frequency sounds is not only coded by tonotopic activation of the auditory nerve, but also by the 
timing of action potentials (Joris and Smith, 2008). This temporal code for sound frequency is 
inseparable from the place-frequency code that frequency coding mainly relies on. In contrast to 
acoustic stimulation, spatially confined optical stimulation would enable activation of SGNs along 
the tonotopic axis with high spectral (and potentially intensity) selectivity, while bypassing the 
implications of cochlear micromechanics. Optogenetic SGN activation would thus allow for 
stimulation of the auditory nerve with arbitrary stimulation patterns, de-coupling spectral, 
temporal and intensity information of the stimulus. These degrees of freedom in stimulus design 
by optogenetics would offer the possibility to address unanswered questions in auditory research 
that were previously limited by cochlear micromechanics: For example, it has been shown that 
the pitch of a fundamental frequency in a harmonic complex is perceived both by animals 
(Heffner and Whitfield, 1976; Tomlinson and Schwarz, 1988) and by humans (Fujioka et al., 2003) 
even if this fundamental frequency has been removed from the original sound (Wang and Walker, 
2012). However, it is not known if the neural correlate of missing fundamental perception 
originates in the cochlea, or rather emerges during central auditory processing. Also, studies on 
the origin of spectrotemporal integration of periodic sounds, such as amplitude-modulated pure 
tones, have been limited by the inherent connection of spectral and temporal properties of 
acoustic stimuli (Wang and Walker, 2012). Optogenetic stimulation of the auditory nerve with 
high spectro-temporal precision might provide insight in these processes, which are thought to 
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contribute to the perception and segregation of auditory objects and scene analysis. Besides 
investigating the processing mechanisms of complex sounds, cochlear optogenetics might also 
contribute to further decipher the role of SGN subtypes in auditory coding: type I SGNs, which 
pass information from inner hair cells to the auditory brainstem, have been categorized into three 
physiologically distinct subtypes, based on their thresholds and firing properties (Kiang et al., 
1965; Liberman, 1978). More recently, molecular correlates of these subtypes have been 
described (Shrestha et al., 2018). Implementation of subtype-specific promoters and selective 
expression of opsins in these subtypes would enable independent activation of SGN populations 
with different properties and most likely function, and could contribute to a deeper 
understanding of sound encoding. Thus, besides promising improved capabilities for hearing 
restoration, cochlear optogenetics would also provide an innovative tool for investigating auditory 
function.  
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AI   primary auditory cortex 
aABR   acoustically evoked auditory brainstem response 
AAV   adeno-associated virus 
ABR   auditory brainstem response 
ANF   auditory nerve fiber 
ANOVA   analysis of variance 
BE   best electrode 
BF   best frequency 
CatCh   calcium translocating channelrhodopsin 
CF   characteristic frequency 
ChR   channelrhodopsin 
ChR2   channelrhodopsin-2 
CI   cochlear implant 
d’   d-prime, sensitivity-index 
dB   decibel 
dB SPL   decibel sound pressure level 
DR   dynamic range 
eABR   electrically evoked auditory brainstem response 
eCI   electrical cochlear implant 
eGFP   enhanced green fluorescent protein 
EDTA    ethylenediaminetetraacetic acid 
ES   export signal 
eYFP   enhanced yellow fluorescent protein 
FDA   food and drug administration 
GaN   gallium nitride 
GC   genome copies 
HEK   human embryonic kidney (cell) 
HI   hearing impairment 
IC   inferior colliculus 
ICC    central nucleus of the inferior colliculus 
hSyn   human synapsin 
Kir   inward-rectifying potassium channel 
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LED   light-emitting diode 
MUA   multi-unit activity 
µLED   microscale light-emitting diode 
NA   numerical aperture 
PBS   phosphate buffered saline 
PFA   paraformaldehyde 
PSTH   peri-stimulus time histogram 
SD   standard deviation 
SEM   standard error of the mean 
SGN   spiral ganglion neuron 
SNHL   sensorineural hearing loss 
SPL   sound pressure level 
STC   spatial tuning curve 
Thy1   thymocyte differentiation antigen 1 
TS   trafficking signal 
oABR   optically evoked auditory brainstem response 
oCI   optogenetic cochlear implant 
RW   round window 
VS   vector strength 
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